Miscellaneous ePI Test
0.1.0 - CI Build
Miscellaneous ePI Test
0.1.0 - CI Build
Miscellaneous ePI Test, published by . This guide is not an authorized publication; it is the continuous build for version 0.1.0 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/cander2/epi-test/ and changes regularly. See the Directory of published versions
<Bundle xmlns="http://hl7.org/fhir">
<id value="bundlepackageleaflet-talzenna01-025-1"/>
<meta>
<versionId value="1"/>
<lastUpdated value="2022-03-01T00:00:00Z"/>
<profile
value="http://hl7.org/fhir/uv/emedicinal-product-info/StructureDefinition/Bundle-uv-epi"/>
</meta>
<language value="en"/>
<identifier>
<system value="https://www.mhra.gov.uk/"/>
<value value="talzenna"/>
</identifier>
<type value="document"/>
<timestamp value="2022-03-01T00:00:00Z"/>
<entry>
<fullUrl value="Composition/compositionuken"/>
<resource>
<Composition>
<id value="compositionuken"/>
<meta>
<profile
value="http://hl7.org/fhir/uv/emedicinal-product-info/StructureDefinition/Composition-uv-epi"/>
</meta>
<language value="en"/>
<text>
<status value="generated"/>
<div xmlns="http://www.w3.org/1999/xhtml" xml:lang="en" lang="en"><a name="Composition_compositionuken"> </a><p><b>Generated Narrative: Composition</b><a name="compositionuken"> </a><a name="hccompositionuken"> </a></p><div style="display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%"><p style="margin-bottom: 0px">Resource Composition "compositionuken" (Language "en") </p><p style="margin-bottom: 0px">Profile: <a href="https://build.fhir.org/ig/HL7/emedicinal-product-info/StructureDefinition-Composition-uv-epi.html">Composition (ePI)</a></p></div><p><b>identifier</b>: <code>https://www.mhra.gov.uk/</code>/0d69fdcb-33cf-407f-8209-a6529856ab4f</p><p><b>status</b>: final</p><p><b>type</b>: Package Leaflet <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (#100000155538)</span></p><p><b>date</b>: 2022-03-01 00:00:00+0000</p><p><b>author</b>: See on this page: Organization/orgpfizerukltd</p><p><b>title</b>: Talzenna® (talazoparib) 0.1 mg, 0.25 mg and 1 mg hard capsules</p></div>
</text>
<identifier>
<system value="https://www.mhra.gov.uk/"/>
<value value="0d69fdcb-33cf-407f-8209-a6529856ab4f"/>
</identifier>
<status value="final"/>
<type>
<coding>
<system value="https://www.mhra.gov.uk/"/>
<code value="100000155538"/>
</coding>
<text value="Package Leaflet"/>
</type>
<subject>
<reference value="MedicinalProductDefinition/mp01mg"/>
</subject>
<subject>
<reference value="MedicinalProductDefinition/mp1mg"/>
</subject>
<subject>
<reference value="MedicinalProductDefinition/mp025mg"/>
</subject>
<date value="2022-03-01T00:00:00Z"/>
<author>
<reference value="Organization/orgpfizerukltd"/>
</author>
<title
value="Talzenna® (talazoparib) 0.1 mg, 0.25 mg and 1 mg hard capsules"/>
<section>
<title value="Package leaflet: Information for the patient"/>
<code>
<coding>
<system value="https://www.mhra.gov.uk/"/>
<code value="200000029894"/>
</coding>
<text value="Package leaflet: Information for the patient"/>
</code>
<text>
<status value="additional"/>
<div xmlns="http://www.w3.org/1999/xhtml">
<p style="text-align: center;" class="mg-01">
<b>Talzenna<sup>®</sup> 0.1 mg hard capsules</b>
</p>
<p style="text-align: center;" class="mg-025">
<b>Talzenna<sup>®</sup> 0.25 mg hard capsules</b>
</p>
<p style="text-align: center;" class="mg-1">
<b>Talzenna<sup>®</sup> 1 mg hard capsules</b>
</p>
<p style="text-align: center;">talazoparib</p>
<p>▼ This medicine is subject to additional monitoring. This will allow quick
identification of new safety information. You can help by reporting any side effects
you may get. See the end of section 4 for how to report side effects.</p>
<p>
<b>Read all of this leaflet carefully before you start taking this medicine because
it contains important information for you.</b>
</p>
<ul>
<li>Keep this leaflet. You may need to read it again.</li>
<li>If you have any further questions, ask your doctor, pharmacist or nurse.</li>
<li>This medicine has been prescribed for you only. Do not pass it on to others. It
may harm them, even if their signs of illness are the same as yours.</li>
<li>If you get any side effects, talk to your doctor, pharmacist or nurse. This
includes any possible side effects not listed in this leaflet. See <a href="#7a996bcf-6f26-4e0e-ba8b-cb1c23c286b8">section 4</a>.</li>
</ul>
</div>
</text>
<section>
<title value="What is in this leaflet"/>
<code>
<coding>
<system value="https://www.mhra.gov.uk/"/>
<code value="100000155538"/>
</coding>
<text value="What is in this leaflet"/>
</code>
<text>
<status value="additional"/>
<div xmlns="http://www.w3.org/1999/xhtml">
<ol>
<li><a href="#5a34d358-e830-4308-8d86-cb1dc8b1ee8c">What Talzenna is and what it is used for</a></li>
<li><a href="#a2f089b4-fef4-497e-81bd-251cd9c7571f">What you need to know before you take Talzenna</a></li>
<li><a href="#958ed385-b409-41d8-a868-fa5ec1fbaba4">How to take Talzenna</a></li>
<li><a href="#7a996bcf-6f26-4e0e-ba8b-cb1c23c286b8">Possible side effects</a></li>
<li><a href="#eb80ccf5-f971-4361-b25c-b8d86c457a00">How to store Talzenna</a></li>
<li><a href="#2531776f-f478-40bc-a19d-6970524b8793">Contents of the pack and other information</a></li>
</ol>
</div>
</text>
</section>
</section>
<section id="5a34d358-e830-4308-8d86-cb1dc8b1ee8c">
<title value="1. What Talzenna is and what it is used for"/>
<code>
<coding>
<system value="https://www.mhra.gov.uk/"/>
<code value="200000029895"/>
</coding>
<text value="1. What X is and what it is used for"/>
</code>
<text>
<status value="additional"/>
<div xmlns="http://www.w3.org/1999/xhtml">
<p>
<b>What Talzenna is and how it works</b>
</p>
<p>Talzenna contains the active substance talazoparib. It is a type of anticancer
medicine known as a ‘PARP (poly-ADP ribose polymerase) inhibitor’.</p>
<p>Talzenna works by blocking PARP, which is an enzyme that
repairs damaged DNA in certain cancer cells. As a result, the cancer cells can no
longer repair themselves and they die.</p>
<p>
<b>What Talzenna is used for</b>
</p>
<p>Talzenna is a medicine used </p>
<ul>
<li><p class="breastCancer">alone to treat adults with breast cancer of a type
known as HER2-negative breast cancer who have an abnormal inherited BRCA gene. Your healthcare provider will perform a test to make sure that Talzenna is right for you. </p></li>
<li><p class="prostateCancer">in combination with a medicine called enzalutamide, to treat adults with prostate cancer who no longer respond to a hormone therapy or surgical treatment to lower testosterone.</p> </li>
</ul>
<p>Talzenna is used when the cancer has spread beyond the original tumour or to other
parts of the body.</p>
<p>If you have any questions about how Talzenna works or why this medicine has been
prescribed for you, ask your doctor.</p>
</div>
</text>
</section>
<section id="a2f089b4-fef4-497e-81bd-251cd9c7571f">
<title value="2. What you need to know before you take Talzenna"/>
<code>
<coding>
<system value="https://www.mhra.gov.uk/"/>
<code value="200000029896"/>
</coding>
<text value="2. What you need to know before you take X"/>
</code>
<section>
<title value="Do not take Talzenna"/>
<code>
<coding>
<system value="https://www.mhra.gov.uk/"/>
<code value="200000029897"/>
</coding>
<text
value="Do not &lt;take&gt;; &lt;use&gt; X"/>
</code>
<text>
<status value="additional"/>
<div xmlns="http://www.w3.org/1999/xhtml">
<ul>
<li class="allergen">
<p>If you are allergic to talazoparib or any of the other ingredients of this
medicine (listed in section 6).</p>
</li>
<li class="breastFeeding">
<p>If you are breast-feeding.</p>
</li>
</ul>
</div>
</text>
</section>
<section>
<title value="Warnings and precautions"/>
<code>
<coding>
<system value="https://www.mhra.gov.uk/"/>
<code value="200000029898"/>
</coding>
<text value="Warnings and precautions"/>
</code>
<text>
<status value="additional"/>
<div xmlns="http://www.w3.org/1999/xhtml">
<p>Talk to your doctor, pharmacist or nurse before taking Talzenna and during your
treatment if you experience signs or symptoms described in this section.</p>
<p>
<u>Low blood cell counts</u>
</p>
<p>Talzenna lowers your blood cell counts, such as your red blood cell count
(anaemia), white blood cell count (neutropenia), or blood platelet count
(thrombocytopenia). Signs and symptoms you need to look out for include:</p>
<ul>
<li>
<p><b>Anaemia: </b>Being short of breath, feeling very tired, pale skin, or fast
heartbeat – these may be signs of a low red blood cell count</p>
</li>
<li>
<p><b>Neutropenia: </b>Infection, developing chills or shivering, or fever –
these may be signs of a low white blood cell count</p>
</li>
<li>
<p><b>Thrombocytopenia: </b>Bruising or bleeding for longer than usual if you
hurt yourself – these may be signs of a low blood platelet count</p>
</li>
</ul>
<p>You will have regular blood tests during treatment with Talzenna to check your
blood cells (white blood cells, red blood cells, and platelets).</p>
<p>
<u>Serious problems with the bone marrow</u>
</p>
<p>Rarely, low blood cell counts may be a sign of more serious problems with the
bone marrow such as myelodysplastic syndrome (MDS) or acute myeloid leukaemia
(AML). Your doctor may want to test your bone marrow to check for these problems.</p>
<p><u>Blood clots</u></p>
<p>Talzenna may cause blood clots in the veins. Tell your doctor, pharmacist or nurse if you experience signs or symptoms of blood clots in the veins such as pain or stiffness, swelling and redness in the affected leg (or arm), chest pain, shortness of breath or lightheadedness.</p>
<p>
<u>Male and female contraception</u>
</p>
<p class="Adolescent Adult Elderly">Women who can become pregnant and men with
partners who are or can become pregnant should use effective contraception.</p>
<p class="Adolescent Adult Elderly">Please see section <a href="#698cd895-3954-4de6-80f1-f65fcc40288f">“Male and female
contraception”</a> below.</p>
</div>
</text>
</section>
<section>
<title value="Children and adolescents"/>
<code>
<coding>
<system value="https://www.mhra.gov.uk/"/>
<code value="200000029899"/>
</coding>
<text value="Children and adolescents"/>
</code>
<text>
<status value="additional"/>
<div xmlns="http://www.w3.org/1999/xhtml" class="Under18">
<p>Talzenna is not to be used in children or adolescents (under 18 years of age).</p>
</div>
</text>
</section>
<section>
<title value="Other medicines and Talzenna"/>
<code>
<coding>
<system value="https://www.mhra.gov.uk/"/>
<code value="200000029900"/>
</coding>
<text value="Other medicines and Talzenna"/>
</code>
<text>
<status value="additional"/>
<div xmlns="http://www.w3.org/1999/xhtml">
<p>Tell your doctor, pharmacist or nurse if you are taking, have recently taken or
might take any other medicines. This includes medicines obtained without a
prescription and herbal medicines. This is because Talzenna can affect the way
some other medicines work. Also some medicines can affect the way Talzenna works.</p>
<p class="Amiodarone carvedilol dronedarone propafenone quinidine ranolazine verapamil Clarithromycin erythromycin Itraconazole ketoconazole Cobicistat darunavir indinavir lopinavir ritonavir saquinavir telaprevir tipranavir Ciclosporin Curcumin turmericRoot">In
particular, the following may increase the risk of side effects with Talzenna:</p>
<ul>
<li class="Amiodarone carvedilol dronedarone propafenone quinidine ranolazine verapamil">
<p>Amiodarone, carvedilol, dronedarone, propafenone, quinidine, ranolazine and
verapamil – generally used to treat heart problems.</p>
</li>
<li class="Clarithromycin erythromycin">
<p>Clarithromycin and erythromycin antibiotics – used to treat bacterial
infections.</p>
</li>
<li class="Itraconazole ketoconazole">
<p>Itraconazole and ketoconazole – used to treat fungal infections.</p>
</li>
<li class="Cobicistat darunavir indinavir lopinavir ritonavir saquinavir telaprevir tipranavir">
<p>Cobicistat, darunavir, indinavir, lopinavir, ritonavir, saquinavir,
telaprevir and tipranavir used to treat HIV infections/AIDS.</p>
</li>
<li class="Ciclosporin">
<p>Ciclosporin – used in organ transplantation to prevent rejection.</p>
</li>
<li class="Lapatinib">
<p>Lapatinib – used to treat patients with certain types of breast cancer.</p>
</li>
<li class="Curcumin turmericRoot">
<p>Curcumin (e.g. found in turmeric root) in some medicines (see also section
Talzenna with food and drink below).</p>
</li>
</ul>
<p class="Carbamazepine phenytoin StJohnsWort">The following medicines may reduce
the effect of Talzenna:</p>
<ul>
<li class="Carbamazepine phenytoin">
<p>Carbamazepine and phenytoin – anti-epileptics used to treat seizures or fits.</p>
</li>
<li class="StJohnsWort">
<p>St. John’s wort (<i>Hypericum perforatum</i>) – a herbal remedy used to treat
mild depression and anxiety.</p>
</li>
</ul>
</div>
</text>
</section>
<section>
<title value="Talzenna with food and drink"/>
<code>
<coding>
<system value="https://www.mhra.gov.uk/"/>
<code value="200000029901"/>
</coding>
<text
value="X with &lt;food&gt; &lt;and&gt; &lt;,&gt; &lt;drink&gt; &lt;and&gt; &lt;alcohol&gt;"/>
</code>
<text>
<status value="additional"/>
<div xmlns="http://www.w3.org/1999/xhtml">
<p>Do not use curcumin in food supplements while you are taking Talzenna as it may
increase Talzenna’s side effects. Curcumin is found in turmeric root and you
should not use large amounts of turmeric root, but using spices in food is not
likely to cause a problem.</p>
</div>
</text>
</section>
<section>
<title value="Pregnancy"/>
<code>
<coding>
<system value="https://www.mhra.gov.uk/"/>
<code value="200000029902"/>
</coding>
<text
value="Pregnancy &lt;and&gt; &lt;,&gt; breast-feeding &lt;and fertility&gt;"/>
</code>
<text>
<status value="additional"/>
<div xmlns="http://www.w3.org/1999/xhtml">
<p>Talzenna could harm an unborn baby. <span class="Female">If you are pregnant or
breast-feeding, think you may be pregnant or are planning to have a baby, ask your
doctor or pharmacist for advice before taking this medicine. Your doctor will
perform a pregnancy test prior to starting Talzenna.</span></p>
<ul>
<li class="Pregnant">
<p>You should not use Talzenna if you are pregnant.</p>
</li>
<li class="Female">
<p>You should not become pregnant while taking Talzenna.</p>
</li>
<li>
<p>Discuss contraception with your doctor if there is any possibility that you
or your partner may become pregnant.</p>
</li>
</ul>
<p id="698cd895-3954-4de6-80f1-f65fcc40288f">
<b>Male and female contraception</b>
</p>
<p class="Female"><b>Women </b>who are able to become pregnant should use effective
birth control (contraception) during treatment with Talzenna and for at least 7
months after the last dose of Talzenna. Since the use of hormonal contraception is
not recommended if you have breast cancer, you should use two non-hormonal
contraception methods.</p>
<p class="Female">Talk to your healthcare provider about birth control methods that
may be right for you.</p>
<p class="Male"><b>Men </b>with female partners who are pregnant or able to become
pregnant should use effective birth control (contraception), even after a
vasectomy, during treatment with Talzenna and for at least 4 months after the last
dose.</p>
</div>
</text>
</section>
<section>
<title value="Breast-feeding"/>
<code>
<coding>
<system value="https://www.mhra.gov.uk/"/>
<code value="200000029902"/>
</coding>
<text value="Breast-feeding"/>
</code>
<text>
<status value="additional"/>
<div xmlns="http://www.w3.org/1999/xhtml">
<p class="breastFeeding">You should not breast-feed while taking Talzenna and for at
least 1 month after the last dose. It is not known if Talzenna passes into breast
milk.</p>
</div>
</text>
</section>
<section>
<title value="Fertility"/>
<code>
<coding>
<system value="https://www.mhra.gov.uk/"/>
<code value="200000029902"/>
</coding>
<text value="Fertility"/>
</code>
<text>
<status value="additional"/>
<div xmlns="http://www.w3.org/1999/xhtml">
<p class="Male">Talazoparib may reduce fertility in men.</p>
</div>
</text>
</section>
<section>
<title value="Driving and using machines"/>
<code>
<coding>
<system value="https://www.mhra.gov.uk/"/>
<code value="200000029903"/>
</coding>
<text value="Driving and using machines"/>
</code>
<text>
<status value="additional"/>
<div xmlns="http://www.w3.org/1999/xhtml">
<p>Talzenna may have a minor influence on the ability to drive and use machines. If
you feel dizzy, weak, or tired (these are very common side effects of Talzenna),
you should not drive or use machines.</p>
</div>
</text>
</section>
</section>
<section id="958ed385-b409-41d8-a868-fa5ec1fbaba4">
<title value="3. How to take Talzenna"/>
<code>
<coding>
<system value="https://www.mhra.gov.uk/"/>
<code value="200000029905"/>
</coding>
<text
value="3. How to &lt;take&gt; &lt;use&gt; X"/>
</code>
<text>
<status value="additional"/>
<div xmlns="http://www.w3.org/1999/xhtml">
<p>Always take this medicine exactly as your doctor or pharmacist has told you. Check
with your doctor or pharmacist if you are not sure.</p>
<p>
<b>How much to take</b>
</p>
<p>Talzenna is taken by mouth once daily. The recommended dose is:</p>
<ul>
<li><p class="breastCancer">for breast cancer: one 1 mg capsule of Talzenna.</p></li>
<li><p class="prostateCancer">for prostate cancer: Talzenna is taken with a medicine called enzalutamide. The usual dose of Talzenna is 0.5 mg (two 0.25 mg capsules).</p></li>
</ul>
<p> If you get certain side effects while you are taking Talzenna alone or in combination with enzalutamide (see <a href="#7a996bcf-6f26-4e0e-ba8b-cb1c23c286b8">section 4</a>), your doctor may lower your dose or stop treatment, either temporarily or permanently. Take Talzenna and enzalutamide exactly as your doctor has told you. </p>
</div>
</text>
<section>
<title value="If you take more Talzenna than you should"/>
<code>
<coding>
<system value="https://www.mhra.gov.uk/"/>
<code value="200000029907"/>
</coding>
<text
value="If you &lt;take&gt; &lt;use&gt; more X than you should"/>
</code>
<text>
<status value="additional"/>
<div xmlns="http://www.w3.org/1999/xhtml">
<p>If you have taken more Talzenna than your normal dose, contact your doctor or
nearest hospital right away. Urgent treatment may be necessary.</p>
<p>Take the carton and this leaflet so that the doctor knows what you have been
taking.</p>
</div>
</text>
</section>
<section>
<title value="If you forget to take Talzenna"/>
<code>
<coding>
<system value="https://www.mhra.gov.uk/"/>
<code value="200000029908"/>
</coding>
<text
value="If you forget to &lt;take&gt; &lt;use&gt; X"/>
</code>
<text>
<status value="additional"/>
<div xmlns="http://www.w3.org/1999/xhtml">
<p>If you miss a dose or vomit, take your next dose as scheduled. Do not take a
double dose to make up for the forgotten or vomited capsules.</p>
</div>
</text>
</section>
<section>
<title value="If you stop taking Talzenna"/>
<code>
<coding>
<system value="https://www.mhra.gov.uk/"/>
<code value="200000029909"/>
</coding>
<text
value="If you stop &lt;taking&gt; &lt;using&gt; X"/>
</code>
<text>
<status value="additional"/>
<div xmlns="http://www.w3.org/1999/xhtml">
<p>Do not stop taking Talzenna unless your doctor tells you to.</p>
<p>If you have any further questions on the use of this medicine, ask your doctor or
pharmacist or nurse.</p>
</div>
</text>
</section>
</section>
<section id="7a996bcf-6f26-4e0e-ba8b-cb1c23c286b8">
<title value="4. Possible side effects"/>
<code>
<coding>
<system value="https://www.mhra.gov.uk/"/>
<code value="200000029910"/>
</coding>
<text value="4. Possible side effects"/>
</code>
<text>
<status value="additional"/>
<div xmlns="http://www.w3.org/1999/xhtml">
<p>Like all medicines, this medicine can cause side effects, although not everybody
gets them.</p>
<p>
<b>Tell your doctor straight away if you notice any of the following symptoms which
could be a sign of serious blood disorder:</b>
</p>
<p><b>Very common</b> (may affect more than 1 in 10 people)</p>
<ul>
<li>Being short of breath, feeling very tired, having pale skin, or fast heartbeat –
these may be signs of a low red blood cell count (anaemia).</li>
<li>Infection, developing chills or shivering, or fever or feeling hot – these may
be signs of a low white blood cell count (neutropenia).</li>
<li>Bruising or bleeding for longer than usual if you hurt yourself – these may be
signs of a low blood platelet count (thrombocytopenia).</li>
</ul>
<p>
<b>Talk to your doctor if you get any other side effects. These can include:</b>
</p>
<p><b>Very common</b> (may affect more than 1 in 10 people)</p>
<ul>
<li>Low counts of white blood cells, red blood cells, and blood platelets</li>
<li>Decreased appetite</li>
<li>Feeling dizzy</li>
<li>Headache</li>
<li>Feeling sick (nausea)</li>
<li>Being sick (vomiting)</li>
<li>Diarrhoea</li>
<li>Pain in the abdomen</li>
<li>Hair loss</li>
</ul>
<p><b>Common</b> (may affect up to 1 in 10 people)</p>
<ul>
<li>Alteration in taste (dysgeusia)</li>
<li>Painful swollen leg, chest pain, shortness of breath, rapid breathing or rapid heart rate as these can be signs of blood clots in the vein</li>
<li>Indigestion</li>
<li>Mouth inflammation</li>
</ul>
<p><b>Uncommon</b> (may affect up to 1 in 100 people)</p>
<ul>
<li>Abnormal blood cell counts due to serious problems with bone marrow (myelodysplastic syndrome or acute myeloid leukaemia). See Warnings and precautions in <a href="#a2f089b4-fef4-497e-81bd-251cd9c7571f">Section 2</a></li>
</ul>
</div>
</text>
<section>
<title value="Reporting of side effects"/>
<code>
<coding>
<system value="https://www.mhra.gov.uk/"/>
<code value="200000029912"/>
</coding>
<text value="Reporting of side effects"/>
</code>
<text>
<status value="additional"/>
<div xmlns="http://www.w3.org/1999/xhtml">
<p>If you get any side effects, talk to your doctor, pharmacist or nurse. This
includes any possible side effects not listed in this leaflet. You can also report
side effects directly via the Yellow Card Scheme at: <a href="http://www.mhra.gov.uk/yellowcard">www.mhra.gov.uk/yellowcard</a> or
search for MHRA Yellow Card in the Google Play or Apple App Store. By reporting
side effects you can help provide more information on the safety of this medicine.</p>
</div>
</text>
</section>
</section>
<section id="eb80ccf5-f971-4361-b25c-b8d86c457a00">
<title value="5. How to store Talzenna"/>
<code>
<coding>
<system value="https://www.mhra.gov.uk/"/>
<code value="200000029913"/>
</coding>
<text value="5. How to store X"/>
</code>
<text>
<status value="additional"/>
<div xmlns="http://www.w3.org/1999/xhtml">
<p>Keep this medicine out of the sight and reach of children.</p>
<p>Do not use this medicine after the expiry date which is stated on the carton and
the bottle or blister after EXP. The expiry date refers to the last day of that
month.</p>
<p>This medicine does not require any special storage conditions.</p>
<p>Do not use this medicine if the pack is damaged or shows signs of tampering.</p>
<p>Do not throw away any medicines via wastewater or household waste. Ask your
pharmacist how to throw away medicines you no longer use. These measures will help
protect the environment.</p>
</div>
</text>
</section>
<section id="2531776f-f478-40bc-a19d-6970524b8793">
<title value="6. Contents of the pack and other information"/>
<code>
<coding>
<system value="https://www.mhra.gov.uk/"/>
<code value="200000029914"/>
</coding>
<text value="6. Contents of the pack and other information"/>
</code>
<section>
<title value="What Talzenna contains"/>
<code>
<coding>
<system value="https://www.mhra.gov.uk/"/>
<code value="200000029915 "/>
</coding>
<text value="What X contains"/>
</code>
<text>
<status value="additional"/>
<div xmlns="http://www.w3.org/1999/xhtml">
<ul>
<li>
<p>The active substance is talazoparib. Talzenna hard capsules come in different
strengths.</p>
</li>
<li class="mg-01">Talzenna 0.1 mg hard capsules: each capsule contains talazoparib tosylate equivalent to 0.1 mg talazoparib.</li>
<li class="mg-025">
<p>Talzenna 0.25 mg hard capsules: each capsule contains talazoparib tosylate
equivalent to 0.25 mg talazoparib.</p>
</li>
<li class="mg-1">
<p>Talzenna 1 mg hard capsules: each capsule contains talazoparib tosylate
equivalent to 1 mg talazoparib.</p>
</li>
</ul>
<p>The other ingredients are:</p>
<ul>
<li>
<p>Capsule content: silicified microcrystalline cellulose (microcrystalline cellulose and silicone dioxide).</p>
</li>
<li class="mg-01">0.1 mg capsule shell: hypromellose and titanium dioxide (E171).</li>
<li class="mg-025">
<p>0.25 mg capsule shell: hypromellose, yellow iron oxide (E172), and
titanium dioxide (E171)</p>
</li>
<li class="mg-1">
<p>1 mg capsule shell: hypromellose, yellow iron oxide (E172), titanium
dioxide (E171), and red iron oxide (E172)</p>
</li>
</ul>
<p>Printing ink: shellac (E904), propylene glycol (E1520), ammonium hydroxide
(E527), black iron oxide (E172), and potassium hydroxide (E525).</p>
</div>
</text>
</section>
<section>
<title value="What Talzenna looks like and contents of the pack"/>
<code>
<coding>
<system value="https://www.mhra.gov.uk/"/>
<code value="200000029916"/>
</coding>
<text value="What X looks like and contents of the pack"/>
</code>
<text>
<status value="additional"/>
<div xmlns="http://www.w3.org/1999/xhtml">
<p class="mg-01"> Talzenna 0.1 mg is supplied as opaque, approximately 14 mm x 5 mm hard capsule with a white cap (printed with “Pfizer” in black) and a white body (printed with “TLZ 0.1” in black).</p>
<p class="mg-025">Talzenna 0.25 mg is supplied as opaque, approximately 14 mm x
5 mm hard capsule with an ivory cap (printed with “Pfizer” in black) and a
white body (printed with “TLZ 0.25” in black).</p>
<p class="mg-1">Talzenna 1 mg is supplied as opaque, approximately 14 mm x 5
mm hard capsule with a light red cap (printed with “Pfizer” in black) and a white
body (printed with “TLZ 1” in black).</p>
<p class="mg-01">Talzenna 0.1 mg is available in plastic bottles of 30 hard capsules.</p>
<p class="mg-025">Talzenna 0.25 mg is available in perforated unit dose blister
packs of 30, or 60, or 90 hard capsules and in plastic bottles of 30 hard
capsules.</p>
<p class="mg-1">Talzenna 1 mg is available in perforated unit dose blister packs of
30 hard capsules and in plastic bottles of 30 hard capsules.</p>
<p>Not all pack sizes may be marketed.</p>
</div>
</text>
</section>
<section>
<title value="Marketing Authorization Holder and Manufacturer"/>
<code>
<coding>
<system value="https://www.mhra.gov.uk/"/>
<code value="200000029917"/>
</coding>
<text value="Marketing Authorization Holder and Manufacturer"/>
</code>
<text>
<status value="additional"/>
<div xmlns="http://www.w3.org/1999/xhtml">
<p>Pfizer Limited</p>
<p>Ramsgate Road</p>
<p>Sandwich</p>
<p>Kent</p>
<p>CT13 9NJ</p>
<p>United Kingdom</p>
<p>
<b>Manufacturer</b>
</p>
<p>Excella GmbH & Co. KG</p>
<p>Nürnberger Strasse 12</p>
<p>90537 Feucht</p>
<p>Germany</p>
<p>For any information about this medicine, please contact:</p>
<p>Medical Information, Pfizer Ltd, Walton Oaks, Dorking Road, Tadworth, Surrey,
KT20 7NS.</p>
<p>Telephone 01304 616161</p>
<p>
<b>This leaflet was last revised in 12/2021</b>
</p>
</div>
</text>
</section>
</section>
</Composition>
</resource>
</entry>
<entry>
<fullUrl value="Ingredient/talazoparib01mg"/>
<resource>
<Ingredient>
<id value="talazoparib01mg"/>
<meta>
<profile
value="http://hl7.org/fhir/uv/emedicinal-product-info/StructureDefinition/Ingredient-uv-epi"/>
</meta>
<text>
<status value="generated"/>
<div xmlns="http://www.w3.org/1999/xhtml"><a name="Ingredient_talazoparib01mg"> </a><p><b>Generated Narrative: Ingredient</b><a name="talazoparib01mg"> </a><a name="hctalazoparib01mg"> </a></p><div style="display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%"><p style="margin-bottom: 0px">Resource Ingredient "talazoparib01mg" </p><p style="margin-bottom: 0px">Profile: <a href="https://build.fhir.org/ig/HL7/emedicinal-product-info/StructureDefinition-Ingredient-uv-epi.html">Ingredient (ePI)</a></p></div><p><b>identifier</b>: <code>https://gsrs.ncats.nih.gov/ginas/app/beta</code>/9QHX048FRV (use: official)</p><p><b>status</b>: active</p><p><b>for</b>: See on this page: ManufacturedItemDefinition/mid025mg</p><p><b>role</b>: Active <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (rmswi#100000072072)</span></p><p><b>allergenicIndicator</b>: false</p><blockquote><p><b>substance</b></p><h3>Codes</h3><table class="grid"><tr><td style="display: none">-</td><td><b>Concept</b></td></tr><tr><td style="display: none">*</td><td>TALAZOPARIB <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (beta#9QHX048FRV)</span></td></tr></table><h3>Strengths</h3><table class="grid"><tr><td style="display: none">-</td><td><b>Presentation[x]</b></td><td><b>Basis</b></td></tr><tr><td style="display: none">*</td><td>0.1 mg</td><td>active ingredient - basis of strength <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (<a href="http://terminology.hl7.org/5.3.0/CodeSystem-v3-RoleClass.html">RoleClass</a>#ACTIB)</span></td></tr></table></blockquote></div>
</text>
<identifier>
<use value="official"/>
<system value="https://gsrs.ncats.nih.gov/ginas/app/beta"/>
<value value="9QHX048FRV"/>
</identifier>
<status value="active"/>
<for>
<reference value="ManufacturedItemDefinition/mid025mg"/>
</for>
<role>
<coding>
<system value="https://spor.ema.europa.eu/rmswi"/>
<code value="100000072072"/>
<display value="Active"/>
</coding>
</role>
<allergenicIndicator value="false"/>
<substance>
<code>
<concept>
<coding>
<system value="https://gsrs.ncats.nih.gov/ginas/app/beta"/>
<code value="9QHX048FRV"/>
<display value="TALAZOPARIB"/>
</coding>
</concept>
</code>
<strength>
<presentationQuantity>
<value value="0.1"/>
<unit value="mg"/>
</presentationQuantity>
<basis>
<coding>
<system
value="http://terminology.hl7.org/CodeSystem/v3-RoleClass"/>
<code value="ACTIB"/>
</coding>
<text value="active ingredient - basis of strength"/>
</basis>
</strength>
</substance>
</Ingredient>
</resource>
</entry>
<entry>
<fullUrl value="Ingredient/talazoparib025mg"/>
<resource>
<Ingredient>
<id value="talazoparib025mg"/>
<meta>
<profile
value="http://hl7.org/fhir/uv/emedicinal-product-info/StructureDefinition/Ingredient-uv-epi"/>
</meta>
<text>
<status value="generated"/>
<div xmlns="http://www.w3.org/1999/xhtml"><a name="Ingredient_talazoparib025mg"> </a><p><b>Generated Narrative: Ingredient</b><a name="talazoparib025mg"> </a><a name="hctalazoparib025mg"> </a></p><div style="display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%"><p style="margin-bottom: 0px">Resource Ingredient "talazoparib025mg" </p><p style="margin-bottom: 0px">Profile: <a href="https://build.fhir.org/ig/HL7/emedicinal-product-info/StructureDefinition-Ingredient-uv-epi.html">Ingredient (ePI)</a></p></div><p><b>identifier</b>: <code>https://gsrs.ncats.nih.gov/ginas/app/beta</code>/9QHX048FRV (use: official)</p><p><b>status</b>: active</p><p><b>for</b>: See on this page: ManufacturedItemDefinition/mid025mg</p><p><b>role</b>: Active <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (rmswi#100000072072)</span></p><p><b>allergenicIndicator</b>: false</p><blockquote><p><b>substance</b></p><h3>Codes</h3><table class="grid"><tr><td style="display: none">-</td><td><b>Concept</b></td></tr><tr><td style="display: none">*</td><td>TALAZOPARIB <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (beta#9QHX048FRV)</span></td></tr></table><h3>Strengths</h3><table class="grid"><tr><td style="display: none">-</td><td><b>Presentation[x]</b></td><td><b>Basis</b></td></tr><tr><td style="display: none">*</td><td>0.25 mg</td><td>active ingredient - basis of strength <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (<a href="http://terminology.hl7.org/5.3.0/CodeSystem-v3-RoleClass.html">RoleClass</a>#ACTIB)</span></td></tr></table></blockquote></div>
</text>
<identifier>
<use value="official"/>
<system value="https://gsrs.ncats.nih.gov/ginas/app/beta"/>
<value value="9QHX048FRV"/>
</identifier>
<status value="active"/>
<for>
<reference value="ManufacturedItemDefinition/mid025mg"/>
</for>
<role>
<coding>
<system value="https://spor.ema.europa.eu/rmswi"/>
<code value="100000072072"/>
<display value="Active"/>
</coding>
</role>
<allergenicIndicator value="false"/>
<substance>
<code>
<concept>
<coding>
<system value="https://gsrs.ncats.nih.gov/ginas/app/beta"/>
<code value="9QHX048FRV"/>
<display value="TALAZOPARIB"/>
</coding>
</concept>
</code>
<strength>
<presentationQuantity>
<value value="0.25"/>
<unit value="mg"/>
</presentationQuantity>
<basis>
<coding>
<system
value="http://terminology.hl7.org/CodeSystem/v3-RoleClass"/>
<code value="ACTIB"/>
</coding>
<text value="active ingredient - basis of strength"/>
</basis>
</strength>
</substance>
</Ingredient>
</resource>
</entry>
<entry>
<fullUrl value="Ingredient/talazoparib1mg"/>
<resource>
<Ingredient>
<id value="talazoparib1mg"/>
<meta>
<profile
value="http://hl7.org/fhir/uv/emedicinal-product-info/StructureDefinition/Ingredient-uv-epi"/>
</meta>
<text>
<status value="generated"/>
<div xmlns="http://www.w3.org/1999/xhtml"><a name="Ingredient_talazoparib1mg"> </a><p><b>Generated Narrative: Ingredient</b><a name="talazoparib1mg"> </a><a name="hctalazoparib1mg"> </a></p><div style="display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%"><p style="margin-bottom: 0px">Resource Ingredient "talazoparib1mg" </p><p style="margin-bottom: 0px">Profile: <a href="https://build.fhir.org/ig/HL7/emedicinal-product-info/StructureDefinition-Ingredient-uv-epi.html">Ingredient (ePI)</a></p></div><p><b>identifier</b>: <code>https://gsrs.ncats.nih.gov/ginas/app/beta</code>/9QHX048FRV (use: official)</p><p><b>status</b>: active</p><p><b>for</b>: See on this page: ManufacturedItemDefinition/mid1mg</p><p><b>role</b>: Active <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (rmswi#100000072072)</span></p><p><b>allergenicIndicator</b>: false</p><blockquote><p><b>substance</b></p><h3>Codes</h3><table class="grid"><tr><td style="display: none">-</td><td><b>Concept</b></td></tr><tr><td style="display: none">*</td><td>TALAZOPARIB <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (beta#9QHX048FRV)</span></td></tr></table><h3>Strengths</h3><table class="grid"><tr><td style="display: none">-</td><td><b>Presentation[x]</b></td><td><b>Basis</b></td></tr><tr><td style="display: none">*</td><td>1 mg</td><td>active ingredient - basis of strength <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (<a href="http://terminology.hl7.org/5.3.0/CodeSystem-v3-RoleClass.html">RoleClass</a>#ACTIB)</span></td></tr></table></blockquote></div>
</text>
<identifier>
<use value="official"/>
<system value="https://gsrs.ncats.nih.gov/ginas/app/beta"/>
<value value="9QHX048FRV"/>
</identifier>
<status value="active"/>
<for>
<reference value="ManufacturedItemDefinition/mid1mg"/>
</for>
<role>
<coding>
<system value="https://spor.ema.europa.eu/rmswi"/>
<code value="100000072072"/>
<display value="Active"/>
</coding>
</role>
<allergenicIndicator value="false"/>
<substance>
<code>
<concept>
<coding>
<system value="https://gsrs.ncats.nih.gov/ginas/app/beta"/>
<code value="9QHX048FRV"/>
<display value="TALAZOPARIB"/>
</coding>
</concept>
</code>
<strength>
<presentationQuantity>
<value value="1"/>
<unit value="mg"/>
</presentationQuantity>
<basis>
<coding>
<system
value="http://terminology.hl7.org/CodeSystem/v3-RoleClass"/>
<code value="ACTIB"/>
</coding>
<text value="active ingredient - basis of strength"/>
</basis>
</strength>
</substance>
</Ingredient>
</resource>
</entry>
<entry>
<fullUrl value="Ingredient/ingredientMICROCRYSTALLINECELLULOSE"/>
<resource>
<Ingredient>
<id value="ingredientMICROCRYSTALLINECELLULOSE"/>
<meta>
<profile
value="http://hl7.org/fhir/uv/emedicinal-product-info/StructureDefinition/Ingredient-uv-epi"/>
</meta>
<text>
<status value="generated"/>
<div xmlns="http://www.w3.org/1999/xhtml"><a name="Ingredient_ingredientMICROCRYSTALLINECELLULOSE"> </a><p><b>Generated Narrative: Ingredient</b><a name="ingredientMICROCRYSTALLINECELLULOSE"> </a><a name="hcingredientMICROCRYSTALLINECELLULOSE"> </a></p><div style="display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%"><p style="margin-bottom: 0px">Resource Ingredient "ingredientMICROCRYSTALLINECELLULOSE" </p><p style="margin-bottom: 0px">Profile: <a href="https://build.fhir.org/ig/HL7/emedicinal-product-info/StructureDefinition-Ingredient-uv-epi.html">Ingredient (ePI)</a></p></div><p><b>identifier</b>: <code>https://gsrs.ncats.nih.gov/ginas/app/beta</code>/OP1R32D61U (use: official)</p><p><b>status</b>: active</p><p><b>for</b>: </p><ul><li>See on this page: ManufacturedItemDefinition/mid01mg</li><li>See on this page: ManufacturedItemDefinition/mid1mg</li><li>See on this page: ManufacturedItemDefinition/mid025mg</li></ul><p><b>role</b>: Excipient <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (rmswi#100000072082)</span></p><p><b>allergenicIndicator</b>: false</p><blockquote><p><b>substance</b></p><h3>Codes</h3><table class="grid"><tr><td style="display: none">-</td><td><b>Concept</b></td></tr><tr><td style="display: none">*</td><td>MICROCRYSTALLINE CELLULOSE <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (beta#OP1R32D61U)</span></td></tr></table></blockquote></div>
</text>
<identifier>
<use value="official"/>
<system value="https://gsrs.ncats.nih.gov/ginas/app/beta"/>
<value value="OP1R32D61U"/>
</identifier>
<status value="active"/>
<for>
<reference value="ManufacturedItemDefinition/mid01mg"/>
</for>
<for>
<reference value="ManufacturedItemDefinition/mid1mg"/>
</for>
<for>
<reference value="ManufacturedItemDefinition/mid025mg"/>
</for>
<role>
<coding>
<system value="https://spor.ema.europa.eu/rmswi"/>
<code value="100000072082"/>
<display value="Excipient"/>
</coding>
</role>
<allergenicIndicator value="false"/>
<substance>
<code>
<concept>
<coding>
<system value="https://gsrs.ncats.nih.gov/ginas/app/beta"/>
<code value="OP1R32D61U"/>
<display value="MICROCRYSTALLINE CELLULOSE"/>
</coding>
</concept>
</code>
</substance>
</Ingredient>
</resource>
</entry>
<entry>
<fullUrl value="Ingredient/ingredientSILICONDIOXIDE"/>
<resource>
<Ingredient>
<id value="ingredientSILICONDIOXIDE"/>
<meta>
<profile
value="http://hl7.org/fhir/uv/emedicinal-product-info/StructureDefinition/Ingredient-uv-epi"/>
</meta>
<text>
<status value="generated"/>
<div xmlns="http://www.w3.org/1999/xhtml"><a name="Ingredient_ingredientSILICONDIOXIDE"> </a><p><b>Generated Narrative: Ingredient</b><a name="ingredientSILICONDIOXIDE"> </a><a name="hcingredientSILICONDIOXIDE"> </a></p><div style="display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%"><p style="margin-bottom: 0px">Resource Ingredient "ingredientSILICONDIOXIDE" </p><p style="margin-bottom: 0px">Profile: <a href="https://build.fhir.org/ig/HL7/emedicinal-product-info/StructureDefinition-Ingredient-uv-epi.html">Ingredient (ePI)</a></p></div><p><b>identifier</b>: <code>https://gsrs.ncats.nih.gov/ginas/app/beta</code>/ETJ7Z6XBU4 (use: official)</p><p><b>status</b>: active</p><p><b>for</b>: </p><ul><li>See on this page: ManufacturedItemDefinition/mid1mg</li><li>See on this page: ManufacturedItemDefinition/mid025mg</li></ul><p><b>role</b>: Excipient <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (rmswi#100000072082)</span></p><p><b>allergenicIndicator</b>: false</p><blockquote><p><b>substance</b></p><h3>Codes</h3><table class="grid"><tr><td style="display: none">-</td><td><b>Concept</b></td></tr><tr><td style="display: none">*</td><td>SILICON DIOXIDE <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (beta#15FIX9V2JP)</span></td></tr></table></blockquote></div>
</text>
<identifier>
<use value="official"/>
<system value="https://gsrs.ncats.nih.gov/ginas/app/beta"/>
<value value="ETJ7Z6XBU4"/>
</identifier>
<status value="active"/>
<for>
<reference value="ManufacturedItemDefinition/mid1mg"/>
</for>
<for>
<reference value="ManufacturedItemDefinition/mid025mg"/>
</for>
<role>
<coding>
<system value="https://spor.ema.europa.eu/rmswi"/>
<code value="100000072082"/>
<display value="Excipient"/>
</coding>
</role>
<allergenicIndicator value="false"/>
<substance>
<code>
<concept>
<coding>
<system value="https://gsrs.ncats.nih.gov/ginas/app/beta"/>
<code value="15FIX9V2JP"/>
<display value="SILICON DIOXIDE"/>
</coding>
</concept>
</code>
</substance>
</Ingredient>
</resource>
</entry>
<entry>
<fullUrl value="Ingredient/ingredientHYPROMELLOSE"/>
<resource>
<Ingredient>
<id value="ingredientHYPROMELLOSE"/>
<meta>
<profile
value="http://hl7.org/fhir/uv/emedicinal-product-info/StructureDefinition/Ingredient-uv-epi"/>
</meta>
<text>
<status value="generated"/>
<div xmlns="http://www.w3.org/1999/xhtml"><a name="Ingredient_ingredientHYPROMELLOSE"> </a><p><b>Generated Narrative: Ingredient</b><a name="ingredientHYPROMELLOSE"> </a><a name="hcingredientHYPROMELLOSE"> </a></p><div style="display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%"><p style="margin-bottom: 0px">Resource Ingredient "ingredientHYPROMELLOSE" </p><p style="margin-bottom: 0px">Profile: <a href="https://build.fhir.org/ig/HL7/emedicinal-product-info/StructureDefinition-Ingredient-uv-epi.html">Ingredient (ePI)</a></p></div><p><b>identifier</b>: <code>https://gsrs.ncats.nih.gov/ginas/app/beta</code>/3NXW29V3WO (use: official)</p><p><b>status</b>: active</p><p><b>for</b>: </p><ul><li>See on this page: ManufacturedItemDefinition/mid01mg</li><li>See on this page: ManufacturedItemDefinition/mid1mg</li><li>See on this page: ManufacturedItemDefinition/mid025mg</li></ul><p><b>role</b>: Excipient <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (rmswi#100000072082)</span></p><p><b>allergenicIndicator</b>: false</p><blockquote><p><b>substance</b></p><h3>Codes</h3><table class="grid"><tr><td style="display: none">-</td><td><b>Concept</b></td></tr><tr><td style="display: none">*</td><td>HYPROMELLOSE <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (beta#3NXW29V3WO)</span></td></tr></table><h3>Strengths</h3><table class="grid"><tr><td style="display: none">-</td><td><b>Basis</b></td></tr><tr><td style="display: none">*</td><td>active ingredient - basis of strength <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (<a href="http://terminology.hl7.org/5.3.0/CodeSystem-v3-RoleClass.html">RoleClass</a>#ACTIB)</span></td></tr></table></blockquote></div>
</text>
<identifier>
<use value="official"/>
<system value="https://gsrs.ncats.nih.gov/ginas/app/beta"/>
<value value="3NXW29V3WO"/>
</identifier>
<status value="active"/>
<for>
<reference value="ManufacturedItemDefinition/mid01mg"/>
</for>
<for>
<reference value="ManufacturedItemDefinition/mid1mg"/>
</for>
<for>
<reference value="ManufacturedItemDefinition/mid025mg"/>
</for>
<role>
<coding>
<system value="https://spor.ema.europa.eu/rmswi"/>
<code value="100000072082"/>
<display value="Excipient"/>
</coding>
</role>
<allergenicIndicator value="false"/>
<substance>
<code>
<concept>
<coding>
<system value="https://gsrs.ncats.nih.gov/ginas/app/beta"/>
<code value="3NXW29V3WO"/>
<display value="HYPROMELLOSE"/>
</coding>
</concept>
</code>
<strength>
<basis>
<coding>
<system
value="http://terminology.hl7.org/CodeSystem/v3-RoleClass"/>
<code value="ACTIB"/>
<display value="active ingredient - basis of strength"/>
</coding>
</basis>
</strength>
</substance>
</Ingredient>
</resource>
</entry>
<entry>
<fullUrl value="Ingredient/ingredientFERRICOXIDEYELLOW"/>
<resource>
<Ingredient>
<id value="ingredientFERRICOXIDEYELLOW"/>
<meta>
<profile
value="http://hl7.org/fhir/uv/emedicinal-product-info/StructureDefinition/Ingredient-uv-epi"/>
</meta>
<text>
<status value="generated"/>
<div xmlns="http://www.w3.org/1999/xhtml"><a name="Ingredient_ingredientFERRICOXIDEYELLOW"> </a><p><b>Generated Narrative: Ingredient</b><a name="ingredientFERRICOXIDEYELLOW"> </a><a name="hcingredientFERRICOXIDEYELLOW"> </a></p><div style="display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%"><p style="margin-bottom: 0px">Resource Ingredient "ingredientFERRICOXIDEYELLOW" </p><p style="margin-bottom: 0px">Profile: <a href="https://build.fhir.org/ig/HL7/emedicinal-product-info/StructureDefinition-Ingredient-uv-epi.html">Ingredient (ePI)</a></p></div><p><b>identifier</b>: <code>https://gsrs.ncats.nih.gov/ginas/app/beta</code>/EX438O2MRT (use: official)</p><p><b>status</b>: active</p><p><b>for</b>: </p><ul><li>See on this page: ManufacturedItemDefinition/mid1mg</li><li>See on this page: ManufacturedItemDefinition/mid025mg</li></ul><p><b>role</b>: Excipient <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (rmswi#100000072082)</span></p><p><b>allergenicIndicator</b>: false</p><blockquote><p><b>substance</b></p><h3>Codes</h3><table class="grid"><tr><td style="display: none">-</td><td><b>Concept</b></td></tr><tr><td style="display: none">*</td><td>YELLOW IRON OXIDE (E172) <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (beta#EX438O2MRT)</span></td></tr></table><h3>Strengths</h3><table class="grid"><tr><td style="display: none">-</td><td><b>Basis</b></td></tr><tr><td style="display: none">*</td><td>active ingredient - basis of strength <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (<a href="http://terminology.hl7.org/5.3.0/CodeSystem-v3-RoleClass.html">RoleClass</a>#ACTIB)</span></td></tr></table></blockquote></div>
</text>
<identifier>
<use value="official"/>
<system value="https://gsrs.ncats.nih.gov/ginas/app/beta"/>
<value value="EX438O2MRT"/>
</identifier>
<status value="active"/>
<for>
<reference value="ManufacturedItemDefinition/mid1mg"/>
</for>
<for>
<reference value="ManufacturedItemDefinition/mid025mg"/>
</for>
<role>
<coding>
<system value="https://spor.ema.europa.eu/rmswi"/>
<code value="100000072082"/>
<display value="Excipient"/>
</coding>
</role>
<allergenicIndicator value="false"/>
<substance>
<code>
<concept>
<coding>
<system value="https://gsrs.ncats.nih.gov/ginas/app/beta"/>
<code value="EX438O2MRT"/>
<display value="YELLOW IRON OXIDE (E172)"/>
</coding>
</concept>
</code>
<strength>
<basis>
<coding>
<system
value="http://terminology.hl7.org/CodeSystem/v3-RoleClass"/>
<code value="ACTIB"/>
<display value="active ingredient - basis of strength"/>
</coding>
</basis>
</strength>
</substance>
</Ingredient>
</resource>
</entry>
<entry>
<fullUrl value="Ingredient/ingredientTITANIUMDIOXIDE"/>
<resource>
<Ingredient>
<id value="ingredientTITANIUMDIOXIDE"/>
<meta>
<profile
value="http://hl7.org/fhir/uv/emedicinal-product-info/StructureDefinition/Ingredient-uv-epi"/>
</meta>
<text>
<status value="generated"/>
<div xmlns="http://www.w3.org/1999/xhtml"><a name="Ingredient_ingredientTITANIUMDIOXIDE"> </a><p><b>Generated Narrative: Ingredient</b><a name="ingredientTITANIUMDIOXIDE"> </a><a name="hcingredientTITANIUMDIOXIDE"> </a></p><div style="display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%"><p style="margin-bottom: 0px">Resource Ingredient "ingredientTITANIUMDIOXIDE" </p><p style="margin-bottom: 0px">Profile: <a href="https://build.fhir.org/ig/HL7/emedicinal-product-info/StructureDefinition-Ingredient-uv-epi.html">Ingredient (ePI)</a></p></div><p><b>identifier</b>: <code>https://gsrs.ncats.nih.gov/ginas/app/beta</code>/15FIX9V2JP (use: official)</p><p><b>status</b>: active</p><p><b>for</b>: </p><ul><li>See on this page: ManufacturedItemDefinition/mid01mg</li><li>See on this page: ManufacturedItemDefinition/mid1mg</li><li>See on this page: ManufacturedItemDefinition/mid025mg</li></ul><p><b>role</b>: Excipient <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (rmswi#100000072082)</span></p><p><b>allergenicIndicator</b>: false</p><blockquote><p><b>substance</b></p><h3>Codes</h3><table class="grid"><tr><td style="display: none">-</td><td><b>Concept</b></td></tr><tr><td style="display: none">*</td><td>TITANIUM DIOXIDE (E171) <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (beta#15FIX9V2JP)</span></td></tr></table><h3>Strengths</h3><table class="grid"><tr><td style="display: none">-</td><td><b>Basis</b></td></tr><tr><td style="display: none">*</td><td>active ingredient - basis of strength <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (<a href="http://terminology.hl7.org/5.3.0/CodeSystem-v3-RoleClass.html">RoleClass</a>#ACTIB)</span></td></tr></table></blockquote></div>
</text>
<identifier>
<use value="official"/>
<system value="https://gsrs.ncats.nih.gov/ginas/app/beta"/>
<value value="15FIX9V2JP"/>
</identifier>
<status value="active"/>
<for>
<reference value="ManufacturedItemDefinition/mid01mg"/>
</for>
<for>
<reference value="ManufacturedItemDefinition/mid1mg"/>
</for>
<for>
<reference value="ManufacturedItemDefinition/mid025mg"/>
</for>
<role>
<coding>
<system value="https://spor.ema.europa.eu/rmswi"/>
<code value="100000072082"/>
<display value="Excipient"/>
</coding>
</role>
<allergenicIndicator value="false"/>
<substance>
<code>
<concept>
<coding>
<system value="https://gsrs.ncats.nih.gov/ginas/app/beta"/>
<code value="15FIX9V2JP"/>
<display value="TITANIUM DIOXIDE (E171)"/>
</coding>
</concept>
</code>
<strength>
<basis>
<coding>
<system
value="http://terminology.hl7.org/CodeSystem/v3-RoleClass"/>
<code value="ACTIB"/>
<display value="active ingredient - basis of strength"/>
</coding>
</basis>
</strength>
</substance>
</Ingredient>
</resource>
</entry>
<entry>
<fullUrl value="Ingredient/ingredientFERRICOXIDERED"/>
<resource>
<Ingredient>
<id value="ingredientFERRICOXIDERED"/>
<meta>
<profile
value="http://hl7.org/fhir/uv/emedicinal-product-info/StructureDefinition/Ingredient-uv-epi"/>
</meta>
<text>
<status value="generated"/>
<div xmlns="http://www.w3.org/1999/xhtml"><a name="Ingredient_ingredientFERRICOXIDERED"> </a><p><b>Generated Narrative: Ingredient</b><a name="ingredientFERRICOXIDERED"> </a><a name="hcingredientFERRICOXIDERED"> </a></p><div style="display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%"><p style="margin-bottom: 0px">Resource Ingredient "ingredientFERRICOXIDERED" </p><p style="margin-bottom: 0px">Profile: <a href="https://build.fhir.org/ig/HL7/emedicinal-product-info/StructureDefinition-Ingredient-uv-epi.html">Ingredient (ePI)</a></p></div><p><b>identifier</b>: <code>https://gsrs.ncats.nih.gov/ginas/app/beta</code>/1K09F3G675 (use: official)</p><p><b>status</b>: active</p><p><b>for</b>: See on this page: ManufacturedItemDefinition/mid1mg</p><p><b>role</b>: Excipient <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (rmswi#100000072082)</span></p><p><b>allergenicIndicator</b>: false</p><blockquote><p><b>substance</b></p><h3>Codes</h3><table class="grid"><tr><td style="display: none">-</td><td><b>Concept</b></td></tr><tr><td style="display: none">*</td><td>FERRIC OXIDE RED <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (beta#1K09F3G675)</span></td></tr></table><h3>Strengths</h3><table class="grid"><tr><td style="display: none">-</td><td><b>Basis</b></td></tr><tr><td style="display: none">*</td><td>active ingredient - basis of strength <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (<a href="http://terminology.hl7.org/5.3.0/CodeSystem-v3-RoleClass.html">RoleClass</a>#ACTIB)</span></td></tr></table></blockquote></div>
</text>
<identifier>
<use value="official"/>
<system value="https://gsrs.ncats.nih.gov/ginas/app/beta"/>
<value value="1K09F3G675"/>
</identifier>
<status value="active"/>
<for>
<reference value="ManufacturedItemDefinition/mid1mg"/>
</for>
<role>
<coding>
<system value="https://spor.ema.europa.eu/rmswi"/>
<code value="100000072082"/>
<display value="Excipient"/>
</coding>
</role>
<allergenicIndicator value="false"/>
<substance>
<code>
<concept>
<coding>
<system value="https://gsrs.ncats.nih.gov/ginas/app/beta"/>
<code value="1K09F3G675"/>
<display value="FERRIC OXIDE RED"/>
</coding>
</concept>
</code>
<strength>
<basis>
<coding>
<system
value="http://terminology.hl7.org/CodeSystem/v3-RoleClass"/>
<code value="ACTIB"/>
<display value="active ingredient - basis of strength"/>
</coding>
</basis>
</strength>
</substance>
</Ingredient>
</resource>
</entry>
<entry>
<fullUrl value="Ingredient/ingredientSHELLAC"/>
<resource>
<Ingredient>
<id value="ingredientSHELLAC"/>
<meta>
<profile
value="http://hl7.org/fhir/uv/emedicinal-product-info/StructureDefinition/Ingredient-uv-epi"/>
</meta>
<text>
<status value="generated"/>
<div xmlns="http://www.w3.org/1999/xhtml"><a name="Ingredient_ingredientSHELLAC"> </a><p><b>Generated Narrative: Ingredient</b><a name="ingredientSHELLAC"> </a><a name="hcingredientSHELLAC"> </a></p><div style="display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%"><p style="margin-bottom: 0px">Resource Ingredient "ingredientSHELLAC" </p><p style="margin-bottom: 0px">Profile: <a href="https://build.fhir.org/ig/HL7/emedicinal-product-info/StructureDefinition-Ingredient-uv-epi.html">Ingredient (ePI)</a></p></div><p><b>identifier</b>: <code>https://gsrs.ncats.nih.gov/ginas/app/beta</code>/46N107B71O (use: official)</p><p><b>status</b>: active</p><p><b>for</b>: </p><ul><li>See on this page: ManufacturedItemDefinition/mid01mg</li><li>See on this page: ManufacturedItemDefinition/mid1mg</li><li>See on this page: ManufacturedItemDefinition/mid025mg</li></ul><p><b>role</b>: Excipient <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (rmswi#100000072082)</span></p><p><b>allergenicIndicator</b>: false</p><blockquote><p><b>substance</b></p><h3>Codes</h3><table class="grid"><tr><td style="display: none">-</td><td><b>Concept</b></td></tr><tr><td style="display: none">*</td><td>SHELLAC (E904) <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (beta#46N107B71O)</span></td></tr></table><h3>Strengths</h3><table class="grid"><tr><td style="display: none">-</td><td><b>Basis</b></td></tr><tr><td style="display: none">*</td><td>active ingredient - basis of strength <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (<a href="http://terminology.hl7.org/5.3.0/CodeSystem-v3-RoleClass.html">RoleClass</a>#ACTIB)</span></td></tr></table></blockquote></div>
</text>
<identifier>
<use value="official"/>
<system value="https://gsrs.ncats.nih.gov/ginas/app/beta"/>
<value value="46N107B71O"/>
</identifier>
<status value="active"/>
<for>
<reference value="ManufacturedItemDefinition/mid01mg"/>
</for>
<for>
<reference value="ManufacturedItemDefinition/mid1mg"/>
</for>
<for>
<reference value="ManufacturedItemDefinition/mid025mg"/>
</for>
<role>
<coding>
<system value="https://spor.ema.europa.eu/rmswi"/>
<code value="100000072082"/>
<display value="Excipient"/>
</coding>
</role>
<allergenicIndicator value="false"/>
<substance>
<code>
<concept>
<coding>
<system value="https://gsrs.ncats.nih.gov/ginas/app/beta"/>
<code value="46N107B71O"/>
<display value="SHELLAC (E904)"/>
</coding>
</concept>
</code>
<strength>
<basis>
<coding>
<system
value="http://terminology.hl7.org/CodeSystem/v3-RoleClass"/>
<code value="ACTIB"/>
<display value="active ingredient - basis of strength"/>
</coding>
</basis>
</strength>
</substance>
</Ingredient>
</resource>
</entry>
<entry>
<fullUrl value="Ingredient/ingredientPROPYLENEGLYCOL"/>
<resource>
<Ingredient>
<id value="ingredientPROPYLENEGLYCOL"/>
<meta>
<profile
value="http://hl7.org/fhir/uv/emedicinal-product-info/StructureDefinition/Ingredient-uv-epi"/>
</meta>
<text>
<status value="generated"/>
<div xmlns="http://www.w3.org/1999/xhtml"><a name="Ingredient_ingredientPROPYLENEGLYCOL"> </a><p><b>Generated Narrative: Ingredient</b><a name="ingredientPROPYLENEGLYCOL"> </a><a name="hcingredientPROPYLENEGLYCOL"> </a></p><div style="display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%"><p style="margin-bottom: 0px">Resource Ingredient "ingredientPROPYLENEGLYCOL" </p><p style="margin-bottom: 0px">Profile: <a href="https://build.fhir.org/ig/HL7/emedicinal-product-info/StructureDefinition-Ingredient-uv-epi.html">Ingredient (ePI)</a></p></div><p><b>identifier</b>: <code>https://gsrs.ncats.nih.gov/ginas/app/beta</code>/6DC9Q167V3 (use: official)</p><p><b>status</b>: active</p><p><b>for</b>: </p><ul><li>See on this page: ManufacturedItemDefinition/mid01mg</li><li>See on this page: ManufacturedItemDefinition/mid1mg</li><li>See on this page: ManufacturedItemDefinition/mid025mg</li></ul><p><b>role</b>: Excipient <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (rmswi#100000072082)</span></p><p><b>allergenicIndicator</b>: false</p><blockquote><p><b>substance</b></p><h3>Codes</h3><table class="grid"><tr><td style="display: none">-</td><td><b>Concept</b></td></tr><tr><td style="display: none">*</td><td>PROPYLENE GLYCOL (E1520) <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (beta#6DC9Q167V3)</span></td></tr></table><h3>Strengths</h3><table class="grid"><tr><td style="display: none">-</td><td><b>Basis</b></td></tr><tr><td style="display: none">*</td><td>active ingredient - basis of strength <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (<a href="http://terminology.hl7.org/5.3.0/CodeSystem-v3-RoleClass.html">RoleClass</a>#ACTIB)</span></td></tr></table></blockquote></div>
</text>
<identifier>
<use value="official"/>
<system value="https://gsrs.ncats.nih.gov/ginas/app/beta"/>
<value value="6DC9Q167V3"/>
</identifier>
<status value="active"/>
<for>
<reference value="ManufacturedItemDefinition/mid01mg"/>
</for>
<for>
<reference value="ManufacturedItemDefinition/mid1mg"/>
</for>
<for>
<reference value="ManufacturedItemDefinition/mid025mg"/>
</for>
<role>
<coding>
<system value="https://spor.ema.europa.eu/rmswi"/>
<code value="100000072082"/>
<display value="Excipient"/>
</coding>
</role>
<allergenicIndicator value="false"/>
<substance>
<code>
<concept>
<coding>
<system value="https://gsrs.ncats.nih.gov/ginas/app/beta"/>
<code value="6DC9Q167V3"/>
<display value="PROPYLENE GLYCOL (E1520)"/>
</coding>
</concept>
</code>
<strength>
<basis>
<coding>
<system
value="http://terminology.hl7.org/CodeSystem/v3-RoleClass"/>
<code value="ACTIB"/>
<display value="active ingredient - basis of strength"/>
</coding>
</basis>
</strength>
</substance>
</Ingredient>
</resource>
</entry>
<entry>
<fullUrl value="Ingredient/ingredientAMMONIUMHYDROXIDE"/>
<resource>
<Ingredient>
<id value="ingredientAMMONIUMHYDROXIDE"/>
<meta>
<profile
value="http://hl7.org/fhir/uv/emedicinal-product-info/StructureDefinition/Ingredient-uv-epi"/>
</meta>
<text>
<status value="generated"/>
<div xmlns="http://www.w3.org/1999/xhtml"><a name="Ingredient_ingredientAMMONIUMHYDROXIDE"> </a><p><b>Generated Narrative: Ingredient</b><a name="ingredientAMMONIUMHYDROXIDE"> </a><a name="hcingredientAMMONIUMHYDROXIDE"> </a></p><div style="display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%"><p style="margin-bottom: 0px">Resource Ingredient "ingredientAMMONIUMHYDROXIDE" </p><p style="margin-bottom: 0px">Profile: <a href="https://build.fhir.org/ig/HL7/emedicinal-product-info/StructureDefinition-Ingredient-uv-epi.html">Ingredient (ePI)</a></p></div><p><b>identifier</b>: <code>https://gsrs.ncats.nih.gov/ginas/app/beta</code>/5138Q19F1X (use: official)</p><p><b>status</b>: active</p><p><b>for</b>: </p><ul><li>See on this page: ManufacturedItemDefinition/mid01mg</li><li>See on this page: ManufacturedItemDefinition/mid1mg</li><li>See on this page: ManufacturedItemDefinition/mid025mg</li></ul><p><b>role</b>: Excipient <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (rmswi#100000072082)</span></p><p><b>allergenicIndicator</b>: false</p><blockquote><p><b>substance</b></p><h3>Codes</h3><table class="grid"><tr><td style="display: none">-</td><td><b>Concept</b></td></tr><tr><td style="display: none">*</td><td>AMMONIUM HYDROXIDE (E527) <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (beta#5138Q19F1X)</span></td></tr></table><h3>Strengths</h3><table class="grid"><tr><td style="display: none">-</td><td><b>Basis</b></td></tr><tr><td style="display: none">*</td><td>active ingredient - basis of strength <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (<a href="http://terminology.hl7.org/5.3.0/CodeSystem-v3-RoleClass.html">RoleClass</a>#ACTIB)</span></td></tr></table></blockquote></div>
</text>
<identifier>
<use value="official"/>
<system value="https://gsrs.ncats.nih.gov/ginas/app/beta"/>
<value value="5138Q19F1X"/>
</identifier>
<status value="active"/>
<for>
<reference value="ManufacturedItemDefinition/mid01mg"/>
</for>
<for>
<reference value="ManufacturedItemDefinition/mid1mg"/>
</for>
<for>
<reference value="ManufacturedItemDefinition/mid025mg"/>
</for>
<role>
<coding>
<system value="https://spor.ema.europa.eu/rmswi"/>
<code value="100000072082"/>
<display value="Excipient"/>
</coding>
</role>
<allergenicIndicator value="false"/>
<substance>
<code>
<concept>
<coding>
<system value="https://gsrs.ncats.nih.gov/ginas/app/beta"/>
<code value="5138Q19F1X"/>
<display value="AMMONIUM HYDROXIDE (E527)"/>
</coding>
</concept>
</code>
<strength>
<basis>
<coding>
<system
value="http://terminology.hl7.org/CodeSystem/v3-RoleClass"/>
<code value="ACTIB"/>
<display value="active ingredient - basis of strength"/>
</coding>
</basis>
</strength>
</substance>
</Ingredient>
</resource>
</entry>
<entry>
<fullUrl value="Ingredient/ingredientBLACKIRONOXIDE"/>
<resource>
<Ingredient>
<id value="ingredientBLACKIRONOXIDE"/>
<meta>
<profile
value="http://hl7.org/fhir/uv/emedicinal-product-info/StructureDefinition/Ingredient-uv-epi"/>
</meta>
<text>
<status value="generated"/>
<div xmlns="http://www.w3.org/1999/xhtml"><a name="Ingredient_ingredientBLACKIRONOXIDE"> </a><p><b>Generated Narrative: Ingredient</b><a name="ingredientBLACKIRONOXIDE"> </a><a name="hcingredientBLACKIRONOXIDE"> </a></p><div style="display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%"><p style="margin-bottom: 0px">Resource Ingredient "ingredientBLACKIRONOXIDE" </p><p style="margin-bottom: 0px">Profile: <a href="https://build.fhir.org/ig/HL7/emedicinal-product-info/StructureDefinition-Ingredient-uv-epi.html">Ingredient (ePI)</a></p></div><p><b>identifier</b>: <code>https://gsrs.ncats.nih.gov/ginas/app/beta</code>/XM0M87F357 (use: official)</p><p><b>status</b>: active</p><p><b>for</b>: </p><ul><li>See on this page: ManufacturedItemDefinition/mid01mg</li><li>See on this page: ManufacturedItemDefinition/mid1mg</li><li>See on this page: ManufacturedItemDefinition/mid025mg</li></ul><p><b>role</b>: Excipient <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (rmswi#100000072082)</span></p><p><b>allergenicIndicator</b>: false</p><blockquote><p><b>substance</b></p><h3>Codes</h3><table class="grid"><tr><td style="display: none">-</td><td><b>Concept</b></td></tr><tr><td style="display: none">*</td><td>BLACK IRON OXIDE (E172) <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (beta#XM0M87F357)</span></td></tr></table><h3>Strengths</h3><table class="grid"><tr><td style="display: none">-</td><td><b>Basis</b></td></tr><tr><td style="display: none">*</td><td>active ingredient - basis of strength <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (<a href="http://terminology.hl7.org/5.3.0/CodeSystem-v3-RoleClass.html">RoleClass</a>#ACTIB)</span></td></tr></table></blockquote></div>
</text>
<identifier>
<use value="official"/>
<system value="https://gsrs.ncats.nih.gov/ginas/app/beta"/>
<value value="XM0M87F357"/>
</identifier>
<status value="active"/>
<for>
<reference value="ManufacturedItemDefinition/mid01mg"/>
</for>
<for>
<reference value="ManufacturedItemDefinition/mid1mg"/>
</for>
<for>
<reference value="ManufacturedItemDefinition/mid025mg"/>
</for>
<role>
<coding>
<system value="https://spor.ema.europa.eu/rmswi"/>
<code value="100000072082"/>
<display value="Excipient"/>
</coding>
</role>
<allergenicIndicator value="false"/>
<substance>
<code>
<concept>
<coding>
<system value="https://gsrs.ncats.nih.gov/ginas/app/beta"/>
<code value="XM0M87F357"/>
<display value="BLACK IRON OXIDE (E172)"/>
</coding>
</concept>
</code>
<strength>
<basis>
<coding>
<system
value="http://terminology.hl7.org/CodeSystem/v3-RoleClass"/>
<code value="ACTIB"/>
<display value="active ingredient - basis of strength"/>
</coding>
</basis>
</strength>
</substance>
</Ingredient>
</resource>
</entry>
<entry>
<fullUrl value="Ingredient/ingredientPotassiumhydroxide"/>
<resource>
<Ingredient>
<id value="ingredientPotassiumhydroxide"/>
<meta>
<profile
value="http://hl7.org/fhir/uv/emedicinal-product-info/StructureDefinition/Ingredient-uv-epi"/>
</meta>
<text>
<status value="generated"/>
<div xmlns="http://www.w3.org/1999/xhtml"><a name="Ingredient_ingredientPotassiumhydroxide"> </a><p><b>Generated Narrative: Ingredient</b><a name="ingredientPotassiumhydroxide"> </a><a name="hcingredientPotassiumhydroxide"> </a></p><div style="display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%"><p style="margin-bottom: 0px">Resource Ingredient "ingredientPotassiumhydroxide" </p><p style="margin-bottom: 0px">Profile: <a href="https://build.fhir.org/ig/HL7/emedicinal-product-info/StructureDefinition-Ingredient-uv-epi.html">Ingredient (ePI)</a></p></div><p><b>identifier</b>: <code>https://gsrs.ncats.nih.gov/ginas/app/beta</code>/WZH3C48M4T (use: official)</p><p><b>status</b>: active</p><p><b>for</b>: </p><ul><li>See on this page: ManufacturedItemDefinition/mid01mg</li><li>See on this page: ManufacturedItemDefinition/mid1mg</li><li>See on this page: ManufacturedItemDefinition/mid025mg</li></ul><p><b>role</b>: Excipient <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (rmswi#100000072082)</span></p><p><b>allergenicIndicator</b>: false</p><blockquote><p><b>substance</b></p><h3>Codes</h3><table class="grid"><tr><td style="display: none">-</td><td><b>Concept</b></td></tr><tr><td style="display: none">*</td><td>POTASSIUM HYDROXIDE (E525) <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (beta#WZH3C48M4T)</span></td></tr></table><h3>Strengths</h3><table class="grid"><tr><td style="display: none">-</td><td><b>Basis</b></td></tr><tr><td style="display: none">*</td><td>active ingredient - basis of strength <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (<a href="http://terminology.hl7.org/5.3.0/CodeSystem-v3-RoleClass.html">RoleClass</a>#ACTIB)</span></td></tr></table></blockquote></div>
</text>
<identifier>
<use value="official"/>
<system value="https://gsrs.ncats.nih.gov/ginas/app/beta"/>
<value value="WZH3C48M4T"/>
</identifier>
<status value="active"/>
<for>
<reference value="ManufacturedItemDefinition/mid01mg"/>
</for>
<for>
<reference value="ManufacturedItemDefinition/mid1mg"/>
</for>
<for>
<reference value="ManufacturedItemDefinition/mid025mg"/>
</for>
<role>
<coding>
<system value="https://spor.ema.europa.eu/rmswi"/>
<code value="100000072082"/>
<display value="Excipient"/>
</coding>
</role>
<allergenicIndicator value="false"/>
<substance>
<code>
<concept>
<coding>
<system value="https://gsrs.ncats.nih.gov/ginas/app/beta"/>
<code value="WZH3C48M4T"/>
<display value="POTASSIUM HYDROXIDE (E525)"/>
</coding>
</concept>
</code>
<strength>
<basis>
<coding>
<system
value="http://terminology.hl7.org/CodeSystem/v3-RoleClass"/>
<code value="ACTIB"/>
<display value="active ingredient - basis of strength"/>
</coding>
</basis>
</strength>
</substance>
</Ingredient>
</resource>
</entry>
<entry>
<fullUrl value="SubstanceDefinition/substancetalazoparib"/>
<resource>
<SubstanceDefinition>
<id value="substancetalazoparib"/>
<meta>
<profile
value="http://hl7.org/fhir/uv/emedicinal-product-info/StructureDefinition/SubstanceDefinition-uv-epi"/>
</meta>
<text>
<status value="generated"/>
<div xmlns="http://www.w3.org/1999/xhtml"><a name="SubstanceDefinition_substancetalazoparib"> </a><p><b>Generated Narrative: SubstanceDefinition</b><a name="substancetalazoparib"> </a><a name="hcsubstancetalazoparib"> </a></p><div style="display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%"><p style="margin-bottom: 0px">Resource SubstanceDefinition "substancetalazoparib" </p><p style="margin-bottom: 0px">Profile: <a href="https://build.fhir.org/ig/HL7/emedicinal-product-info/StructureDefinition-SubstanceDefinition-uv-epi.html">SubstanceDefinition (ePI)</a></p></div><p><b>identifier</b>: <code>https://gsrs.ncats.nih.gov/ginas/app/beta/</code>/9QHX048FRV (use: official)</p><p><b>version</b>: 1</p><p><b>status</b>: Validated (UNII) <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (#1)</span></p><h3>MolecularWeights</h3><table class="grid"><tr><td style="display: none">-</td><td><b>Type</b></td><td><b>Amount</b></td></tr><tr><td style="display: none">*</td><td>exact <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> ()</span></td><td>380.35</td></tr></table><h3>Structures</h3><table class="grid"><tr><td style="display: none">-</td><td><b>MolecularFormula</b></td></tr><tr><td style="display: none">*</td><td>C19H14F2N6O</td></tr></table><h3>Names</h3><table class="grid"><tr><td style="display: none">-</td><td><b>Name</b></td><td><b>Type</b></td></tr><tr><td style="display: none">*</td><td>(8S,9R)-5-fluoro-8-(4-fluorophenyl)-9-(1-methyl-1H-1,2,4-triazol-5-yl)-2,7,8,9-tetrahydro-3H-pyrido[4,3,2-de]phthalazin-3-one</td><td>Chemical Name <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (#x)</span></td></tr></table></div>
</text>
<identifier>
<use value="official"/>
<system value="https://gsrs.ncats.nih.gov/ginas/app/beta/"/>
<value value="9QHX048FRV"/>
</identifier>
<version value="1"/>
<status>
<coding>
<system value="https://gsrs.ncats.nih.gov/ginas/app/beta/"/>
<code value="1"/>
<display value="Validated (UNII)"/>
</coding>
</status>
<molecularWeight>
<type>
<text value="exact"/>
</type>
<amount>
<value value="380.35"/>
</amount>
</molecularWeight>
<structure>
<molecularFormula value="C19H14F2N6O"/>
</structure>
<name>
<name
value="(8S,9R)-5-fluoro-8-(4-fluorophenyl)-9-(1-methyl-1H-1,2,4-triazol-5-yl)-2,7,8,9-tetrahydro-3H-pyrido[4,3,2-de]phthalazin-3-one"/>
<type>
<coding>
<system value="https://gsrs.ncats.nih.gov/ginas/app/beta/"/>
<code value="x"/>
<display value="Chemical Name"/>
</coding>
</type>
</name>
</SubstanceDefinition>
</resource>
</entry>
<entry>
<fullUrl value="ManufacturedItemDefinition/mid01mg"/>
<resource>
<ManufacturedItemDefinition>
<id value="mid01mg"/>
<meta>
<profile
value="http://hl7.org/fhir/uv/emedicinal-product-info/StructureDefinition/ManufacturedItemDefinition-uv-epi"/>
</meta>
<text>
<status value="generated"/>
<div xmlns="http://www.w3.org/1999/xhtml"><a name="ManufacturedItemDefinition_mid01mg"> </a><p><b>Generated Narrative: ManufacturedItemDefinition</b><a name="mid01mg"> </a><a name="hcmid01mg"> </a></p><div style="display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%"><p style="margin-bottom: 0px">Resource ManufacturedItemDefinition "mid01mg" </p><p style="margin-bottom: 0px">Profile: <a href="https://build.fhir.org/ig/HL7/emedicinal-product-info/StructureDefinition-ManufacturedItemDefinition-uv-epi.html">ManufacturedItemDefinition (ePI)</a></p></div><p><b>identifier</b>: <code>https://www.mhra.gov.uk/</code>/99b900c6-4776-4cde-8125-4f6de8e98b98 (use: official)</p><p><b>status</b>: active</p><p><b>manufacturedDoseForm</b>: Capsule, hard <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (#100000073375)</span></p><p><b>unitOfPresentation</b>: Capsule <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (rmswi#200000002113)</span></p><p><b>manufacturer</b>: See on this page: Organization/orgexcellagmbh</p></div>
</text>
<identifier>
<use value="official"/>
<system value="https://www.mhra.gov.uk/"/>
<value value="99b900c6-4776-4cde-8125-4f6de8e98b98"/>
</identifier>
<status value="active"/>
<manufacturedDoseForm>
<coding>
<system value="https://spor.ema.europa.eu/rmswi/"/>
<code value="100000073375"/>
<display value="Capsule, hard"/>
</coding>
</manufacturedDoseForm>
<unitOfPresentation>
<coding>
<system value="https://spor.ema.europa.eu/rmswi"/>
<code value="200000002113"/>
<display value="Capsule"/>
</coding>
</unitOfPresentation>
<manufacturer>🔗
<reference value="Organization/orgexcellagmbh"/>
</manufacturer>
</ManufacturedItemDefinition>
</resource>
</entry>
<entry>
<fullUrl value="ManufacturedItemDefinition/mid025mg"/>
<resource>
<ManufacturedItemDefinition>
<id value="mid025mg"/>
<meta>
<profile
value="http://hl7.org/fhir/uv/emedicinal-product-info/StructureDefinition/ManufacturedItemDefinition-uv-epi"/>
</meta>
<text>
<status value="generated"/>
<div xmlns="http://www.w3.org/1999/xhtml"><a name="ManufacturedItemDefinition_mid025mg"> </a><p><b>Generated Narrative: ManufacturedItemDefinition</b><a name="mid025mg"> </a><a name="hcmid025mg"> </a></p><div style="display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%"><p style="margin-bottom: 0px">Resource ManufacturedItemDefinition "mid025mg" </p><p style="margin-bottom: 0px">Profile: <a href="https://build.fhir.org/ig/HL7/emedicinal-product-info/StructureDefinition-ManufacturedItemDefinition-uv-epi.html">ManufacturedItemDefinition (ePI)</a></p></div><p><b>identifier</b>: <code>https://www.mhra.gov.uk/</code>/99b900c6-4776-4cde-8125-4f6de8e98b98 (use: official)</p><p><b>status</b>: active</p><p><b>manufacturedDoseForm</b>: Capsule, hard <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (#100000073375)</span></p><p><b>unitOfPresentation</b>: Capsule <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (rmswi#200000002113)</span></p><p><b>manufacturer</b>: See on this page: Organization/orgexcellagmbh</p></div>
</text>
<identifier>
<use value="official"/>
<system value="https://www.mhra.gov.uk/"/>
<value value="99b900c6-4776-4cde-8125-4f6de8e98b98"/>
</identifier>
<status value="active"/>
<manufacturedDoseForm>
<coding>
<system value="https://spor.ema.europa.eu/rmswi/"/>
<code value="100000073375"/>
<display value="Capsule, hard"/>
</coding>
</manufacturedDoseForm>
<unitOfPresentation>
<coding>
<system value="https://spor.ema.europa.eu/rmswi"/>
<code value="200000002113"/>
<display value="Capsule"/>
</coding>
</unitOfPresentation>
<manufacturer>🔗
<reference value="Organization/orgexcellagmbh"/>
</manufacturer>
</ManufacturedItemDefinition>
</resource>
</entry>
<entry>
<fullUrl value="ManufacturedItemDefinition/mid1mg"/>
<resource>
<ManufacturedItemDefinition>
<id value="mid1mg"/>
<meta>
<profile
value="http://hl7.org/fhir/uv/emedicinal-product-info/StructureDefinition/ManufacturedItemDefinition-uv-epi"/>
</meta>
<text>
<status value="generated"/>
<div xmlns="http://www.w3.org/1999/xhtml"><a name="ManufacturedItemDefinition_mid1mg"> </a><p><b>Generated Narrative: ManufacturedItemDefinition</b><a name="mid1mg"> </a><a name="hcmid1mg"> </a></p><div style="display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%"><p style="margin-bottom: 0px">Resource ManufacturedItemDefinition "mid1mg" </p><p style="margin-bottom: 0px">Profile: <a href="https://build.fhir.org/ig/HL7/emedicinal-product-info/StructureDefinition-ManufacturedItemDefinition-uv-epi.html">ManufacturedItemDefinition (ePI)</a></p></div><p><b>identifier</b>: <code>https://www.mhra.gov.uk/</code>/df62fddf-6856-48d0-950a-a87f8fb0cac5 (use: official)</p><p><b>status</b>: active</p><p><b>manufacturedDoseForm</b>: Capsule, hard <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (#100000073375)</span></p><p><b>unitOfPresentation</b>: Capsule <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (rmswi#200000002113)</span></p><p><b>manufacturer</b>: See on this page: Organization/orgexcellagmbh</p></div>
</text>
<identifier>
<use value="official"/>
<system value="https://www.mhra.gov.uk/"/>
<value value="df62fddf-6856-48d0-950a-a87f8fb0cac5"/>
</identifier>
<status value="active"/>
<manufacturedDoseForm>
<coding>
<system value="https://spor.ema.europa.eu/rmswi/"/>
<code value="100000073375"/>
<display value="Capsule, hard"/>
</coding>
</manufacturedDoseForm>
<unitOfPresentation>
<coding>
<system value="https://spor.ema.europa.eu/rmswi"/>
<code value="200000002113"/>
<display value="Capsule"/>
</coding>
</unitOfPresentation>
<manufacturer>🔗
<reference value="Organization/orgexcellagmbh"/>
</manufacturer>
</ManufacturedItemDefinition>
</resource>
</entry>
<entry>
<fullUrl value="AdministrableProductDefinition/ap01mg"/>
<resource>
<AdministrableProductDefinition>
<id value="ap01mg"/>
<meta>
<profile
value="http://hl7.org/fhir/uv/emedicinal-product-info/StructureDefinition/AdministrableProductDefinition-uv-epi"/>
</meta>
<text>
<status value="generated"/>
<div xmlns="http://www.w3.org/1999/xhtml"><a name="AdministrableProductDefinition_ap01mg"> </a><p><b>Generated Narrative: AdministrableProductDefinition</b><a name="ap01mg"> </a><a name="hcap01mg"> </a></p><div style="display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%"><p style="margin-bottom: 0px">Resource AdministrableProductDefinition "ap01mg" </p><p style="margin-bottom: 0px">Profile: <a href="https://build.fhir.org/ig/HL7/emedicinal-product-info/StructureDefinition-AdministrableProductDefinition-uv-epi.html">AdministrableProductDefinition (ePI)</a></p></div><p><b>identifier</b>: <code>https://www.who-umc.org/phpid</code>/identifier</p><p><b>status</b>: active</p><p><b>formOf</b>: See on this page: MedicinalProductDefinition/mp01mg</p><p><b>administrableDoseForm</b>: Capsule, hard <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (rmswi#100000073375)</span></p><p><b>unitOfPresentation</b>: Capsule <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (rmswi#200000002113)</span></p><p><b>producedFrom</b>: See on this page: ManufacturedItemDefinition/mid01mg</p><blockquote><p><b>routeOfAdministration</b></p><p><b>code</b>: Oral use <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (rmswi#100000073619)</span></p><h3>TargetSpecies</h3><table class="grid"><tr><td style="display: none">-</td><td><b>Code</b></td></tr><tr><td style="display: none">*</td><td>Human <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (rmswi#100000109093)</span></td></tr></table></blockquote></div>
</text>
<identifier>
<system value="https://www.who-umc.org/phpid"/>
<value value="identifier"/>
</identifier>
<status value="active"/>
<formOf>
<reference value="MedicinalProductDefinition/mp01mg"/>
</formOf>
<administrableDoseForm>
<coding>
<system value="https://spor.ema.europa.eu/rmswi"/>
<code value="100000073375"/>
<display value="Capsule, hard"/>
</coding>
</administrableDoseForm>
<unitOfPresentation>
<coding>
<system value="https://spor.ema.europa.eu/rmswi"/>
<code value="200000002113"/>
<display value="Capsule"/>
</coding>
</unitOfPresentation>
<producedFrom>
<reference value="ManufacturedItemDefinition/mid01mg"/>
</producedFrom>
<routeOfAdministration>
<code>
<coding>
<system value="https://spor.ema.europa.eu/rmswi"/>
<code value="100000073619"/>
<display value="Oral use"/>
</coding>
</code>
<targetSpecies>
<code>
<coding>
<system value="https://spor.ema.europa.eu/rmswi"/>
<code value="100000109093"/>
<display value="Human"/>
</coding>
</code>
</targetSpecies>
</routeOfAdministration>
</AdministrableProductDefinition>
</resource>
</entry>
<entry>
<fullUrl value="AdministrableProductDefinition/ap025mg"/>
<resource>
<AdministrableProductDefinition>
<id value="ap025mg"/>
<meta>
<profile
value="http://hl7.org/fhir/uv/emedicinal-product-info/StructureDefinition/AdministrableProductDefinition-uv-epi"/>
</meta>
<text>
<status value="generated"/>
<div xmlns="http://www.w3.org/1999/xhtml"><a name="AdministrableProductDefinition_ap025mg"> </a><p><b>Generated Narrative: AdministrableProductDefinition</b><a name="ap025mg"> </a><a name="hcap025mg"> </a></p><div style="display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%"><p style="margin-bottom: 0px">Resource AdministrableProductDefinition "ap025mg" </p><p style="margin-bottom: 0px">Profile: <a href="https://build.fhir.org/ig/HL7/emedicinal-product-info/StructureDefinition-AdministrableProductDefinition-uv-epi.html">AdministrableProductDefinition (ePI)</a></p></div><p><b>identifier</b>: <code>https://www.who-umc.org/phpid</code>/identifier</p><p><b>status</b>: active</p><p><b>formOf</b>: See on this page: MedicinalProductDefinition/mp025mg</p><p><b>administrableDoseForm</b>: Capsule, hard <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (rmswi#100000073375)</span></p><p><b>unitOfPresentation</b>: Capsule <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (rmswi#200000002113)</span></p><p><b>producedFrom</b>: See on this page: ManufacturedItemDefinition/mid025mg</p><blockquote><p><b>routeOfAdministration</b></p><p><b>code</b>: Oral use <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (rmswi#100000073619)</span></p><h3>TargetSpecies</h3><table class="grid"><tr><td style="display: none">-</td><td><b>Code</b></td></tr><tr><td style="display: none">*</td><td>Human <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (rmswi#100000109093)</span></td></tr></table></blockquote></div>
</text>
<identifier>
<system value="https://www.who-umc.org/phpid"/>
<value value="identifier"/>
</identifier>
<status value="active"/>
<formOf>
<reference value="MedicinalProductDefinition/mp025mg"/>
</formOf>
<administrableDoseForm>
<coding>
<system value="https://spor.ema.europa.eu/rmswi"/>
<code value="100000073375"/>
<display value="Capsule, hard"/>
</coding>
</administrableDoseForm>
<unitOfPresentation>
<coding>
<system value="https://spor.ema.europa.eu/rmswi"/>
<code value="200000002113"/>
<display value="Capsule"/>
</coding>
</unitOfPresentation>
<producedFrom>
<reference value="ManufacturedItemDefinition/mid025mg"/>
</producedFrom>
<routeOfAdministration>
<code>
<coding>
<system value="https://spor.ema.europa.eu/rmswi"/>
<code value="100000073619"/>
<display value="Oral use"/>
</coding>
</code>
<targetSpecies>
<code>
<coding>
<system value="https://spor.ema.europa.eu/rmswi"/>
<code value="100000109093"/>
<display value="Human"/>
</coding>
</code>
</targetSpecies>
</routeOfAdministration>
</AdministrableProductDefinition>
</resource>
</entry>
<entry>
<fullUrl value="AdministrableProductDefinition/ap1mg"/>
<resource>
<AdministrableProductDefinition>
<id value="ap1mg"/>
<meta>
<profile
value="http://hl7.org/fhir/uv/emedicinal-product-info/StructureDefinition/AdministrableProductDefinition-uv-epi"/>
</meta>
<text>
<status value="generated"/>
<div xmlns="http://www.w3.org/1999/xhtml"><a name="AdministrableProductDefinition_ap1mg"> </a><p><b>Generated Narrative: AdministrableProductDefinition</b><a name="ap1mg"> </a><a name="hcap1mg"> </a></p><div style="display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%"><p style="margin-bottom: 0px">Resource AdministrableProductDefinition "ap1mg" </p><p style="margin-bottom: 0px">Profile: <a href="https://build.fhir.org/ig/HL7/emedicinal-product-info/StructureDefinition-AdministrableProductDefinition-uv-epi.html">AdministrableProductDefinition (ePI)</a></p></div><p><b>identifier</b>: <code>https://www.who-umc.org/phpid</code>/identifier</p><p><b>status</b>: active</p><p><b>formOf</b>: See on this page: MedicinalProductDefinition/mp1mg</p><p><b>administrableDoseForm</b>: Capsule, hard <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (rmswi#100000073375)</span></p><p><b>unitOfPresentation</b>: Capsule <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (rmswi#200000002113)</span></p><p><b>producedFrom</b>: See on this page: ManufacturedItemDefinition/mid1mg</p><blockquote><p><b>routeOfAdministration</b></p><p><b>code</b>: Oral use <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (rmswi#100000073619)</span></p><h3>TargetSpecies</h3><table class="grid"><tr><td style="display: none">-</td><td><b>Code</b></td></tr><tr><td style="display: none">*</td><td>Human <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (rmswi#100000109093)</span></td></tr></table></blockquote></div>
</text>
<identifier>
<system value="https://www.who-umc.org/phpid"/>
<value value="identifier"/>
</identifier>
<status value="active"/>
<formOf>
<reference value="MedicinalProductDefinition/mp1mg"/>
</formOf>
<administrableDoseForm>
<coding>
<system value="https://spor.ema.europa.eu/rmswi"/>
<code value="100000073375"/>
<display value="Capsule, hard"/>
</coding>
</administrableDoseForm>
<unitOfPresentation>
<coding>
<system value="https://spor.ema.europa.eu/rmswi"/>
<code value="200000002113"/>
<display value="Capsule"/>
</coding>
</unitOfPresentation>
<producedFrom>
<reference value="ManufacturedItemDefinition/mid1mg"/>
</producedFrom>
<routeOfAdministration>
<code>
<coding>
<system value="https://spor.ema.europa.eu/rmswi"/>
<code value="100000073619"/>
<display value="Oral use"/>
</coding>
</code>
<targetSpecies>
<code>
<coding>
<system value="https://spor.ema.europa.eu/rmswi"/>
<code value="100000109093"/>
<display value="Human"/>
</coding>
</code>
</targetSpecies>
</routeOfAdministration>
</AdministrableProductDefinition>
</resource>
</entry>
<entry>
<fullUrl value="RegulatedAuthorization/authorization01mg"/>
<resource>
<RegulatedAuthorization>
<id value="authorization01mg"/>
<meta>
<profile
value="http://hl7.org/fhir/uv/emedicinal-product-info/StructureDefinition/RegulatedAuthorization-uv-epi"/>
</meta>
<text>
<status value="generated"/>
<div xmlns="http://www.w3.org/1999/xhtml"><a name="RegulatedAuthorization_authorization01mg"> </a><p><b>Generated Narrative: RegulatedAuthorization</b><a name="authorization01mg"> </a><a name="hcauthorization01mg"> </a></p><div style="display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%"><p style="margin-bottom: 0px">Resource RegulatedAuthorization "authorization01mg" </p><p style="margin-bottom: 0px">Profile: <a href="https://build.fhir.org/ig/HL7/emedicinal-product-info/StructureDefinition-RegulatedAuthorization-uv-epi.html">RegulatedAuthorization (ePI)</a></p></div><p><b>identifier</b>: <code>https://spor.ema.europa.eu/pmswi</code>/6ae5b5d9-7372-494c-874b-7dc67d386d2e (use: official)</p><p><b>subject</b>: See on this page: MedicinalProductDefinition/mp01mg</p><p><b>type</b>: Marketing Authorisation <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (rmswi#220000000061)</span></p><p><b>region</b>: United Kingdom <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (<a href="http://terminology.hl7.org/5.3.0/CodeSystem-ISO3166Part1.html">ISO 3166-1 Codes for the representation of names of countries and their subdivisions — Part 1: Country code</a>#GBR)</span></p><p><b>status</b>: Active <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (<a href="http://hl7.org/fhir/R5/codesystem-publication-status.html">PublicationStatus</a>#active)</span></p><p><b>statusDate</b>: 2022-03-01 00:00:00+0000</p><p><b>holder</b>: See on this page: Organization/orgpfizerukltd</p></div>
</text>
<identifier>
<use value="official"/>
<system value="https://spor.ema.europa.eu/pmswi"/>
<value value="6ae5b5d9-7372-494c-874b-7dc67d386d2e"/>
</identifier>
<subject>
<reference value="MedicinalProductDefinition/mp01mg"/>
</subject>
<type>
<coding>
<system value="https://spor.ema.europa.eu/rmswi"/>
<code value="220000000061"/>
<display value="Marketing Authorisation"/>
</coding>
</type>
<region>
<coding>
<system value="urn:iso:std:iso:3166"/>
<code value="GBR"/>
<display value="United Kingdom"/>
</coding>
</region>
<status>
<coding>
<system value="http://hl7.org/fhir/publication-status"/>
<code value="active"/>
<display value="Active"/>
</coding>
</status>
<statusDate value="2022-03-01T00:00:00Z"/>
<holder>
<reference value="Organization/orgpfizerukltd"/>
</holder>
</RegulatedAuthorization>
</resource>
</entry>
<entry>
<fullUrl value="RegulatedAuthorization/authorization025mg"/>
<resource>
<RegulatedAuthorization>
<id value="authorization025mg"/>
<meta>
<profile
value="http://hl7.org/fhir/uv/emedicinal-product-info/StructureDefinition/RegulatedAuthorization-uv-epi"/>
</meta>
<text>
<status value="generated"/>
<div xmlns="http://www.w3.org/1999/xhtml"><a name="RegulatedAuthorization_authorization025mg"> </a><p><b>Generated Narrative: RegulatedAuthorization</b><a name="authorization025mg"> </a><a name="hcauthorization025mg"> </a></p><div style="display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%"><p style="margin-bottom: 0px">Resource RegulatedAuthorization "authorization025mg" </p><p style="margin-bottom: 0px">Profile: <a href="https://build.fhir.org/ig/HL7/emedicinal-product-info/StructureDefinition-RegulatedAuthorization-uv-epi.html">RegulatedAuthorization (ePI)</a></p></div><p><b>identifier</b>: <code>https://spor.ema.europa.eu/pmswi</code>/6ae5b5d9-7372-494c-874b-7dc67d386d2e (use: official)</p><p><b>subject</b>: See on this page: MedicinalProductDefinition/mp025mg</p><p><b>type</b>: Marketing Authorisation <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (rmswi#220000000061)</span></p><p><b>region</b>: United Kingdom <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (<a href="http://terminology.hl7.org/5.3.0/CodeSystem-ISO3166Part1.html">ISO 3166-1 Codes for the representation of names of countries and their subdivisions — Part 1: Country code</a>#GBR)</span></p><p><b>status</b>: Active <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (<a href="http://hl7.org/fhir/R5/codesystem-publication-status.html">PublicationStatus</a>#active)</span></p><p><b>statusDate</b>: 2022-03-01 00:00:00+0000</p><p><b>holder</b>: See on this page: Organization/orgpfizerukltd</p></div>
</text>
<identifier>
<use value="official"/>
<system value="https://spor.ema.europa.eu/pmswi"/>
<value value="6ae5b5d9-7372-494c-874b-7dc67d386d2e"/>
</identifier>
<subject>
<reference value="MedicinalProductDefinition/mp025mg"/>
</subject>
<type>
<coding>
<system value="https://spor.ema.europa.eu/rmswi"/>
<code value="220000000061"/>
<display value="Marketing Authorisation"/>
</coding>
</type>
<region>
<coding>
<system value="urn:iso:std:iso:3166"/>
<code value="GBR"/>
<display value="United Kingdom"/>
</coding>
</region>
<status>
<coding>
<system value="http://hl7.org/fhir/publication-status"/>
<code value="active"/>
<display value="Active"/>
</coding>
</status>
<statusDate value="2022-03-01T00:00:00Z"/>
<holder>
<reference value="Organization/orgpfizerukltd"/>
</holder>
</RegulatedAuthorization>
</resource>
</entry>
<entry>
<fullUrl value="RegulatedAuthorization/authorization1mg"/>
<resource>
<RegulatedAuthorization>
<id value="authorization1mg"/>
<meta>
<profile
value="http://hl7.org/fhir/uv/emedicinal-product-info/StructureDefinition/RegulatedAuthorization-uv-epi"/>
</meta>
<text>
<status value="generated"/>
<div xmlns="http://www.w3.org/1999/xhtml"><a name="RegulatedAuthorization_authorization1mg"> </a><p><b>Generated Narrative: RegulatedAuthorization</b><a name="authorization1mg"> </a><a name="hcauthorization1mg"> </a></p><div style="display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%"><p style="margin-bottom: 0px">Resource RegulatedAuthorization "authorization1mg" </p><p style="margin-bottom: 0px">Profile: <a href="https://build.fhir.org/ig/HL7/emedicinal-product-info/StructureDefinition-RegulatedAuthorization-uv-epi.html">RegulatedAuthorization (ePI)</a></p></div><p><b>identifier</b>: <code>https://spor.ema.europa.eu/pmswi</code>/5321fb02-cd43-4c7e-bba5-b1d628815a54 (use: official)</p><p><b>subject</b>: See on this page: MedicinalProductDefinition/mp1mg</p><p><b>type</b>: Marketing Authorisation <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (rmswi#220000000061)</span></p><p><b>region</b>: United Kingdom <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (<a href="http://terminology.hl7.org/5.3.0/CodeSystem-ISO3166Part1.html">ISO 3166-1 Codes for the representation of names of countries and their subdivisions — Part 1: Country code</a>#GBR)</span></p><p><b>status</b>: Active <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (<a href="http://hl7.org/fhir/R5/codesystem-publication-status.html">PublicationStatus</a>#active)</span></p><p><b>statusDate</b>: 2022-03-01 00:00:00+0000</p><p><b>holder</b>: See on this page: Organization/orgpfizerukltd</p></div>
</text>
<identifier>
<use value="official"/>
<system value="https://spor.ema.europa.eu/pmswi"/>
<value value="5321fb02-cd43-4c7e-bba5-b1d628815a54"/>
</identifier>
<subject>
<reference value="MedicinalProductDefinition/mp1mg"/>
</subject>
<type>
<coding>
<system value="https://spor.ema.europa.eu/rmswi"/>
<code value="220000000061"/>
<display value="Marketing Authorisation"/>
</coding>
</type>
<region>
<coding>
<system value="urn:iso:std:iso:3166"/>
<code value="GBR"/>
<display value="United Kingdom"/>
</coding>
</region>
<status>
<coding>
<system value="http://hl7.org/fhir/publication-status"/>
<code value="active"/>
<display value="Active"/>
</coding>
</status>
<statusDate value="2022-03-01T00:00:00Z"/>
<holder>
<reference value="Organization/orgpfizerukltd"/>
</holder>
</RegulatedAuthorization>
</resource>
</entry>
<entry>
<fullUrl value="Organization/orgpfizerukltd"/>
<resource>
<Organization>
<id value="orgpfizerukltd"/>
<meta>
<profile
value="http://hl7.org/fhir/uv/emedicinal-product-info/StructureDefinition/Organization-uv-epi"/>
</meta>
<text>
<status value="generated"/>
<div xmlns="http://www.w3.org/1999/xhtml"><a name="Organization_orgpfizerukltd"> </a><p><b>Generated Narrative: Organization</b><a name="orgpfizerukltd"> </a><a name="hcorgpfizerukltd"> </a></p><div style="display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%"><p style="margin-bottom: 0px">Resource Organization "orgpfizerukltd" </p><p style="margin-bottom: 0px">Profile: <a href="https://build.fhir.org/ig/HL7/emedicinal-product-info/StructureDefinition-Organization-uv-epi.html">Organization (ePI)</a></p></div><p><b>identifier</b>: <code>https://spor.ema.europa.eu/omswi</code>/ORG-100000789 (use: official)</p><p><b>active</b>: true</p><p><b>type</b>: Marketing authorisation holder <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (rmswi#220000000034)</span></p><p><b>name</b>: Pfizer Limited</p><h3>Contacts</h3><table class="grid"><tr><td style="display: none">-</td><td><b>Address</b></td></tr><tr><td style="display: none">*</td><td>Pfizer Limited Ramsgate Road, Sandwich, Kent, CT13 9NJ, United Kingdom(work)</td></tr></table></div>
</text>
<identifier>
<use value="official"/>
<system value="https://spor.ema.europa.eu/omswi"/>
<value value="ORG-100000789"/>
</identifier>
<active value="true"/>
<type>
<coding>
<system value="https://spor.ema.europa.eu/rmswi"/>
<code value="220000000034"/>
<display value="Marketing authorisation holder"/>
</coding>
<text value="Marketing authorisation holder"/>
</type>
<name value="Pfizer Limited"/>
<contact>
<address>
<use value="work"/>
<type value="physical"/>
<text
value="Pfizer Limited Ramsgate Road, Sandwich, Kent, CT13 9NJ, United Kingdom"/>
<line value="Ramsgate Road"/>
<city value="Sandwich"/>
<country value="UK"/>
</address>
</contact>
</Organization>
</resource>
</entry>
<entry>
<fullUrl value="Organization/orgpfizerukltd"/>
<resource>
<Organization>
<id value="orgexcellagmbh"/>
<meta>
<profile
value="http://hl7.org/fhir/uv/emedicinal-product-info/StructureDefinition/Organization-uv-epi"/>
</meta>
<text>
<status value="generated"/>
<div xmlns="http://www.w3.org/1999/xhtml"><a name="Organization_orgexcellagmbh"> </a><p><b>Generated Narrative: Organization</b><a name="orgexcellagmbh"> </a><a name="hcorgexcellagmbh"> </a></p><div style="display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%"><p style="margin-bottom: 0px">Resource Organization "orgexcellagmbh" </p><p style="margin-bottom: 0px">Profile: <a href="https://build.fhir.org/ig/HL7/emedicinal-product-info/StructureDefinition-Organization-uv-epi.html">Organization (ePI)</a></p></div><p><b>identifier</b>: <code>https://spor.ema.europa.eu/omswi</code>/ORG-100012030 (use: official)</p><p><b>active</b>: true</p><p><b>type</b>: Manufacturer <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (rmswi#220000000033)</span></p><p><b>name</b>: Excella GmbH & Co. KG</p><h3>Contacts</h3><table class="grid"><tr><td style="display: none">-</td><td><b>Address</b></td></tr><tr><td style="display: none">*</td><td>Excella GmbH & Co. KG, Nürnberger Strasse 12, 90537 Feucht, Germany(work)</td></tr></table></div>
</text>
<identifier>
<use value="official"/>
<system value="https://spor.ema.europa.eu/omswi"/>
<value value="ORG-100012030"/>
</identifier>
<active value="true"/>
<type>
<coding>
<system value="https://spor.ema.europa.eu/rmswi"/>
<code value="220000000033"/>
<display value="Manufacturer"/>
</coding>
<text value="Manufacturer"/>
</type>
<name value="Excella GmbH & Co. KG"/>
<contact>
<address>
<use value="work"/>
<type value="physical"/>
<text
value="Excella GmbH & Co. KG, Nürnberger Strasse 12, 90537 Feucht, Germany"/>
<line value="Nürnberger Strasse 12"/>
<city value="Feucht"/>
<country value="DE"/>
</address>
</contact>
</Organization>
</resource>
</entry>
<entry>
<fullUrl value="PackagedProductDefinition/ppd01mgbottle30"/>
<resource>
<PackagedProductDefinition>
<id value="ppd01mgbottle30"/>
<meta>
<profile
value="http://hl7.org/fhir/uv/emedicinal-product-info/StructureDefinition/PackagedProductDefinition-uv-epi"/>
</meta>
<text>
<status value="generated"/>
<div xmlns="http://www.w3.org/1999/xhtml"><a name="PackagedProductDefinition_ppd01mgbottle30"> </a><p><b>Generated Narrative: PackagedProductDefinition</b><a name="ppd01mgbottle30"> </a><a name="hcppd01mgbottle30"> </a></p><div style="display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%"><p style="margin-bottom: 0px">Resource PackagedProductDefinition "ppd01mgbottle30" </p><p style="margin-bottom: 0px">Profile: <a href="https://build.fhir.org/ig/HL7/emedicinal-product-info/StructureDefinition-PackagedProductDefinition-uv-epi.html">PackagedProductDefinition (ePI)</a></p></div><p><b>identifier</b>: <code>https://spor.ema.europa.eu/pmswi</code>/2f8c49a7-e592-43ae-b802-55557bd20470 (use: official)</p><p><b>name</b>: Talzenna 0.1 mg plastic bottle of 30 hard capsules</p><p><b>type</b>: Chemical Medicinal Product <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (rmswi#100000155527)</span></p><p><b>packageFor</b>: See on this page: MedicinalProductDefinition/mp01mg</p><p><b>status</b>: Active <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (<a href="http://hl7.org/fhir/R5/codesystem-publication-status.html">PublicationStatus</a>#active)</span></p><p><b>statusDate</b>: 2022-03-01 00:00:00+0000</p><p><b>containedItemQuantity</b>: 0.1 mg<span style="background: LightGoldenRodYellow"> (Details: UCUM code mg = 'mg')</span></p><p><b>manufacturer</b>: See on this page: Organization/orgexcellagmbh</p><h3>Packagings</h3><table class="grid"><tr><td style="display: none">-</td><td><b>Identifier</b></td><td><b>Type</b></td><td><b>Quantity</b></td><td><b>Material</b></td></tr><tr><td style="display: none">*</td><td><code>https://spor.ema.europa.eu/pmswi</code>/5913fadd-6172-4282-ad02-19ab9d063b66</td><td>Bottle <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (rmswi#100000073497)</span></td><td>30</td><td>PolyVinyl Chloride <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (rmswi#200000003222)</span></td></tr></table></div>
</text>
<identifier>
<use value="official"/>
<system value="https://spor.ema.europa.eu/pmswi"/>
<value value="2f8c49a7-e592-43ae-b802-55557bd20470"/>
</identifier>
<name value="Talzenna 0.1 mg plastic bottle of 30 hard capsules"/>
<type>
<coding>
<system value="https://spor.ema.europa.eu/rmswi"/>
<code value="100000155527"/>
<display value="Chemical Medicinal Product"/>
</coding>
</type>
<packageFor>
<reference value="MedicinalProductDefinition/mp01mg"/>
</packageFor>
<status>
<coding>
<system value="http://hl7.org/fhir/publication-status"/>
<code value="active"/>
<display value="Active"/>
</coding>
</status>
<statusDate value="2022-03-01T00:00:00Z"/>
<containedItemQuantity>
<value value="0.1"/>
<system value="http://unitsofmeasure.org"/>
<code value="mg"/>
</containedItemQuantity>
<manufacturer>🔗
<reference value="Organization/orgexcellagmbh"/>
</manufacturer>
<packaging>
<identifier>
<system value="https://spor.ema.europa.eu/pmswi"/>
<value value="5913fadd-6172-4282-ad02-19ab9d063b66"/>
</identifier>
<type>
<coding>
<system value="https://spor.ema.europa.eu/rmswi"/>
<code value="100000073497"/>
<display value="Bottle"/>
</coding>
</type>
<quantity value="30"/>
<material>
<coding>
<system value="https://spor.ema.europa.eu/rmswi"/>
<code value="200000003222"/>
<display value="PolyVinyl Chloride"/>
</coding>
</material>
</packaging>
</PackagedProductDefinition>
</resource>
</entry>
<entry>
<fullUrl value="PackagedProductDefinition/ppd025mgblister30"/>
<resource>
<PackagedProductDefinition>
<id value="ppd025mgblister30"/>
<meta>
<profile
value="http://hl7.org/fhir/uv/emedicinal-product-info/StructureDefinition/PackagedProductDefinition-uv-epi"/>
</meta>
<text>
<status value="generated"/>
<div xmlns="http://www.w3.org/1999/xhtml"><a name="PackagedProductDefinition_ppd025mgblister30"> </a><p><b>Generated Narrative: PackagedProductDefinition</b><a name="ppd025mgblister30"> </a><a name="hcppd025mgblister30"> </a></p><div style="display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%"><p style="margin-bottom: 0px">Resource PackagedProductDefinition "ppd025mgblister30" </p><p style="margin-bottom: 0px">Profile: <a href="https://build.fhir.org/ig/HL7/emedicinal-product-info/StructureDefinition-PackagedProductDefinition-uv-epi.html">PackagedProductDefinition (ePI)</a></p></div><p><b>identifier</b>: <code>https://spor.ema.europa.eu/pmswi</code>/b42ab299-e84b-4be3-bdbb-a66cd4c8c6ab (use: official)</p><p><b>name</b>: Talzenna 0.25 mg perforated unit dose blister packs of 30 hard capsules</p><p><b>type</b>: Chemical Medicinal Product <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (rmswi#100000155527)</span></p><p><b>packageFor</b>: See on this page: MedicinalProductDefinition/mp025mg</p><p><b>status</b>: Active <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (<a href="http://hl7.org/fhir/R5/codesystem-publication-status.html">PublicationStatus</a>#active)</span></p><p><b>statusDate</b>: 2022-03-01 00:00:00+0000</p><p><b>containedItemQuantity</b>: 0.25 mg<span style="background: LightGoldenRodYellow"> (Details: UCUM code mg = 'mg')</span></p><p><b>manufacturer</b>: See on this page: Organization/orgexcellagmbh</p><h3>Packagings</h3><table class="grid"><tr><td style="display: none">-</td><td><b>Identifier</b></td><td><b>Type</b></td><td><b>Quantity</b></td><td><b>Material</b></td></tr><tr><td style="display: none">*</td><td><code>https://spor.ema.europa.eu/pmswi</code>/5913fadd-6172-4282-ad02-19ab9d063b66</td><td>Blister <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (rmswi#100000073496)</span></td><td>30</td><td>PolyVinyl Chloride <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (rmswi#200000003222)</span></td></tr></table></div>
</text>
<identifier>
<use value="official"/>
<system value="https://spor.ema.europa.eu/pmswi"/>
<value value="b42ab299-e84b-4be3-bdbb-a66cd4c8c6ab"/>
</identifier>
<name
value="Talzenna 0.25 mg perforated unit dose blister packs of 30 hard capsules"/>
<type>
<coding>
<system value="https://spor.ema.europa.eu/rmswi"/>
<code value="100000155527"/>
<display value="Chemical Medicinal Product"/>
</coding>
</type>
<packageFor>
<reference value="MedicinalProductDefinition/mp025mg"/>
</packageFor>
<status>
<coding>
<system value="http://hl7.org/fhir/publication-status"/>
<code value="active"/>
<display value="Active"/>
</coding>
</status>
<statusDate value="2022-03-01T00:00:00Z"/>
<containedItemQuantity>
<value value="0.25"/>
<system value="http://unitsofmeasure.org"/>
<code value="mg"/>
</containedItemQuantity>
<manufacturer>🔗
<reference value="Organization/orgexcellagmbh"/>
</manufacturer>
<packaging>
<identifier>
<system value="https://spor.ema.europa.eu/pmswi"/>
<value value="5913fadd-6172-4282-ad02-19ab9d063b66"/>
</identifier>
<type>
<coding>
<system value="https://spor.ema.europa.eu/rmswi"/>
<code value="100000073496"/>
<display value="Blister"/>
</coding>
</type>
<quantity value="30"/>
<material>
<coding>
<system value="https://spor.ema.europa.eu/rmswi"/>
<code value="200000003222"/>
<display value="PolyVinyl Chloride"/>
</coding>
</material>
</packaging>
</PackagedProductDefinition>
</resource>
</entry>
<entry>
<fullUrl value="PackagedProductDefinition/ppd025mgblister30"/>
<resource>
<PackagedProductDefinition>
<id value="ppd025mgblister30"/>
<meta>
<profile
value="http://hl7.org/fhir/uv/emedicinal-product-info/StructureDefinition/PackagedProductDefinition-uv-epi"/>
</meta>
<text>
<status value="generated"/>
<div xmlns="http://www.w3.org/1999/xhtml"><a name="PackagedProductDefinition_ppd025mgblister30"> </a><p><b>Generated Narrative: PackagedProductDefinition</b><a name="ppd025mgblister30"> </a><a name="hcppd025mgblister30"> </a></p><div style="display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%"><p style="margin-bottom: 0px">Resource PackagedProductDefinition "ppd025mgblister30" </p><p style="margin-bottom: 0px">Profile: <a href="https://build.fhir.org/ig/HL7/emedicinal-product-info/StructureDefinition-PackagedProductDefinition-uv-epi.html">PackagedProductDefinition (ePI)</a></p></div><p><b>identifier</b>: <code>https://spor.ema.europa.eu/pmswi</code>/b42ab299-e84b-4be3-bdbb-a66cd4c8c6ab (use: official)</p><p><b>name</b>: Talzenna 0.25 mg perforated unit dose blister packs of 30 hard capsules</p><p><b>type</b>: Chemical Medicinal Product <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (rmswi#100000155527)</span></p><p><b>packageFor</b>: See on this page: MedicinalProductDefinition/mp025mg</p><p><b>status</b>: Active <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (<a href="http://hl7.org/fhir/R5/codesystem-publication-status.html">PublicationStatus</a>#active)</span></p><p><b>statusDate</b>: 2022-03-01 00:00:00+0000</p><p><b>containedItemQuantity</b>: 0.25 mg<span style="background: LightGoldenRodYellow"> (Details: UCUM code mg = 'mg')</span></p><p><b>manufacturer</b>: See on this page: Organization/orgexcellagmbh</p><h3>Packagings</h3><table class="grid"><tr><td style="display: none">-</td><td><b>Identifier</b></td><td><b>Type</b></td><td><b>Quantity</b></td><td><b>Material</b></td></tr><tr><td style="display: none">*</td><td><code>https://spor.ema.europa.eu/pmswi</code>/5913fadd-6172-4282-ad02-19ab9d063b66</td><td>Blister <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (rmswi#100000073496)</span></td><td>30</td><td>PolyVinyl Chloride <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (rmswi#200000003222)</span></td></tr></table></div>
</text>
<identifier>
<use value="official"/>
<system value="https://spor.ema.europa.eu/pmswi"/>
<value value="b42ab299-e84b-4be3-bdbb-a66cd4c8c6ab"/>
</identifier>
<name
value="Talzenna 0.25 mg perforated unit dose blister packs of 30 hard capsules"/>
<type>
<coding>
<system value="https://spor.ema.europa.eu/rmswi"/>
<code value="100000155527"/>
<display value="Chemical Medicinal Product"/>
</coding>
</type>
<packageFor>
<reference value="MedicinalProductDefinition/mp025mg"/>
</packageFor>
<status>
<coding>
<system value="http://hl7.org/fhir/publication-status"/>
<code value="active"/>
<display value="Active"/>
</coding>
</status>
<statusDate value="2022-03-01T00:00:00Z"/>
<containedItemQuantity>
<value value="0.25"/>
<system value="http://unitsofmeasure.org"/>
<code value="mg"/>
</containedItemQuantity>
<manufacturer>🔗
<reference value="Organization/orgexcellagmbh"/>
</manufacturer>
<packaging>
<identifier>
<system value="https://spor.ema.europa.eu/pmswi"/>
<value value="5913fadd-6172-4282-ad02-19ab9d063b66"/>
</identifier>
<type>
<coding>
<system value="https://spor.ema.europa.eu/rmswi"/>
<code value="100000073496"/>
<display value="Blister"/>
</coding>
</type>
<quantity value="30"/>
<material>
<coding>
<system value="https://spor.ema.europa.eu/rmswi"/>
<code value="200000003222"/>
<display value="PolyVinyl Chloride"/>
</coding>
</material>
</packaging>
</PackagedProductDefinition>
</resource>
</entry>
<entry>
<fullUrl value="PackagedProductDefinition/ppd025mgblister60"/>
<resource>
<PackagedProductDefinition>
<id value="ppd025mgblister60"/>
<meta>
<profile
value="http://hl7.org/fhir/uv/emedicinal-product-info/StructureDefinition/PackagedProductDefinition-uv-epi"/>
</meta>
<text>
<status value="generated"/>
<div xmlns="http://www.w3.org/1999/xhtml"><a name="PackagedProductDefinition_ppd025mgblister60"> </a><p><b>Generated Narrative: PackagedProductDefinition</b><a name="ppd025mgblister60"> </a><a name="hcppd025mgblister60"> </a></p><div style="display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%"><p style="margin-bottom: 0px">Resource PackagedProductDefinition "ppd025mgblister60" </p><p style="margin-bottom: 0px">Profile: <a href="https://build.fhir.org/ig/HL7/emedicinal-product-info/StructureDefinition-PackagedProductDefinition-uv-epi.html">PackagedProductDefinition (ePI)</a></p></div><p><b>identifier</b>: <code>https://spor.ema.europa.eu/pmswi</code>/9aec5a08-17f6-44f0-bd7b-c75fcff62628 (use: official)</p><p><b>name</b>: Talzenna 0.25 mg perforated unit dose blister packs 60 hard capsules</p><p><b>type</b>: Chemical Medicinal Product <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (rmswi#100000155527)</span></p><p><b>packageFor</b>: See on this page: MedicinalProductDefinition/mp025mg</p><p><b>status</b>: Active <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (<a href="http://hl7.org/fhir/R5/codesystem-publication-status.html">PublicationStatus</a>#active)</span></p><p><b>statusDate</b>: 2022-03-01 00:00:00+0000</p><p><b>containedItemQuantity</b>: 0.25 mg<span style="background: LightGoldenRodYellow"> (Details: UCUM code mg = 'mg')</span></p><p><b>manufacturer</b>: See on this page: Organization/orgexcellagmbh</p><h3>Packagings</h3><table class="grid"><tr><td style="display: none">-</td><td><b>Identifier</b></td><td><b>Type</b></td><td><b>Quantity</b></td><td><b>Material</b></td></tr><tr><td style="display: none">*</td><td><code>https://spor.ema.europa.eu/pmswi</code>/5913fadd-6172-4282-ad02-19ab9d063b66</td><td>Blister <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (rmswi#100000073496)</span></td><td>60</td><td>PolyVinyl Chloride <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (rmswi#200000003222)</span></td></tr></table></div>
</text>
<identifier>
<use value="official"/>
<system value="https://spor.ema.europa.eu/pmswi"/>
<value value="9aec5a08-17f6-44f0-bd7b-c75fcff62628"/>
</identifier>
<name
value="Talzenna 0.25 mg perforated unit dose blister packs 60 hard capsules"/>
<type>
<coding>
<system value="https://spor.ema.europa.eu/rmswi"/>
<code value="100000155527"/>
<display value="Chemical Medicinal Product"/>
</coding>
</type>
<packageFor>
<reference value="MedicinalProductDefinition/mp025mg"/>
</packageFor>
<status>
<coding>
<system value="http://hl7.org/fhir/publication-status"/>
<code value="active"/>
<display value="Active"/>
</coding>
</status>
<statusDate value="2022-03-01T00:00:00Z"/>
<containedItemQuantity>
<value value="0.25"/>
<system value="http://unitsofmeasure.org"/>
<code value="mg"/>
</containedItemQuantity>
<manufacturer>🔗
<reference value="Organization/orgexcellagmbh"/>
</manufacturer>
<packaging>
<identifier>
<system value="https://spor.ema.europa.eu/pmswi"/>
<value value="5913fadd-6172-4282-ad02-19ab9d063b66"/>
</identifier>
<type>
<coding>
<system value="https://spor.ema.europa.eu/rmswi"/>
<code value="100000073496"/>
<display value="Blister"/>
</coding>
</type>
<quantity value="60"/>
<material>
<coding>
<system value="https://spor.ema.europa.eu/rmswi"/>
<code value="200000003222"/>
<display value="PolyVinyl Chloride"/>
</coding>
</material>
</packaging>
</PackagedProductDefinition>
</resource>
</entry>
<entry>
<fullUrl value="PackagedProductDefinition/ppd025mgblister90"/>
<resource>
<PackagedProductDefinition>
<id value="ppd025mgblister90"/>
<meta>
<profile
value="http://hl7.org/fhir/uv/emedicinal-product-info/StructureDefinition/PackagedProductDefinition-uv-epi"/>
</meta>
<text>
<status value="generated"/>
<div xmlns="http://www.w3.org/1999/xhtml"><a name="PackagedProductDefinition_ppd025mgblister90"> </a><p><b>Generated Narrative: PackagedProductDefinition</b><a name="ppd025mgblister90"> </a><a name="hcppd025mgblister90"> </a></p><div style="display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%"><p style="margin-bottom: 0px">Resource PackagedProductDefinition "ppd025mgblister90" </p><p style="margin-bottom: 0px">Profile: <a href="https://build.fhir.org/ig/HL7/emedicinal-product-info/StructureDefinition-PackagedProductDefinition-uv-epi.html">PackagedProductDefinition (ePI)</a></p></div><p><b>identifier</b>: <code>https://spor.ema.europa.eu/pmswi</code>/11967e26-c2d5-46aa-a51f-21a0f9c7bfd0 (use: official)</p><p><b>name</b>: Talzenna 0.25 mg perforated unit dose blister packs of 90 hard capsules</p><p><b>type</b>: Chemical Medicinal Product <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (rmswi#100000155527)</span></p><p><b>packageFor</b>: See on this page: MedicinalProductDefinition/mp025mg</p><p><b>status</b>: Active <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (<a href="http://hl7.org/fhir/R5/codesystem-publication-status.html">PublicationStatus</a>#active)</span></p><p><b>statusDate</b>: 2022-03-01 00:00:00+0000</p><p><b>containedItemQuantity</b>: 0.25 mg<span style="background: LightGoldenRodYellow"> (Details: UCUM code mg = 'mg')</span></p><p><b>manufacturer</b>: See on this page: Organization/orgexcellagmbh</p><h3>Packagings</h3><table class="grid"><tr><td style="display: none">-</td><td><b>Identifier</b></td><td><b>Type</b></td><td><b>Quantity</b></td><td><b>Material</b></td></tr><tr><td style="display: none">*</td><td><code>https://spor.ema.europa.eu/pmswi</code>/5913fadd-6172-4282-ad02-19ab9d063b66</td><td>Blister <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (rmswi#100000073496)</span></td><td>90</td><td>PolyVinyl Chloride <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (rmswi#200000003222)</span></td></tr></table></div>
</text>
<identifier>
<use value="official"/>
<system value="https://spor.ema.europa.eu/pmswi"/>
<value value="11967e26-c2d5-46aa-a51f-21a0f9c7bfd0"/>
</identifier>
<name
value="Talzenna 0.25 mg perforated unit dose blister packs of 90 hard capsules"/>
<type>
<coding>
<system value="https://spor.ema.europa.eu/rmswi"/>
<code value="100000155527"/>
<display value="Chemical Medicinal Product"/>
</coding>
</type>
<packageFor>
<reference value="MedicinalProductDefinition/mp025mg"/>
</packageFor>
<status>
<coding>
<system value="http://hl7.org/fhir/publication-status"/>
<code value="active"/>
<display value="Active"/>
</coding>
</status>
<statusDate value="2022-03-01T00:00:00Z"/>
<containedItemQuantity>
<value value="0.25"/>
<system value="http://unitsofmeasure.org"/>
<code value="mg"/>
</containedItemQuantity>
<manufacturer>🔗
<reference value="Organization/orgexcellagmbh"/>
</manufacturer>
<packaging>
<identifier>
<system value="https://spor.ema.europa.eu/pmswi"/>
<value value="5913fadd-6172-4282-ad02-19ab9d063b66"/>
</identifier>
<type>
<coding>
<system value="https://spor.ema.europa.eu/rmswi"/>
<code value="100000073496"/>
<display value="Blister"/>
</coding>
</type>
<quantity value="90"/>
<material>
<coding>
<system value="https://spor.ema.europa.eu/rmswi"/>
<code value="200000003222"/>
<display value="PolyVinyl Chloride"/>
</coding>
</material>
</packaging>
</PackagedProductDefinition>
</resource>
</entry>
<entry>
<fullUrl value="PackagedProductDefinition/ppd025mgbottle30"/>
<resource>
<PackagedProductDefinition>
<id value="ppd025mgbottle30"/>
<meta>
<profile
value="http://hl7.org/fhir/uv/emedicinal-product-info/StructureDefinition/PackagedProductDefinition-uv-epi"/>
</meta>
<text>
<status value="generated"/>
<div xmlns="http://www.w3.org/1999/xhtml"><a name="PackagedProductDefinition_ppd025mgbottle30"> </a><p><b>Generated Narrative: PackagedProductDefinition</b><a name="ppd025mgbottle30"> </a><a name="hcppd025mgbottle30"> </a></p><div style="display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%"><p style="margin-bottom: 0px">Resource PackagedProductDefinition "ppd025mgbottle30" </p><p style="margin-bottom: 0px">Profile: <a href="https://build.fhir.org/ig/HL7/emedicinal-product-info/StructureDefinition-PackagedProductDefinition-uv-epi.html">PackagedProductDefinition (ePI)</a></p></div><p><b>identifier</b>: <code>https://spor.ema.europa.eu/pmswi</code>/2f8c49a7-e592-43ae-b802-55557bd20470 (use: official)</p><p><b>name</b>: Talzenna 0.25 mg plastic bottle of 30 hard capsules</p><p><b>type</b>: Chemical Medicinal Product <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (rmswi#100000155527)</span></p><p><b>packageFor</b>: See on this page: MedicinalProductDefinition/mp025mg</p><p><b>status</b>: Active <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (<a href="http://hl7.org/fhir/R5/codesystem-publication-status.html">PublicationStatus</a>#active)</span></p><p><b>statusDate</b>: 2022-03-01 00:00:00+0000</p><p><b>containedItemQuantity</b>: 0.25 mg<span style="background: LightGoldenRodYellow"> (Details: UCUM code mg = 'mg')</span></p><p><b>manufacturer</b>: See on this page: Organization/orgexcellagmbh</p><h3>Packagings</h3><table class="grid"><tr><td style="display: none">-</td><td><b>Identifier</b></td><td><b>Type</b></td><td><b>Quantity</b></td><td><b>Material</b></td></tr><tr><td style="display: none">*</td><td><code>https://spor.ema.europa.eu/pmswi</code>/5913fadd-6172-4282-ad02-19ab9d063b66</td><td>Bottle <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (rmswi#100000073497)</span></td><td>30</td><td>PolyVinyl Chloride <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (rmswi#200000003222)</span></td></tr></table></div>
</text>
<identifier>
<use value="official"/>
<system value="https://spor.ema.europa.eu/pmswi"/>
<value value="2f8c49a7-e592-43ae-b802-55557bd20470"/>
</identifier>
<name value="Talzenna 0.25 mg plastic bottle of 30 hard capsules"/>
<type>
<coding>
<system value="https://spor.ema.europa.eu/rmswi"/>
<code value="100000155527"/>
<display value="Chemical Medicinal Product"/>
</coding>
</type>
<packageFor>
<reference value="MedicinalProductDefinition/mp025mg"/>
</packageFor>
<status>
<coding>
<system value="http://hl7.org/fhir/publication-status"/>
<code value="active"/>
<display value="Active"/>
</coding>
</status>
<statusDate value="2022-03-01T00:00:00Z"/>
<containedItemQuantity>
<value value="0.25"/>
<system value="http://unitsofmeasure.org"/>
<code value="mg"/>
</containedItemQuantity>
<manufacturer>🔗
<reference value="Organization/orgexcellagmbh"/>
</manufacturer>
<packaging>
<identifier>
<system value="https://spor.ema.europa.eu/pmswi"/>
<value value="5913fadd-6172-4282-ad02-19ab9d063b66"/>
</identifier>
<type>
<coding>
<system value="https://spor.ema.europa.eu/rmswi"/>
<code value="100000073497"/>
<display value="Bottle"/>
</coding>
</type>
<quantity value="30"/>
<material>
<coding>
<system value="https://spor.ema.europa.eu/rmswi"/>
<code value="200000003222"/>
<display value="PolyVinyl Chloride"/>
</coding>
</material>
</packaging>
</PackagedProductDefinition>
</resource>
</entry>
<entry>
<fullUrl value="PackagedProductDefinition/ppd1mgblister30"/>
<resource>
<PackagedProductDefinition>
<id value="ppd1mgblister30"/>
<meta>
<profile
value="http://hl7.org/fhir/uv/emedicinal-product-info/StructureDefinition/PackagedProductDefinition-uv-epi"/>
</meta>
<text>
<status value="generated"/>
<div xmlns="http://www.w3.org/1999/xhtml"><a name="PackagedProductDefinition_ppd1mgblister30"> </a><p><b>Generated Narrative: PackagedProductDefinition</b><a name="ppd1mgblister30"> </a><a name="hcppd1mgblister30"> </a></p><div style="display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%"><p style="margin-bottom: 0px">Resource PackagedProductDefinition "ppd1mgblister30" </p><p style="margin-bottom: 0px">Profile: <a href="https://build.fhir.org/ig/HL7/emedicinal-product-info/StructureDefinition-PackagedProductDefinition-uv-epi.html">PackagedProductDefinition (ePI)</a></p></div><p><b>identifier</b>: <code>https://spor.ema.europa.eu/pmswi</code>/bcbdb341-2b7b-4fc5-b2c8-3762eba00670 (use: official)</p><p><b>name</b>: Talzenna 1 mg perforated unit dose blister packs of 30 hard capsules</p><p><b>type</b>: Chemical Medicinal Product <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (rmswi#100000155527)</span></p><p><b>packageFor</b>: See on this page: MedicinalProductDefinition/mp1mg</p><p><b>status</b>: Active <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (<a href="http://hl7.org/fhir/R5/codesystem-publication-status.html">PublicationStatus</a>#active)</span></p><p><b>statusDate</b>: 2022-03-01 00:00:00+0000</p><p><b>containedItemQuantity</b>: 1 mg<span style="background: LightGoldenRodYellow"> (Details: UCUM code mg = 'mg')</span></p><p><b>manufacturer</b>: See on this page: Organization/orgexcellagmbh</p><h3>Packagings</h3><table class="grid"><tr><td style="display: none">-</td><td><b>Identifier</b></td><td><b>Type</b></td><td><b>Quantity</b></td><td><b>Material</b></td></tr><tr><td style="display: none">*</td><td><code>https://spor.ema.europa.eu/pmswi</code>/5913fadd-6172-4282-ad02-19ab9d063b66</td><td>Blister <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (rmswi#100000073496)</span></td><td>30</td><td>PolyVinyl Chloride <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (rmswi#200000003222)</span></td></tr></table></div>
</text>
<identifier>
<use value="official"/>
<system value="https://spor.ema.europa.eu/pmswi"/>
<value value="bcbdb341-2b7b-4fc5-b2c8-3762eba00670"/>
</identifier>
<name
value="Talzenna 1 mg perforated unit dose blister packs of 30 hard capsules"/>
<type>
<coding>
<system value="https://spor.ema.europa.eu/rmswi"/>
<code value="100000155527"/>
<display value="Chemical Medicinal Product"/>
</coding>
</type>
<packageFor>
<reference value="MedicinalProductDefinition/mp1mg"/>
</packageFor>
<status>
<coding>
<system value="http://hl7.org/fhir/publication-status"/>
<code value="active"/>
<display value="Active"/>
</coding>
</status>
<statusDate value="2022-03-01T00:00:00Z"/>
<containedItemQuantity>
<value value="1"/>
<system value="http://unitsofmeasure.org"/>
<code value="mg"/>
</containedItemQuantity>
<manufacturer>🔗
<reference value="Organization/orgexcellagmbh"/>
</manufacturer>
<packaging>
<identifier>
<system value="https://spor.ema.europa.eu/pmswi"/>
<value value="5913fadd-6172-4282-ad02-19ab9d063b66"/>
</identifier>
<type>
<coding>
<system value="https://spor.ema.europa.eu/rmswi"/>
<code value="100000073496"/>
<display value="Blister"/>
</coding>
</type>
<quantity value="30"/>
<material>
<coding>
<system value="https://spor.ema.europa.eu/rmswi"/>
<code value="200000003222"/>
<display value="PolyVinyl Chloride"/>
</coding>
</material>
</packaging>
</PackagedProductDefinition>
</resource>
</entry>
<entry>
<fullUrl value="PackagedProductDefinition/ppd1mgbottle30"/>
<resource>
<PackagedProductDefinition>
<id value="ppd1mgbottle30"/>
<meta>
<profile
value="http://hl7.org/fhir/uv/emedicinal-product-info/StructureDefinition/PackagedProductDefinition-uv-epi"/>
</meta>
<text>
<status value="generated"/>
<div xmlns="http://www.w3.org/1999/xhtml"><a name="PackagedProductDefinition_ppd1mgbottle30"> </a><p><b>Generated Narrative: PackagedProductDefinition</b><a name="ppd1mgbottle30"> </a><a name="hcppd1mgbottle30"> </a></p><div style="display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%"><p style="margin-bottom: 0px">Resource PackagedProductDefinition "ppd1mgbottle30" </p><p style="margin-bottom: 0px">Profile: <a href="https://build.fhir.org/ig/HL7/emedicinal-product-info/StructureDefinition-PackagedProductDefinition-uv-epi.html">PackagedProductDefinition (ePI)</a></p></div><p><b>identifier</b>: <code>https://spor.ema.europa.eu/pmswi</code>/4ef88adf-91dc-4a21-855c-f511134ced68 (use: official)</p><p><b>name</b>: Talzenna 1 mg plastic bottle of 30 hard capsules</p><p><b>type</b>: Chemical Medicinal Product <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (rmswi#100000155527)</span></p><p><b>packageFor</b>: See on this page: MedicinalProductDefinition/mp1mg</p><p><b>status</b>: Active <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (<a href="http://hl7.org/fhir/R5/codesystem-publication-status.html">PublicationStatus</a>#active)</span></p><p><b>statusDate</b>: 2022-03-01 00:00:00+0000</p><p><b>containedItemQuantity</b>: 1 mg<span style="background: LightGoldenRodYellow"> (Details: UCUM code mg = 'mg')</span></p><p><b>manufacturer</b>: See on this page: Organization/orgexcellagmbh</p><h3>Packagings</h3><table class="grid"><tr><td style="display: none">-</td><td><b>Identifier</b></td><td><b>Type</b></td><td><b>Quantity</b></td><td><b>Material</b></td></tr><tr><td style="display: none">*</td><td><code>https://spor.ema.europa.eu/pmswi</code>/5913fadd-6172-4282-ad02-19ab9d063b66</td><td>Bottle <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (rmswi#100000073497)</span></td><td>30</td><td>PolyVinyl Chloride <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (rmswi#200000003222)</span></td></tr></table></div>
</text>
<identifier>
<use value="official"/>
<system value="https://spor.ema.europa.eu/pmswi"/>
<value value="4ef88adf-91dc-4a21-855c-f511134ced68"/>
</identifier>
<name value="Talzenna 1 mg plastic bottle of 30 hard capsules"/>
<type>
<coding>
<system value="https://spor.ema.europa.eu/rmswi"/>
<code value="100000155527"/>
<display value="Chemical Medicinal Product"/>
</coding>
</type>
<packageFor>
<reference value="MedicinalProductDefinition/mp1mg"/>
</packageFor>
<status>
<coding>
<system value="http://hl7.org/fhir/publication-status"/>
<code value="active"/>
<display value="Active"/>
</coding>
</status>
<statusDate value="2022-03-01T00:00:00Z"/>
<containedItemQuantity>
<value value="1"/>
<system value="http://unitsofmeasure.org"/>
<code value="mg"/>
</containedItemQuantity>
<manufacturer>🔗
<reference value="Organization/orgexcellagmbh"/>
</manufacturer>
<packaging>
<identifier>
<system value="https://spor.ema.europa.eu/pmswi"/>
<value value="5913fadd-6172-4282-ad02-19ab9d063b66"/>
</identifier>
<type>
<coding>
<system value="https://spor.ema.europa.eu/rmswi"/>
<code value="100000073497"/>
<display value="Bottle"/>
</coding>
</type>
<quantity value="30"/>
<material>
<coding>
<system value="https://spor.ema.europa.eu/rmswi"/>
<code value="200000003222"/>
<display value="PolyVinyl Chloride"/>
</coding>
</material>
</packaging>
</PackagedProductDefinition>
</resource>
</entry>
<entry>
<fullUrl value="MedicinalProductDefinition/mp01mg"/>
<resource>
<MedicinalProductDefinition>
<id value="mp01mg"/>
<meta>
<profile
value="http://hl7.org/fhir/uv/emedicinal-product-info/StructureDefinition/MedicinalProductDefinition-uv-epi"/>
</meta>
<text>
<status value="generated"/>
<div xmlns="http://www.w3.org/1999/xhtml"><a name="MedicinalProductDefinition_mp01mg"> </a><p><b>Generated Narrative: MedicinalProductDefinition</b><a name="mp01mg"> </a><a name="hcmp01mg"> </a></p><div style="display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%"><p style="margin-bottom: 0px">Resource MedicinalProductDefinition "mp01mg" </p><p style="margin-bottom: 0px">Profile: <a href="https://build.fhir.org/ig/HL7/emedicinal-product-info/StructureDefinition-MedicinalProductDefinition-uv-epi.html">MedicinalProductDefinition (ePI)</a></p></div><p><b>identifier</b>: <code>http://www.mhra.gov.uk/</code>/33e34b03-d69c-4ed6-af46-7a33d30189a1</p><p><b>type</b>: Medicinal Product <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (<a href="http://hl7.org/fhir/R5/codesystem-medicinal-product-type.html">Medicinal Product Type</a>#MedicinalProduct)</span></p><p><b>domain</b>: Human use <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (<a href="http://hl7.org/fhir/R5/codesystem-medicinal-product-domain.html">Medicinal Product Domain</a>#Human)</span></p><p><b>status</b>: active <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (<a href="http://hl7.org/fhir/R5/codesystem-publication-status.html">PublicationStatus</a>#active)</span></p><p><b>legalStatusOfSupply</b>: Medicinal product subject to medical prescription <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (rmswi#100000072084)</span></p><blockquote><p><b>name</b></p><p><b>productName</b>: Talzenna® (talazoparib) 0.1 mg hard capsules</p><p><b>type</b>: Full name <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (220000000000#220000000001)</span></p><blockquote><p><b>part</b></p><p><b>part</b>: Talzenna</p><p><b>type</b>: Invented name part <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (220000000000#220000000002)</span></p></blockquote><blockquote><p><b>part</b></p><p><b>part</b>: talazoparib</p><p><b>type</b>: Scientific name part <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (220000000000#220000000003)</span></p></blockquote><blockquote><p><b>part</b></p><p><b>part</b>: 0.1 mg</p><p><b>type</b>: Strength part <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (220000000000#220000000004)</span></p></blockquote><blockquote><p><b>part</b></p><p><b>part</b>: Capsule, hard</p><p><b>type</b>: Pharmaceutical dose form part <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (220000000000#220000000005)</span></p></blockquote><h3>Usages</h3><table class="grid"><tr><td style="display: none">-</td><td><b>Country</b></td><td><b>Jurisdiction</b></td><td><b>Language</b></td></tr><tr><td style="display: none">*</td><td>United Kingdom <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (<a href="http://terminology.hl7.org/5.3.0/CodeSystem-ISO3166Part1.html">ISO 3166-1 Codes for the representation of names of countries and their subdivisions — Part 1: Country code</a>#GBR)</span></td><td>United Kingdom <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (<a href="http://terminology.hl7.org/5.3.0/CodeSystem-ISO3166Part1.html">ISO 3166-1 Codes for the representation of names of countries and their subdivisions — Part 1: Country code</a>#GBR)</span></td><td>English <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (<a href="http://terminology.hl7.org/5.3.0/CodeSystem-v3-ietf3066.html">Tags for the Identification of Languages</a>#en)</span></td></tr></table></blockquote></div>
</text>
<identifier>
<system value="http://www.mhra.gov.uk/"/>
<value value="33e34b03-d69c-4ed6-af46-7a33d30189a1"/>
</identifier>
<type>
<coding>
<system value="http://hl7.org/fhir/medicinal-product-type"/>
<code value="MedicinalProduct"/>
<display value="Medicinal Product"/>
</coding>
</type>
<domain>
<coding>
<system value="http://hl7.org/fhir/medicinal-product-domain"/>
<code value="Human"/>
<display value="Human use"/>
</coding>
</domain>
<status>
<coding>
<system value="http://hl7.org/fhir/publication-status"/>
<code value="active"/>
<display value="active"/>
</coding>
</status>
<legalStatusOfSupply>
<coding>
<system value="https://spor.ema.europa.eu/rmswi"/>
<code value="100000072084"/>
<display
value="Medicinal product subject to medical prescription"/>
</coding>
</legalStatusOfSupply>
<name>
<productName value="Talzenna® (talazoparib) 0.1 mg hard capsules"/>
<type>
<coding>
<system value="https://spor.ema.europa.eu/lists/220000000000"/>
<code value="220000000001"/>
</coding>
<text value="Full name"/>
</type>
<part>
<part value="Talzenna"/>
<type>
<coding>
<system
value="https://spor.ema.europa.eu/lists/220000000000"/>
<code value="220000000002"/>
</coding>
<text value="Invented name part"/>
</type>
</part>
<part>
<part value="talazoparib"/>
<type>
<coding>
<system
value="https://spor.ema.europa.eu/lists/220000000000"/>
<code value="220000000003"/>
</coding>
<text value="Scientific name part"/>
</type>
</part>
<part>
<part value="0.1 mg"/>
<type>
<coding>
<system
value="https://spor.ema.europa.eu/lists/220000000000"/>
<code value="220000000004"/>
</coding>
<text value="Strength part"/>
</type>
</part>
<part>
<part value="Capsule, hard"/>
<type>
<coding>
<system
value="https://spor.ema.europa.eu/lists/220000000000"/>
<code value="220000000005"/>
</coding>
<text value="Pharmaceutical dose form part"/>
</type>
</part>
<usage>
<country>
<coding>
<system value="urn:iso:std:iso:3166"/>
<code value="GBR"/>
<display value="United Kingdom"/>
</coding>
</country>
<jurisdiction>
<coding>
<system value="urn:iso:std:iso:3166"/>
<code value="GBR"/>
<display value="United Kingdom"/>
</coding>
</jurisdiction>
<language>
<coding>
<system value="urn:ietf:bcp:47"/>
<code value="en"/>
<display value="English"/>
</coding>
</language>
</usage>
</name>
</MedicinalProductDefinition>
</resource>
</entry>
<entry>
<fullUrl value="MedicinalProductDefinition/mp025mg"/>
<resource>
<MedicinalProductDefinition>
<id value="mp025mg"/>
<meta>
<profile
value="http://hl7.org/fhir/uv/emedicinal-product-info/StructureDefinition/MedicinalProductDefinition-uv-epi"/>
</meta>
<text>
<status value="generated"/>
<div xmlns="http://www.w3.org/1999/xhtml"><a name="MedicinalProductDefinition_mp025mg"> </a><p><b>Generated Narrative: MedicinalProductDefinition</b><a name="mp025mg"> </a><a name="hcmp025mg"> </a></p><div style="display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%"><p style="margin-bottom: 0px">Resource MedicinalProductDefinition "mp025mg" </p><p style="margin-bottom: 0px">Profile: <a href="https://build.fhir.org/ig/HL7/emedicinal-product-info/StructureDefinition-MedicinalProductDefinition-uv-epi.html">MedicinalProductDefinition (ePI)</a></p></div><p><b>identifier</b>: <code>http://www.mhra.gov.uk/</code>/471bb15-7f52-4fcd-b615-8674ce6eb91e</p><p><b>type</b>: Medicinal Product <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (<a href="http://hl7.org/fhir/R5/codesystem-medicinal-product-type.html">Medicinal Product Type</a>#MedicinalProduct)</span></p><p><b>domain</b>: Human use <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (<a href="http://hl7.org/fhir/R5/codesystem-medicinal-product-domain.html">Medicinal Product Domain</a>#Human)</span></p><p><b>status</b>: active <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (<a href="http://hl7.org/fhir/R5/codesystem-publication-status.html">PublicationStatus</a>#active)</span></p><p><b>legalStatusOfSupply</b>: Medicinal product subject to medical prescription <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (rmswi#100000072084)</span></p><blockquote><p><b>name</b></p><p><b>productName</b>: Talzenna® (talazoparib) 0.25 mg hard capsules</p><p><b>type</b>: Full name <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (220000000000#220000000001)</span></p><blockquote><p><b>part</b></p><p><b>part</b>: Talzenna</p><p><b>type</b>: Invented name part <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (220000000000#220000000002)</span></p></blockquote><blockquote><p><b>part</b></p><p><b>part</b>: talazoparib</p><p><b>type</b>: Scientific name part <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (220000000000#220000000003)</span></p></blockquote><blockquote><p><b>part</b></p><p><b>part</b>: 0.25 mg</p><p><b>type</b>: Strength part <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (220000000000#220000000004)</span></p></blockquote><blockquote><p><b>part</b></p><p><b>part</b>: Capsule, hard</p><p><b>type</b>: Pharmaceutical dose form part <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (220000000000#220000000005)</span></p></blockquote><h3>Usages</h3><table class="grid"><tr><td style="display: none">-</td><td><b>Country</b></td><td><b>Jurisdiction</b></td><td><b>Language</b></td></tr><tr><td style="display: none">*</td><td>United Kingdom <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (<a href="http://terminology.hl7.org/5.3.0/CodeSystem-ISO3166Part1.html">ISO 3166-1 Codes for the representation of names of countries and their subdivisions — Part 1: Country code</a>#GBR)</span></td><td>United Kingdom <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (<a href="http://terminology.hl7.org/5.3.0/CodeSystem-ISO3166Part1.html">ISO 3166-1 Codes for the representation of names of countries and their subdivisions — Part 1: Country code</a>#GBR)</span></td><td>English <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (<a href="http://terminology.hl7.org/5.3.0/CodeSystem-v3-ietf3066.html">Tags for the Identification of Languages</a>#en)</span></td></tr></table></blockquote></div>
</text>
<identifier>
<system value="http://www.mhra.gov.uk/"/>
<value value="471bb15-7f52-4fcd-b615-8674ce6eb91e"/>
</identifier>
<type>
<coding>
<system value="http://hl7.org/fhir/medicinal-product-type"/>
<code value="MedicinalProduct"/>
<display value="Medicinal Product"/>
</coding>
</type>
<domain>
<coding>
<system value="http://hl7.org/fhir/medicinal-product-domain"/>
<code value="Human"/>
<display value="Human use"/>
</coding>
</domain>
<status>
<coding>
<system value="http://hl7.org/fhir/publication-status"/>
<code value="active"/>
<display value="active"/>
</coding>
</status>
<legalStatusOfSupply>
<coding>
<system value="https://spor.ema.europa.eu/rmswi"/>
<code value="100000072084"/>
<display
value="Medicinal product subject to medical prescription"/>
</coding>
</legalStatusOfSupply>
<name>
<productName value="Talzenna® (talazoparib) 0.25 mg hard capsules"/>
<type>
<coding>
<system value="https://spor.ema.europa.eu/lists/220000000000"/>
<code value="220000000001"/>
</coding>
<text value="Full name"/>
</type>
<part>
<part value="Talzenna"/>
<type>
<coding>
<system
value="https://spor.ema.europa.eu/lists/220000000000"/>
<code value="220000000002"/>
</coding>
<text value="Invented name part"/>
</type>
</part>
<part>
<part value="talazoparib"/>
<type>
<coding>
<system
value="https://spor.ema.europa.eu/lists/220000000000"/>
<code value="220000000003"/>
</coding>
<text value="Scientific name part"/>
</type>
</part>
<part>
<part value="0.25 mg"/>
<type>
<coding>
<system
value="https://spor.ema.europa.eu/lists/220000000000"/>
<code value="220000000004"/>
</coding>
<text value="Strength part"/>
</type>
</part>
<part>
<part value="Capsule, hard"/>
<type>
<coding>
<system
value="https://spor.ema.europa.eu/lists/220000000000"/>
<code value="220000000005"/>
</coding>
<text value="Pharmaceutical dose form part"/>
</type>
</part>
<usage>
<country>
<coding>
<system value="urn:iso:std:iso:3166"/>
<code value="GBR"/>
<display value="United Kingdom"/>
</coding>
</country>
<jurisdiction>
<coding>
<system value="urn:iso:std:iso:3166"/>
<code value="GBR"/>
<display value="United Kingdom"/>
</coding>
</jurisdiction>
<language>
<coding>
<system value="urn:ietf:bcp:47"/>
<code value="en"/>
<display value="English"/>
</coding>
</language>
</usage>
</name>
</MedicinalProductDefinition>
</resource>
</entry>
<entry>
<fullUrl value="MedicinalProductDefinition/mp1mg"/>
<resource>
<MedicinalProductDefinition>
<id value="mp1mg"/>
<meta>
<profile
value="http://hl7.org/fhir/uv/emedicinal-product-info/StructureDefinition/MedicinalProductDefinition-uv-epi"/>
</meta>
<text>
<status value="generated"/>
<div xmlns="http://www.w3.org/1999/xhtml"><a name="MedicinalProductDefinition_mp1mg"> </a><p><b>Generated Narrative: MedicinalProductDefinition</b><a name="mp1mg"> </a><a name="hcmp1mg"> </a></p><div style="display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%"><p style="margin-bottom: 0px">Resource MedicinalProductDefinition "mp1mg" </p><p style="margin-bottom: 0px">Profile: <a href="https://build.fhir.org/ig/HL7/emedicinal-product-info/StructureDefinition-MedicinalProductDefinition-uv-epi.html">MedicinalProductDefinition (ePI)</a></p></div><p><b>identifier</b>: <code>http://www.mhra.gov.uk/</code>/4471bb15-7f52-4fcd-b615-8674ce6eb91e</p><p><b>type</b>: Medicinal Product <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (<a href="http://hl7.org/fhir/R5/codesystem-medicinal-product-type.html">Medicinal Product Type</a>#MedicinalProduct)</span></p><p><b>domain</b>: Human use <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (<a href="http://hl7.org/fhir/R5/codesystem-medicinal-product-domain.html">Medicinal Product Domain</a>#Human)</span></p><p><b>status</b>: active <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (<a href="http://hl7.org/fhir/R5/codesystem-publication-status.html">PublicationStatus</a>#active)</span></p><p><b>legalStatusOfSupply</b>: Medicinal product subject to medical prescription <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (rmswi#100000072084)</span></p><blockquote><p><b>name</b></p><p><b>productName</b>: Talzenna® (talazoparib) 1 mg hard capsules</p><p><b>type</b>: Full name <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (220000000000#220000000001)</span></p><blockquote><p><b>part</b></p><p><b>part</b>: Talzenna</p><p><b>type</b>: Invented name part <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (220000000000#220000000002)</span></p></blockquote><blockquote><p><b>part</b></p><p><b>part</b>: talazoparib</p><p><b>type</b>: Scientific name part <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (220000000000#220000000003)</span></p></blockquote><blockquote><p><b>part</b></p><p><b>part</b>: 1 mg</p><p><b>type</b>: Strength part <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (220000000000#220000000004)</span></p></blockquote><blockquote><p><b>part</b></p><p><b>part</b>: Capsule, hard</p><p><b>type</b>: Pharmaceutical dose form part <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (220000000000#220000000005)</span></p></blockquote><h3>Usages</h3><table class="grid"><tr><td style="display: none">-</td><td><b>Country</b></td><td><b>Jurisdiction</b></td><td><b>Language</b></td></tr><tr><td style="display: none">*</td><td>United Kingdom <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (<a href="http://terminology.hl7.org/5.3.0/CodeSystem-ISO3166Part1.html">ISO 3166-1 Codes for the representation of names of countries and their subdivisions — Part 1: Country code</a>#GBR)</span></td><td>United Kingdom <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (<a href="http://terminology.hl7.org/5.3.0/CodeSystem-ISO3166Part1.html">ISO 3166-1 Codes for the representation of names of countries and their subdivisions — Part 1: Country code</a>#GBR)</span></td><td>English <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (<a href="http://terminology.hl7.org/5.3.0/CodeSystem-v3-ietf3066.html">Tags for the Identification of Languages</a>#en)</span></td></tr></table></blockquote></div>
</text>
<identifier>
<system value="http://www.mhra.gov.uk/"/>
<value value="4471bb15-7f52-4fcd-b615-8674ce6eb91e"/>
</identifier>
<type>
<coding>
<system value="http://hl7.org/fhir/medicinal-product-type"/>
<code value="MedicinalProduct"/>
<display value="Medicinal Product"/>
</coding>
</type>
<domain>
<coding>
<system value="http://hl7.org/fhir/medicinal-product-domain"/>
<code value="Human"/>
<display value="Human use"/>
</coding>
</domain>
<status>
<coding>
<system value="http://hl7.org/fhir/publication-status"/>
<code value="active"/>
<display value="active"/>
</coding>
</status>
<legalStatusOfSupply>
<coding>
<system value="https://spor.ema.europa.eu/rmswi"/>
<code value="100000072084"/>
<display
value="Medicinal product subject to medical prescription"/>
</coding>
</legalStatusOfSupply>
<name>
<productName value="Talzenna® (talazoparib) 1 mg hard capsules"/>
<type>
<coding>
<system value="https://spor.ema.europa.eu/lists/220000000000"/>
<code value="220000000001"/>
</coding>
<text value="Full name"/>
</type>
<part>
<part value="Talzenna"/>
<type>
<coding>
<system
value="https://spor.ema.europa.eu/lists/220000000000"/>
<code value="220000000002"/>
</coding>
<text value="Invented name part"/>
</type>
</part>
<part>
<part value="talazoparib"/>
<type>
<coding>
<system
value="https://spor.ema.europa.eu/lists/220000000000"/>
<code value="220000000003"/>
</coding>
<text value="Scientific name part"/>
</type>
</part>
<part>
<part value="1 mg"/>
<type>
<coding>
<system
value="https://spor.ema.europa.eu/lists/220000000000"/>
<code value="220000000004"/>
</coding>
<text value="Strength part"/>
</type>
</part>
<part>
<part value="Capsule, hard"/>
<type>
<coding>
<system
value="https://spor.ema.europa.eu/lists/220000000000"/>
<code value="220000000005"/>
</coding>
<text value="Pharmaceutical dose form part"/>
</type>
</part>
<usage>
<country>
<coding>
<system value="urn:iso:std:iso:3166"/>
<code value="GBR"/>
<display value="United Kingdom"/>
</coding>
</country>
<jurisdiction>
<coding>
<system value="urn:iso:std:iso:3166"/>
<code value="GBR"/>
<display value="United Kingdom"/>
</coding>
</jurisdiction>
<language>
<coding>
<system value="urn:ietf:bcp:47"/>
<code value="en"/>
<display value="English"/>
</coding>
</language>
</usage>
</name>
</MedicinalProductDefinition>
</resource>
</entry>
<entry>
<fullUrl value="ClinicalUseDefinition/interactionAmiodarone"/>
<resource>
<ClinicalUseDefinition>
<id value="36fdf79a-1b9c-11ee-be56-0242ac120002"/>
<meta>
<profile
value="http://hl7.org/fhir/uv/emedicinal-product-info/StructureDefinition/ClinicalUseDefinition-interaction-uv-epi"/>
</meta>
<text>
<status value="generated"/>
<div xmlns="http://www.w3.org/1999/xhtml"><a name="ClinicalUseDefinition_36fdf79a-1b9c-11ee-be56-0242ac120002"> </a><p><b>Generated Narrative: ClinicalUseDefinition</b><a name="36fdf79a-1b9c-11ee-be56-0242ac120002"> </a><a name="hc36fdf79a-1b9c-11ee-be56-0242ac120002"> </a></p><div style="display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%"><p style="margin-bottom: 0px">Resource ClinicalUseDefinition "36fdf79a-1b9c-11ee-be56-0242ac120002" </p><p style="margin-bottom: 0px">Profile: <a href="https://build.fhir.org/ig/HL7/emedicinal-product-info/StructureDefinition-ClinicalUseDefinition-interaction-uv-epi.html">ClinicalUseDefinition Interaction (ePI)</a></p></div><p><b>identifier</b>: <code>https://gsrs.ncats.nih.gov/ginas/app/beta</code>/N3RQ532IUT (use: official)</p><p><b>type</b>: interaction</p><p><b>subject</b>: </p><ul><li>See on this page: MedicinalProductDefinition/mp01mg</li><li>See on this page: MedicinalProductDefinition/mp025mg</li><li>See on this page: MedicinalProductDefinition/mp1mg</li></ul><blockquote><p><b>interaction</b></p><h3>Interactants</h3><table class="grid"><tr><td style="display: none">-</td><td><b>Item[x]</b></td></tr><tr><td style="display: none">*</td><td>Amiodarone <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (beta#N3RQ532IUT)</span></td></tr></table></blockquote></div>
</text>
<identifier>
<use value="official"/>
<system value="https://gsrs.ncats.nih.gov/ginas/app/beta"/>
<value value="N3RQ532IUT"/>
</identifier>
<type value="interaction"/>
<subject>
<reference value="MedicinalProductDefinition/mp01mg"/>
</subject>
<subject>
<reference value="MedicinalProductDefinition/mp025mg"/>
</subject>
<subject>
<reference value="MedicinalProductDefinition/mp1mg"/>
</subject>
<interaction>
<interactant>
<itemCodeableConcept>
<coding>
<system value="https://gsrs.ncats.nih.gov/ginas/app/beta"/>
<code value="N3RQ532IUT"/>
<display value="Amiodarone"/>
</coding>
</itemCodeableConcept>
</interactant>
</interaction>
</ClinicalUseDefinition>
</resource>
</entry>
<entry>
<fullUrl value="ClinicalUseDefinition/interactioncarvedilol"/>
<resource>
<ClinicalUseDefinition>
<id value="81a382e7-8e11-4097-a3fb-362de8c9377e"/>
<meta>
<profile
value="http://hl7.org/fhir/uv/emedicinal-product-info/StructureDefinition/ClinicalUseDefinition-interaction-uv-epi"/>
</meta>
<text>
<status value="generated"/>
<div xmlns="http://www.w3.org/1999/xhtml"><a name="ClinicalUseDefinition_81a382e7-8e11-4097-a3fb-362de8c9377e"> </a><p><b>Generated Narrative: ClinicalUseDefinition</b><a name="81a382e7-8e11-4097-a3fb-362de8c9377e"> </a><a name="hc81a382e7-8e11-4097-a3fb-362de8c9377e"> </a></p><div style="display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%"><p style="margin-bottom: 0px">Resource ClinicalUseDefinition "81a382e7-8e11-4097-a3fb-362de8c9377e" </p><p style="margin-bottom: 0px">Profile: <a href="https://build.fhir.org/ig/HL7/emedicinal-product-info/StructureDefinition-ClinicalUseDefinition-interaction-uv-epi.html">ClinicalUseDefinition Interaction (ePI)</a></p></div><p><b>identifier</b>: <code>https://gsrs.ncats.nih.gov/ginas/app/beta</code>/0K47UL67F2 (use: official)</p><p><b>type</b>: interaction</p><p><b>subject</b>: </p><ul><li>See on this page: MedicinalProductDefinition/mp01mg</li><li>See on this page: MedicinalProductDefinition/mp025mg</li><li>See on this page: MedicinalProductDefinition/mp1mg</li></ul><blockquote><p><b>interaction</b></p><h3>Interactants</h3><table class="grid"><tr><td style="display: none">-</td><td><b>Item[x]</b></td></tr><tr><td style="display: none">*</td><td>carvedilol <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (beta#0K47UL67F2)</span></td></tr></table></blockquote></div>
</text>
<identifier>
<use value="official"/>
<system value="https://gsrs.ncats.nih.gov/ginas/app/beta"/>
<value value="0K47UL67F2"/>
</identifier>
<type value="interaction"/>
<subject>
<reference value="MedicinalProductDefinition/mp01mg"/>
</subject>
<subject>
<reference value="MedicinalProductDefinition/mp025mg"/>
</subject>
<subject>
<reference value="MedicinalProductDefinition/mp1mg"/>
</subject>
<interaction>
<interactant>
<itemCodeableConcept>
<coding>
<system value="https://gsrs.ncats.nih.gov/ginas/app/beta"/>
<code value="0K47UL67F2"/>
<display value="carvedilol"/>
</coding>
</itemCodeableConcept>
</interactant>
</interaction>
</ClinicalUseDefinition>
</resource>
</entry>
<entry>
<fullUrl value="ClinicalUseDefinition/interactiondronedarone"/>
<resource>
<ClinicalUseDefinition>
<id value="3a099eb4-fc14-41c3-bc14-8e5a4b5c51e9"/>
<meta>
<profile
value="http://hl7.org/fhir/uv/emedicinal-product-info/StructureDefinition/ClinicalUseDefinition-interaction-uv-epi"/>
</meta>
<text>
<status value="generated"/>
<div xmlns="http://www.w3.org/1999/xhtml"><a name="ClinicalUseDefinition_3a099eb4-fc14-41c3-bc14-8e5a4b5c51e9"> </a><p><b>Generated Narrative: ClinicalUseDefinition</b><a name="3a099eb4-fc14-41c3-bc14-8e5a4b5c51e9"> </a><a name="hc3a099eb4-fc14-41c3-bc14-8e5a4b5c51e9"> </a></p><div style="display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%"><p style="margin-bottom: 0px">Resource ClinicalUseDefinition "3a099eb4-fc14-41c3-bc14-8e5a4b5c51e9" </p><p style="margin-bottom: 0px">Profile: <a href="https://build.fhir.org/ig/HL7/emedicinal-product-info/StructureDefinition-ClinicalUseDefinition-interaction-uv-epi.html">ClinicalUseDefinition Interaction (ePI)</a></p></div><p><b>identifier</b>: <code>https://gsrs.ncats.nih.gov/ginas/app/beta</code>/JQZ1L091Y2 (use: official)</p><p><b>type</b>: interaction</p><p><b>subject</b>: </p><ul><li>See on this page: MedicinalProductDefinition/mp01mg</li><li>See on this page: MedicinalProductDefinition/mp025mg</li><li>See on this page: MedicinalProductDefinition/mp1mg</li></ul><blockquote><p><b>interaction</b></p><h3>Interactants</h3><table class="grid"><tr><td style="display: none">-</td><td><b>Item[x]</b></td></tr><tr><td style="display: none">*</td><td>dronedarone <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (beta#JQZ1L091Y2)</span></td></tr></table></blockquote></div>
</text>
<identifier>
<use value="official"/>
<system value="https://gsrs.ncats.nih.gov/ginas/app/beta"/>
<value value="JQZ1L091Y2"/>
</identifier>
<type value="interaction"/>
<subject>
<reference value="MedicinalProductDefinition/mp01mg"/>
</subject>
<subject>
<reference value="MedicinalProductDefinition/mp025mg"/>
</subject>
<subject>
<reference value="MedicinalProductDefinition/mp1mg"/>
</subject>
<interaction>
<interactant>
<itemCodeableConcept>
<coding>
<system value="https://gsrs.ncats.nih.gov/ginas/app/beta"/>
<code value="JQZ1L091Y2"/>
<display value="dronedarone"/>
</coding>
</itemCodeableConcept>
</interactant>
</interaction>
</ClinicalUseDefinition>
</resource>
</entry>
<entry>
<fullUrl value="ClinicalUseDefinition/interactionpropafenone"/>
<resource>
<ClinicalUseDefinition>
<id value="341721cd-5b7e-4b97-895e-e489b1310f9b"/>
<meta>
<profile
value="http://hl7.org/fhir/uv/emedicinal-product-info/StructureDefinition/ClinicalUseDefinition-interaction-uv-epi"/>
</meta>
<text>
<status value="generated"/>
<div xmlns="http://www.w3.org/1999/xhtml"><a name="ClinicalUseDefinition_341721cd-5b7e-4b97-895e-e489b1310f9b"> </a><p><b>Generated Narrative: ClinicalUseDefinition</b><a name="341721cd-5b7e-4b97-895e-e489b1310f9b"> </a><a name="hc341721cd-5b7e-4b97-895e-e489b1310f9b"> </a></p><div style="display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%"><p style="margin-bottom: 0px">Resource ClinicalUseDefinition "341721cd-5b7e-4b97-895e-e489b1310f9b" </p><p style="margin-bottom: 0px">Profile: <a href="https://build.fhir.org/ig/HL7/emedicinal-product-info/StructureDefinition-ClinicalUseDefinition-interaction-uv-epi.html">ClinicalUseDefinition Interaction (ePI)</a></p></div><p><b>identifier</b>: <code>https://gsrs.ncats.nih.gov/ginas/app/beta</code>/68IQX3T69U (use: official)</p><p><b>type</b>: interaction</p><p><b>subject</b>: </p><ul><li>See on this page: MedicinalProductDefinition/mp01mg</li><li>See on this page: MedicinalProductDefinition/mp025mg</li><li>See on this page: MedicinalProductDefinition/mp1mg</li></ul><blockquote><p><b>interaction</b></p><h3>Interactants</h3><table class="grid"><tr><td style="display: none">-</td><td><b>Item[x]</b></td></tr><tr><td style="display: none">*</td><td>propafenone <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (beta#68IQX3T69U)</span></td></tr></table></blockquote></div>
</text>
<identifier>
<use value="official"/>
<system value="https://gsrs.ncats.nih.gov/ginas/app/beta"/>
<value value="68IQX3T69U"/>
</identifier>
<type value="interaction"/>
<subject>
<reference value="MedicinalProductDefinition/mp01mg"/>
</subject>
<subject>
<reference value="MedicinalProductDefinition/mp025mg"/>
</subject>
<subject>
<reference value="MedicinalProductDefinition/mp1mg"/>
</subject>
<interaction>
<interactant>
<itemCodeableConcept>
<coding>
<system value="https://gsrs.ncats.nih.gov/ginas/app/beta"/>
<code value="68IQX3T69U"/>
<display value="propafenone"/>
</coding>
</itemCodeableConcept>
</interactant>
</interaction>
</ClinicalUseDefinition>
</resource>
</entry>
<entry>
<fullUrl value="ClinicalUseDefinition/interactionquinidine"/>
<resource>
<ClinicalUseDefinition>
<id value="c15dd79b-e98e-4f1b-8a05-50f12b0c19d7"/>
<meta>
<profile
value="http://hl7.org/fhir/uv/emedicinal-product-info/StructureDefinition/ClinicalUseDefinition-interaction-uv-epi"/>
</meta>
<text>
<status value="generated"/>
<div xmlns="http://www.w3.org/1999/xhtml"><a name="ClinicalUseDefinition_c15dd79b-e98e-4f1b-8a05-50f12b0c19d7"> </a><p><b>Generated Narrative: ClinicalUseDefinition</b><a name="c15dd79b-e98e-4f1b-8a05-50f12b0c19d7"> </a><a name="hcc15dd79b-e98e-4f1b-8a05-50f12b0c19d7"> </a></p><div style="display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%"><p style="margin-bottom: 0px">Resource ClinicalUseDefinition "c15dd79b-e98e-4f1b-8a05-50f12b0c19d7" </p><p style="margin-bottom: 0px">Profile: <a href="https://build.fhir.org/ig/HL7/emedicinal-product-info/StructureDefinition-ClinicalUseDefinition-interaction-uv-epi.html">ClinicalUseDefinition Interaction (ePI)</a></p></div><p><b>identifier</b>: <code>https://gsrs.ncats.nih.gov/ginas/app/beta</code>/ITX08688JL (use: official)</p><p><b>type</b>: interaction</p><p><b>subject</b>: </p><ul><li>See on this page: MedicinalProductDefinition/mp01mg</li><li>See on this page: MedicinalProductDefinition/mp025mg</li><li>See on this page: MedicinalProductDefinition/mp1mg</li></ul><blockquote><p><b>interaction</b></p><h3>Interactants</h3><table class="grid"><tr><td style="display: none">-</td><td><b>Item[x]</b></td></tr><tr><td style="display: none">*</td><td>quinidine <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (beta#ITX08688JL)</span></td></tr></table></blockquote></div>
</text>
<identifier>
<use value="official"/>
<system value="https://gsrs.ncats.nih.gov/ginas/app/beta"/>
<value value="ITX08688JL"/>
</identifier>
<type value="interaction"/>
<subject>
<reference value="MedicinalProductDefinition/mp01mg"/>
</subject>
<subject>
<reference value="MedicinalProductDefinition/mp025mg"/>
</subject>
<subject>
<reference value="MedicinalProductDefinition/mp1mg"/>
</subject>
<interaction>
<interactant>
<itemCodeableConcept>
<coding>
<system value="https://gsrs.ncats.nih.gov/ginas/app/beta"/>
<code value="ITX08688JL"/>
<display value="quinidine"/>
</coding>
</itemCodeableConcept>
</interactant>
</interaction>
</ClinicalUseDefinition>
</resource>
</entry>
<entry>
<fullUrl value="ClinicalUseDefinition/interactionranolazine"/>
<resource>
<ClinicalUseDefinition>
<id value="5a54b656-5e2c-4be0-b93f-7d540cb64711"/>
<meta>
<profile
value="http://hl7.org/fhir/uv/emedicinal-product-info/StructureDefinition/ClinicalUseDefinition-interaction-uv-epi"/>
</meta>
<text>
<status value="generated"/>
<div xmlns="http://www.w3.org/1999/xhtml"><a name="ClinicalUseDefinition_5a54b656-5e2c-4be0-b93f-7d540cb64711"> </a><p><b>Generated Narrative: ClinicalUseDefinition</b><a name="5a54b656-5e2c-4be0-b93f-7d540cb64711"> </a><a name="hc5a54b656-5e2c-4be0-b93f-7d540cb64711"> </a></p><div style="display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%"><p style="margin-bottom: 0px">Resource ClinicalUseDefinition "5a54b656-5e2c-4be0-b93f-7d540cb64711" </p><p style="margin-bottom: 0px">Profile: <a href="https://build.fhir.org/ig/HL7/emedicinal-product-info/StructureDefinition-ClinicalUseDefinition-interaction-uv-epi.html">ClinicalUseDefinition Interaction (ePI)</a></p></div><p><b>identifier</b>: <code>https://gsrs.ncats.nih.gov/ginas/app/beta</code>/A6IEZ5M406 (use: official)</p><p><b>type</b>: interaction</p><p><b>subject</b>: </p><ul><li>See on this page: MedicinalProductDefinition/mp01mg</li><li>See on this page: MedicinalProductDefinition/mp025mg</li><li>See on this page: MedicinalProductDefinition/mp1mg</li></ul><blockquote><p><b>interaction</b></p><h3>Interactants</h3><table class="grid"><tr><td style="display: none">-</td><td><b>Item[x]</b></td></tr><tr><td style="display: none">*</td><td>ranolazine <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (beta#A6IEZ5M406)</span></td></tr></table></blockquote></div>
</text>
<identifier>
<use value="official"/>
<system value="https://gsrs.ncats.nih.gov/ginas/app/beta"/>
<value value="A6IEZ5M406"/>
</identifier>
<type value="interaction"/>
<subject>
<reference value="MedicinalProductDefinition/mp01mg"/>
</subject>
<subject>
<reference value="MedicinalProductDefinition/mp025mg"/>
</subject>
<subject>
<reference value="MedicinalProductDefinition/mp1mg"/>
</subject>
<interaction>
<interactant>
<itemCodeableConcept>
<coding>
<system value="https://gsrs.ncats.nih.gov/ginas/app/beta"/>
<code value="A6IEZ5M406"/>
<display value="ranolazine"/>
</coding>
</itemCodeableConcept>
</interactant>
</interaction>
</ClinicalUseDefinition>
</resource>
</entry>
<entry>
<fullUrl value="ClinicalUseDefinition/interactionverapamil"/>
<resource>
<ClinicalUseDefinition>
<id value="4907c33b-e1ae-40a7-9e7c-242653c92e60"/>
<meta>
<profile
value="http://hl7.org/fhir/uv/emedicinal-product-info/StructureDefinition/ClinicalUseDefinition-interaction-uv-epi"/>
</meta>
<text>
<status value="generated"/>
<div xmlns="http://www.w3.org/1999/xhtml"><a name="ClinicalUseDefinition_4907c33b-e1ae-40a7-9e7c-242653c92e60"> </a><p><b>Generated Narrative: ClinicalUseDefinition</b><a name="4907c33b-e1ae-40a7-9e7c-242653c92e60"> </a><a name="hc4907c33b-e1ae-40a7-9e7c-242653c92e60"> </a></p><div style="display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%"><p style="margin-bottom: 0px">Resource ClinicalUseDefinition "4907c33b-e1ae-40a7-9e7c-242653c92e60" </p><p style="margin-bottom: 0px">Profile: <a href="https://build.fhir.org/ig/HL7/emedicinal-product-info/StructureDefinition-ClinicalUseDefinition-interaction-uv-epi.html">ClinicalUseDefinition Interaction (ePI)</a></p></div><p><b>identifier</b>: <code>https://gsrs.ncats.nih.gov/ginas/app/beta</code>/CJ0O37KU29 (use: official)</p><p><b>type</b>: interaction</p><p><b>subject</b>: </p><ul><li>See on this page: MedicinalProductDefinition/mp01mg</li><li>See on this page: MedicinalProductDefinition/mp025mg</li><li>See on this page: MedicinalProductDefinition/mp1mg</li></ul><blockquote><p><b>interaction</b></p><h3>Interactants</h3><table class="grid"><tr><td style="display: none">-</td><td><b>Item[x]</b></td></tr><tr><td style="display: none">*</td><td>verapamil <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (beta#CJ0O37KU29)</span></td></tr></table></blockquote></div>
</text>
<identifier>
<use value="official"/>
<system value="https://gsrs.ncats.nih.gov/ginas/app/beta"/>
<value value="CJ0O37KU29"/>
</identifier>
<type value="interaction"/>
<subject>
<reference value="MedicinalProductDefinition/mp01mg"/>
</subject>
<subject>
<reference value="MedicinalProductDefinition/mp025mg"/>
</subject>
<subject>
<reference value="MedicinalProductDefinition/mp1mg"/>
</subject>
<interaction>
<interactant>
<itemCodeableConcept>
<coding>
<system value="https://gsrs.ncats.nih.gov/ginas/app/beta"/>
<code value="CJ0O37KU29"/>
<display value="verapamil"/>
</coding>
</itemCodeableConcept>
</interactant>
</interaction>
</ClinicalUseDefinition>
</resource>
</entry>
<entry>
<fullUrl value="ClinicalUseDefinition/interactionClarithromycin"/>
<resource>
<ClinicalUseDefinition>
<id value="05a52022-c29a-4883-873b-c4cfaf05a696"/>
<meta>
<profile
value="http://hl7.org/fhir/uv/emedicinal-product-info/StructureDefinition/ClinicalUseDefinition-interaction-uv-epi"/>
</meta>
<text>
<status value="generated"/>
<div xmlns="http://www.w3.org/1999/xhtml"><a name="ClinicalUseDefinition_05a52022-c29a-4883-873b-c4cfaf05a696"> </a><p><b>Generated Narrative: ClinicalUseDefinition</b><a name="05a52022-c29a-4883-873b-c4cfaf05a696"> </a><a name="hc05a52022-c29a-4883-873b-c4cfaf05a696"> </a></p><div style="display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%"><p style="margin-bottom: 0px">Resource ClinicalUseDefinition "05a52022-c29a-4883-873b-c4cfaf05a696" </p><p style="margin-bottom: 0px">Profile: <a href="https://build.fhir.org/ig/HL7/emedicinal-product-info/StructureDefinition-ClinicalUseDefinition-interaction-uv-epi.html">ClinicalUseDefinition Interaction (ePI)</a></p></div><p><b>identifier</b>: <code>https://gsrs.ncats.nih.gov/ginas/app/beta</code>/H1250JIK0A (use: official)</p><p><b>type</b>: interaction</p><p><b>subject</b>: </p><ul><li>See on this page: MedicinalProductDefinition/mp01mg</li><li>See on this page: MedicinalProductDefinition/mp025mg</li><li>See on this page: MedicinalProductDefinition/mp1mg</li></ul><blockquote><p><b>interaction</b></p><h3>Interactants</h3><table class="grid"><tr><td style="display: none">-</td><td><b>Item[x]</b></td></tr><tr><td style="display: none">*</td><td>Clarithromycin <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (beta#H1250JIK0A)</span></td></tr></table></blockquote></div>
</text>
<identifier>
<use value="official"/>
<system value="https://gsrs.ncats.nih.gov/ginas/app/beta"/>
<value value="H1250JIK0A"/>
</identifier>
<type value="interaction"/>
<subject>
<reference value="MedicinalProductDefinition/mp01mg"/>
</subject>
<subject>
<reference value="MedicinalProductDefinition/mp025mg"/>
</subject>
<subject>
<reference value="MedicinalProductDefinition/mp1mg"/>
</subject>
<interaction>
<interactant>
<itemCodeableConcept>
<coding>
<system value="https://gsrs.ncats.nih.gov/ginas/app/beta"/>
<code value="H1250JIK0A"/>
<display value="Clarithromycin"/>
</coding>
</itemCodeableConcept>
</interactant>
</interaction>
</ClinicalUseDefinition>
</resource>
</entry>
<entry>
<fullUrl value="ClinicalUseDefinition/interactionerythromycin"/>
<resource>
<ClinicalUseDefinition>
<id value="e0b859d1-beac-494d-b7d9-fe793efbbd96"/>
<meta>
<profile
value="http://hl7.org/fhir/uv/emedicinal-product-info/StructureDefinition/ClinicalUseDefinition-interaction-uv-epi"/>
</meta>
<text>
<status value="generated"/>
<div xmlns="http://www.w3.org/1999/xhtml"><a name="ClinicalUseDefinition_e0b859d1-beac-494d-b7d9-fe793efbbd96"> </a><p><b>Generated Narrative: ClinicalUseDefinition</b><a name="e0b859d1-beac-494d-b7d9-fe793efbbd96"> </a><a name="hce0b859d1-beac-494d-b7d9-fe793efbbd96"> </a></p><div style="display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%"><p style="margin-bottom: 0px">Resource ClinicalUseDefinition "e0b859d1-beac-494d-b7d9-fe793efbbd96" </p><p style="margin-bottom: 0px">Profile: <a href="https://build.fhir.org/ig/HL7/emedicinal-product-info/StructureDefinition-ClinicalUseDefinition-interaction-uv-epi.html">ClinicalUseDefinition Interaction (ePI)</a></p></div><p><b>identifier</b>: <code>https://gsrs.ncats.nih.gov/ginas/app/beta</code>/63937KV33D (use: official)</p><p><b>type</b>: interaction</p><p><b>subject</b>: </p><ul><li>See on this page: MedicinalProductDefinition/mp01mg</li><li>See on this page: MedicinalProductDefinition/mp025mg</li><li>See on this page: MedicinalProductDefinition/mp1mg</li></ul><blockquote><p><b>interaction</b></p><h3>Interactants</h3><table class="grid"><tr><td style="display: none">-</td><td><b>Item[x]</b></td></tr><tr><td style="display: none">*</td><td>erythromycin <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (beta#63937KV33D)</span></td></tr></table></blockquote></div>
</text>
<identifier>
<use value="official"/>
<system value="https://gsrs.ncats.nih.gov/ginas/app/beta"/>
<value value="63937KV33D"/>
</identifier>
<type value="interaction"/>
<subject>
<reference value="MedicinalProductDefinition/mp01mg"/>
</subject>
<subject>
<reference value="MedicinalProductDefinition/mp025mg"/>
</subject>
<subject>
<reference value="MedicinalProductDefinition/mp1mg"/>
</subject>
<interaction>
<interactant>
<itemCodeableConcept>
<coding>
<system value="https://gsrs.ncats.nih.gov/ginas/app/beta"/>
<code value="63937KV33D"/>
<display value="erythromycin"/>
</coding>
</itemCodeableConcept>
</interactant>
</interaction>
</ClinicalUseDefinition>
</resource>
</entry>
<entry>
<fullUrl value="ClinicalUseDefinition/interactionItraconazole"/>
<resource>
<ClinicalUseDefinition>
<id value="e09c86b1-b802-4c2e-b8eb-6b49192fadfe"/>
<meta>
<profile
value="http://hl7.org/fhir/uv/emedicinal-product-info/StructureDefinition/ClinicalUseDefinition-interaction-uv-epi"/>
</meta>
<text>
<status value="generated"/>
<div xmlns="http://www.w3.org/1999/xhtml"><a name="ClinicalUseDefinition_e09c86b1-b802-4c2e-b8eb-6b49192fadfe"> </a><p><b>Generated Narrative: ClinicalUseDefinition</b><a name="e09c86b1-b802-4c2e-b8eb-6b49192fadfe"> </a><a name="hce09c86b1-b802-4c2e-b8eb-6b49192fadfe"> </a></p><div style="display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%"><p style="margin-bottom: 0px">Resource ClinicalUseDefinition "e09c86b1-b802-4c2e-b8eb-6b49192fadfe" </p><p style="margin-bottom: 0px">Profile: <a href="https://build.fhir.org/ig/HL7/emedicinal-product-info/StructureDefinition-ClinicalUseDefinition-interaction-uv-epi.html">ClinicalUseDefinition Interaction (ePI)</a></p></div><p><b>identifier</b>: <code>https://gsrs.ncats.nih.gov/ginas/app/beta</code>/304NUG5GF4 (use: official)</p><p><b>type</b>: interaction</p><p><b>subject</b>: </p><ul><li>See on this page: MedicinalProductDefinition/mp01mg</li><li>See on this page: MedicinalProductDefinition/mp025mg</li><li>See on this page: MedicinalProductDefinition/mp1mg</li></ul><blockquote><p><b>interaction</b></p><h3>Interactants</h3><table class="grid"><tr><td style="display: none">-</td><td><b>Item[x]</b></td></tr><tr><td style="display: none">*</td><td>Itraconazole <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (beta#304NUG5GF4)</span></td></tr></table></blockquote></div>
</text>
<identifier>
<use value="official"/>
<system value="https://gsrs.ncats.nih.gov/ginas/app/beta"/>
<value value="304NUG5GF4"/>
</identifier>
<type value="interaction"/>
<subject>
<reference value="MedicinalProductDefinition/mp01mg"/>
</subject>
<subject>
<reference value="MedicinalProductDefinition/mp025mg"/>
</subject>
<subject>
<reference value="MedicinalProductDefinition/mp1mg"/>
</subject>
<interaction>
<interactant>
<itemCodeableConcept>
<coding>
<system value="https://gsrs.ncats.nih.gov/ginas/app/beta"/>
<code value="304NUG5GF4"/>
<display value="Itraconazole"/>
</coding>
</itemCodeableConcept>
</interactant>
</interaction>
</ClinicalUseDefinition>
</resource>
</entry>
<entry>
<fullUrl value="ClinicalUseDefinition/interactionketoconazole"/>
<resource>
<ClinicalUseDefinition>
<id value="b31a89e6-abda-40eb-ba77-5ec9357b62e7"/>
<meta>
<profile
value="http://hl7.org/fhir/uv/emedicinal-product-info/StructureDefinition/ClinicalUseDefinition-interaction-uv-epi"/>
</meta>
<text>
<status value="generated"/>
<div xmlns="http://www.w3.org/1999/xhtml"><a name="ClinicalUseDefinition_b31a89e6-abda-40eb-ba77-5ec9357b62e7"> </a><p><b>Generated Narrative: ClinicalUseDefinition</b><a name="b31a89e6-abda-40eb-ba77-5ec9357b62e7"> </a><a name="hcb31a89e6-abda-40eb-ba77-5ec9357b62e7"> </a></p><div style="display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%"><p style="margin-bottom: 0px">Resource ClinicalUseDefinition "b31a89e6-abda-40eb-ba77-5ec9357b62e7" </p><p style="margin-bottom: 0px">Profile: <a href="https://build.fhir.org/ig/HL7/emedicinal-product-info/StructureDefinition-ClinicalUseDefinition-interaction-uv-epi.html">ClinicalUseDefinition Interaction (ePI)</a></p></div><p><b>identifier</b>: <code>https://gsrs.ncats.nih.gov/ginas/app/beta</code>/R9400W927I (use: official)</p><p><b>type</b>: interaction</p><p><b>subject</b>: </p><ul><li>See on this page: MedicinalProductDefinition/mp01mg</li><li>See on this page: MedicinalProductDefinition/mp025mg</li><li>See on this page: MedicinalProductDefinition/mp1mg</li></ul><blockquote><p><b>interaction</b></p><h3>Interactants</h3><table class="grid"><tr><td style="display: none">-</td><td><b>Item[x]</b></td></tr><tr><td style="display: none">*</td><td>ketoconazole <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (beta#R9400W927I)</span></td></tr></table></blockquote></div>
</text>
<identifier>
<use value="official"/>
<system value="https://gsrs.ncats.nih.gov/ginas/app/beta"/>
<value value="R9400W927I"/>
</identifier>
<type value="interaction"/>
<subject>
<reference value="MedicinalProductDefinition/mp01mg"/>
</subject>
<subject>
<reference value="MedicinalProductDefinition/mp025mg"/>
</subject>
<subject>
<reference value="MedicinalProductDefinition/mp1mg"/>
</subject>
<interaction>
<interactant>
<itemCodeableConcept>
<coding>
<system value="https://gsrs.ncats.nih.gov/ginas/app/beta"/>
<code value="R9400W927I"/>
<display value="ketoconazole"/>
</coding>
</itemCodeableConcept>
</interactant>
</interaction>
</ClinicalUseDefinition>
</resource>
</entry>
<entry>
<fullUrl value="ClinicalUseDefinition/interactionCobicistat"/>
<resource>
<ClinicalUseDefinition>
<id value="f0914110-749f-4afa-982a-627eacb5720b"/>
<meta>
<profile
value="http://hl7.org/fhir/uv/emedicinal-product-info/StructureDefinition/ClinicalUseDefinition-interaction-uv-epi"/>
</meta>
<text>
<status value="generated"/>
<div xmlns="http://www.w3.org/1999/xhtml"><a name="ClinicalUseDefinition_f0914110-749f-4afa-982a-627eacb5720b"> </a><p><b>Generated Narrative: ClinicalUseDefinition</b><a name="f0914110-749f-4afa-982a-627eacb5720b"> </a><a name="hcf0914110-749f-4afa-982a-627eacb5720b"> </a></p><div style="display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%"><p style="margin-bottom: 0px">Resource ClinicalUseDefinition "f0914110-749f-4afa-982a-627eacb5720b" </p><p style="margin-bottom: 0px">Profile: <a href="https://build.fhir.org/ig/HL7/emedicinal-product-info/StructureDefinition-ClinicalUseDefinition-interaction-uv-epi.html">ClinicalUseDefinition Interaction (ePI)</a></p></div><p><b>identifier</b>: <code>https://gsrs.ncats.nih.gov/ginas/app/beta</code>/LW2E03M5PG (use: official)</p><p><b>type</b>: interaction</p><p><b>subject</b>: </p><ul><li>See on this page: MedicinalProductDefinition/mp01mg</li><li>See on this page: MedicinalProductDefinition/mp025mg</li><li>See on this page: MedicinalProductDefinition/mp1mg</li></ul><blockquote><p><b>interaction</b></p><h3>Interactants</h3><table class="grid"><tr><td style="display: none">-</td><td><b>Item[x]</b></td></tr><tr><td style="display: none">*</td><td>Cobicistat <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (beta#LW2E03M5PG)</span></td></tr></table></blockquote></div>
</text>
<identifier>
<use value="official"/>
<system value="https://gsrs.ncats.nih.gov/ginas/app/beta"/>
<value value="LW2E03M5PG"/>
</identifier>
<type value="interaction"/>
<subject>
<reference value="MedicinalProductDefinition/mp01mg"/>
</subject>
<subject>
<reference value="MedicinalProductDefinition/mp025mg"/>
</subject>
<subject>
<reference value="MedicinalProductDefinition/mp1mg"/>
</subject>
<interaction>
<interactant>
<itemCodeableConcept>
<coding>
<system value="https://gsrs.ncats.nih.gov/ginas/app/beta"/>
<code value="LW2E03M5PG"/>
<display value="Cobicistat"/>
</coding>
</itemCodeableConcept>
</interactant>
</interaction>
</ClinicalUseDefinition>
</resource>
</entry>
<entry>
<fullUrl value="ClinicalUseDefinition/interactiondarunavir"/>
<resource>
<ClinicalUseDefinition>
<id value="b40984a8-0a6b-43d0-911a-ff5b927fb4ca"/>
<meta>
<profile
value="http://hl7.org/fhir/uv/emedicinal-product-info/StructureDefinition/ClinicalUseDefinition-interaction-uv-epi"/>
</meta>
<text>
<status value="generated"/>
<div xmlns="http://www.w3.org/1999/xhtml"><a name="ClinicalUseDefinition_b40984a8-0a6b-43d0-911a-ff5b927fb4ca"> </a><p><b>Generated Narrative: ClinicalUseDefinition</b><a name="b40984a8-0a6b-43d0-911a-ff5b927fb4ca"> </a><a name="hcb40984a8-0a6b-43d0-911a-ff5b927fb4ca"> </a></p><div style="display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%"><p style="margin-bottom: 0px">Resource ClinicalUseDefinition "b40984a8-0a6b-43d0-911a-ff5b927fb4ca" </p><p style="margin-bottom: 0px">Profile: <a href="https://build.fhir.org/ig/HL7/emedicinal-product-info/StructureDefinition-ClinicalUseDefinition-interaction-uv-epi.html">ClinicalUseDefinition Interaction (ePI)</a></p></div><p><b>identifier</b>: <code>https://gsrs.ncats.nih.gov/ginas/app/beta</code>/YO603Y8113 (use: official)</p><p><b>type</b>: interaction</p><p><b>subject</b>: </p><ul><li>See on this page: MedicinalProductDefinition/mp01mg</li><li>See on this page: MedicinalProductDefinition/mp025mg</li><li>See on this page: MedicinalProductDefinition/mp1mg</li></ul><blockquote><p><b>interaction</b></p><h3>Interactants</h3><table class="grid"><tr><td style="display: none">-</td><td><b>Item[x]</b></td></tr><tr><td style="display: none">*</td><td>darunavir <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (beta#YO603Y8113)</span></td></tr></table></blockquote></div>
</text>
<identifier>
<use value="official"/>
<system value="https://gsrs.ncats.nih.gov/ginas/app/beta"/>
<value value="YO603Y8113"/>
</identifier>
<type value="interaction"/>
<subject>
<reference value="MedicinalProductDefinition/mp01mg"/>
</subject>
<subject>
<reference value="MedicinalProductDefinition/mp025mg"/>
</subject>
<subject>
<reference value="MedicinalProductDefinition/mp1mg"/>
</subject>
<interaction>
<interactant>
<itemCodeableConcept>
<coding>
<system value="https://gsrs.ncats.nih.gov/ginas/app/beta"/>
<code value="YO603Y8113"/>
<display value="darunavir"/>
</coding>
</itemCodeableConcept>
</interactant>
</interaction>
</ClinicalUseDefinition>
</resource>
</entry>
<entry>
<fullUrl value="ClinicalUseDefinition/interactionindinavir"/>
<resource>
<ClinicalUseDefinition>
<id value="8d54b4fd-1b9f-4114-991a-0a08e1dc2d98"/>
<meta>
<profile
value="http://hl7.org/fhir/uv/emedicinal-product-info/StructureDefinition/ClinicalUseDefinition-interaction-uv-epi"/>
</meta>
<text>
<status value="generated"/>
<div xmlns="http://www.w3.org/1999/xhtml"><a name="ClinicalUseDefinition_8d54b4fd-1b9f-4114-991a-0a08e1dc2d98"> </a><p><b>Generated Narrative: ClinicalUseDefinition</b><a name="8d54b4fd-1b9f-4114-991a-0a08e1dc2d98"> </a><a name="hc8d54b4fd-1b9f-4114-991a-0a08e1dc2d98"> </a></p><div style="display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%"><p style="margin-bottom: 0px">Resource ClinicalUseDefinition "8d54b4fd-1b9f-4114-991a-0a08e1dc2d98" </p><p style="margin-bottom: 0px">Profile: <a href="https://build.fhir.org/ig/HL7/emedicinal-product-info/StructureDefinition-ClinicalUseDefinition-interaction-uv-epi.html">ClinicalUseDefinition Interaction (ePI)</a></p></div><p><b>identifier</b>: <code>https://gsrs.ncats.nih.gov/ginas/app/beta</code>/5W6YA9PKKH (use: official)</p><p><b>type</b>: interaction</p><p><b>subject</b>: </p><ul><li>See on this page: MedicinalProductDefinition/mp01mg</li><li>See on this page: MedicinalProductDefinition/mp025mg</li><li>See on this page: MedicinalProductDefinition/mp1mg</li></ul><blockquote><p><b>interaction</b></p><h3>Interactants</h3><table class="grid"><tr><td style="display: none">-</td><td><b>Item[x]</b></td></tr><tr><td style="display: none">*</td><td>indinavir <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (beta#5W6YA9PKKH)</span></td></tr></table></blockquote></div>
</text>
<identifier>
<use value="official"/>
<system value="https://gsrs.ncats.nih.gov/ginas/app/beta"/>
<value value="5W6YA9PKKH"/>
</identifier>
<type value="interaction"/>
<subject>
<reference value="MedicinalProductDefinition/mp01mg"/>
</subject>
<subject>
<reference value="MedicinalProductDefinition/mp025mg"/>
</subject>
<subject>
<reference value="MedicinalProductDefinition/mp1mg"/>
</subject>
<interaction>
<interactant>
<itemCodeableConcept>
<coding>
<system value="https://gsrs.ncats.nih.gov/ginas/app/beta"/>
<code value="5W6YA9PKKH"/>
<display value="indinavir"/>
</coding>
</itemCodeableConcept>
</interactant>
</interaction>
</ClinicalUseDefinition>
</resource>
</entry>
<entry>
<fullUrl value="ClinicalUseDefinition/interactionlopinavir"/>
<resource>
<ClinicalUseDefinition>
<id value="3e52afa2-3310-4e52-9d61-7bfcfd97a25f"/>
<meta>
<profile
value="http://hl7.org/fhir/uv/emedicinal-product-info/StructureDefinition/ClinicalUseDefinition-interaction-uv-epi"/>
</meta>
<text>
<status value="generated"/>
<div xmlns="http://www.w3.org/1999/xhtml"><a name="ClinicalUseDefinition_3e52afa2-3310-4e52-9d61-7bfcfd97a25f"> </a><p><b>Generated Narrative: ClinicalUseDefinition</b><a name="3e52afa2-3310-4e52-9d61-7bfcfd97a25f"> </a><a name="hc3e52afa2-3310-4e52-9d61-7bfcfd97a25f"> </a></p><div style="display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%"><p style="margin-bottom: 0px">Resource ClinicalUseDefinition "3e52afa2-3310-4e52-9d61-7bfcfd97a25f" </p><p style="margin-bottom: 0px">Profile: <a href="https://build.fhir.org/ig/HL7/emedicinal-product-info/StructureDefinition-ClinicalUseDefinition-interaction-uv-epi.html">ClinicalUseDefinition Interaction (ePI)</a></p></div><p><b>identifier</b>: <code>https://gsrs.ncats.nih.gov/ginas/app/beta</code>/2494G1JF75 (use: official)</p><p><b>type</b>: interaction</p><p><b>subject</b>: </p><ul><li>See on this page: MedicinalProductDefinition/mp01mg</li><li>See on this page: MedicinalProductDefinition/mp025mg</li><li>See on this page: MedicinalProductDefinition/mp1mg</li></ul><blockquote><p><b>interaction</b></p><h3>Interactants</h3><table class="grid"><tr><td style="display: none">-</td><td><b>Item[x]</b></td></tr><tr><td style="display: none">*</td><td>lopinavir <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (beta#2494G1JF75)</span></td></tr></table></blockquote></div>
</text>
<identifier>
<use value="official"/>
<system value="https://gsrs.ncats.nih.gov/ginas/app/beta"/>
<value value="2494G1JF75"/>
</identifier>
<type value="interaction"/>
<subject>
<reference value="MedicinalProductDefinition/mp01mg"/>
</subject>
<subject>
<reference value="MedicinalProductDefinition/mp025mg"/>
</subject>
<subject>
<reference value="MedicinalProductDefinition/mp1mg"/>
</subject>
<interaction>
<interactant>
<itemCodeableConcept>
<coding>
<system value="https://gsrs.ncats.nih.gov/ginas/app/beta"/>
<code value="2494G1JF75"/>
<display value="lopinavir"/>
</coding>
</itemCodeableConcept>
</interactant>
</interaction>
</ClinicalUseDefinition>
</resource>
</entry>
<entry>
<fullUrl value="ClinicalUseDefinition/interactionritonavir"/>
<resource>
<ClinicalUseDefinition>
<id value="9654bfac-8458-4172-b74f-680a95036cff"/>
<meta>
<profile
value="http://hl7.org/fhir/uv/emedicinal-product-info/StructureDefinition/ClinicalUseDefinition-interaction-uv-epi"/>
</meta>
<text>
<status value="generated"/>
<div xmlns="http://www.w3.org/1999/xhtml"><a name="ClinicalUseDefinition_9654bfac-8458-4172-b74f-680a95036cff"> </a><p><b>Generated Narrative: ClinicalUseDefinition</b><a name="9654bfac-8458-4172-b74f-680a95036cff"> </a><a name="hc9654bfac-8458-4172-b74f-680a95036cff"> </a></p><div style="display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%"><p style="margin-bottom: 0px">Resource ClinicalUseDefinition "9654bfac-8458-4172-b74f-680a95036cff" </p><p style="margin-bottom: 0px">Profile: <a href="https://build.fhir.org/ig/HL7/emedicinal-product-info/StructureDefinition-ClinicalUseDefinition-interaction-uv-epi.html">ClinicalUseDefinition Interaction (ePI)</a></p></div><p><b>identifier</b>: <code>https://gsrs.ncats.nih.gov/ginas/app/beta</code>/O3J8G9O825 (use: official)</p><p><b>type</b>: interaction</p><p><b>subject</b>: </p><ul><li>See on this page: MedicinalProductDefinition/mp01mg</li><li>See on this page: MedicinalProductDefinition/mp025mg</li><li>See on this page: MedicinalProductDefinition/mp1mg</li></ul><blockquote><p><b>interaction</b></p><h3>Interactants</h3><table class="grid"><tr><td style="display: none">-</td><td><b>Item[x]</b></td></tr><tr><td style="display: none">*</td><td>ritonavir <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (beta#O3J8G9O825)</span></td></tr></table></blockquote></div>
</text>
<identifier>
<use value="official"/>
<system value="https://gsrs.ncats.nih.gov/ginas/app/beta"/>
<value value="O3J8G9O825"/>
</identifier>
<type value="interaction"/>
<subject>
<reference value="MedicinalProductDefinition/mp01mg"/>
</subject>
<subject>
<reference value="MedicinalProductDefinition/mp025mg"/>
</subject>
<subject>
<reference value="MedicinalProductDefinition/mp1mg"/>
</subject>
<interaction>
<interactant>
<itemCodeableConcept>
<coding>
<system value="https://gsrs.ncats.nih.gov/ginas/app/beta"/>
<code value="O3J8G9O825"/>
<display value="ritonavir"/>
</coding>
</itemCodeableConcept>
</interactant>
</interaction>
</ClinicalUseDefinition>
</resource>
</entry>
<entry>
<fullUrl value="ClinicalUseDefinition/interactionsaquinavir"/>
<resource>
<ClinicalUseDefinition>
<id value="374f27ff-35f8-4e01-8fa5-53aafc8b48d6"/>
<meta>
<profile
value="http://hl7.org/fhir/uv/emedicinal-product-info/StructureDefinition/ClinicalUseDefinition-interaction-uv-epi"/>
</meta>
<text>
<status value="generated"/>
<div xmlns="http://www.w3.org/1999/xhtml"><a name="ClinicalUseDefinition_374f27ff-35f8-4e01-8fa5-53aafc8b48d6"> </a><p><b>Generated Narrative: ClinicalUseDefinition</b><a name="374f27ff-35f8-4e01-8fa5-53aafc8b48d6"> </a><a name="hc374f27ff-35f8-4e01-8fa5-53aafc8b48d6"> </a></p><div style="display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%"><p style="margin-bottom: 0px">Resource ClinicalUseDefinition "374f27ff-35f8-4e01-8fa5-53aafc8b48d6" </p><p style="margin-bottom: 0px">Profile: <a href="https://build.fhir.org/ig/HL7/emedicinal-product-info/StructureDefinition-ClinicalUseDefinition-interaction-uv-epi.html">ClinicalUseDefinition Interaction (ePI)</a></p></div><p><b>identifier</b>: <code>https://gsrs.ncats.nih.gov/ginas/app/beta</code>/L3JE09KZ2F (use: official)</p><p><b>type</b>: interaction</p><p><b>subject</b>: </p><ul><li>See on this page: MedicinalProductDefinition/mp01mg</li><li>See on this page: MedicinalProductDefinition/mp025mg</li><li>See on this page: MedicinalProductDefinition/mp1mg</li></ul><blockquote><p><b>interaction</b></p><h3>Interactants</h3><table class="grid"><tr><td style="display: none">-</td><td><b>Item[x]</b></td></tr><tr><td style="display: none">*</td><td>saquinavir <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (beta#L3JE09KZ2F)</span></td></tr></table></blockquote></div>
</text>
<identifier>
<use value="official"/>
<system value="https://gsrs.ncats.nih.gov/ginas/app/beta"/>
<value value="L3JE09KZ2F"/>
</identifier>
<type value="interaction"/>
<subject>
<reference value="MedicinalProductDefinition/mp01mg"/>
</subject>
<subject>
<reference value="MedicinalProductDefinition/mp025mg"/>
</subject>
<subject>
<reference value="MedicinalProductDefinition/mp1mg"/>
</subject>
<interaction>
<interactant>
<itemCodeableConcept>
<coding>
<system value="https://gsrs.ncats.nih.gov/ginas/app/beta"/>
<code value="L3JE09KZ2F"/>
<display value="saquinavir"/>
</coding>
</itemCodeableConcept>
</interactant>
</interaction>
</ClinicalUseDefinition>
</resource>
</entry>
<entry>
<fullUrl value="ClinicalUseDefinition/interactiontelaprevir"/>
<resource>
<ClinicalUseDefinition>
<id value="e416132b-4b3c-4aee-860f-604fa409ddc1"/>
<meta>
<profile
value="http://hl7.org/fhir/uv/emedicinal-product-info/StructureDefinition/ClinicalUseDefinition-interaction-uv-epi"/>
</meta>
<text>
<status value="generated"/>
<div xmlns="http://www.w3.org/1999/xhtml"><a name="ClinicalUseDefinition_e416132b-4b3c-4aee-860f-604fa409ddc1"> </a><p><b>Generated Narrative: ClinicalUseDefinition</b><a name="e416132b-4b3c-4aee-860f-604fa409ddc1"> </a><a name="hce416132b-4b3c-4aee-860f-604fa409ddc1"> </a></p><div style="display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%"><p style="margin-bottom: 0px">Resource ClinicalUseDefinition "e416132b-4b3c-4aee-860f-604fa409ddc1" </p><p style="margin-bottom: 0px">Profile: <a href="https://build.fhir.org/ig/HL7/emedicinal-product-info/StructureDefinition-ClinicalUseDefinition-interaction-uv-epi.html">ClinicalUseDefinition Interaction (ePI)</a></p></div><p><b>identifier</b>: <code>https://gsrs.ncats.nih.gov/ginas/app/beta</code>/655M5O3W0U (use: official)</p><p><b>type</b>: interaction</p><p><b>subject</b>: </p><ul><li>See on this page: MedicinalProductDefinition/mp01mg</li><li>See on this page: MedicinalProductDefinition/mp025mg</li><li>See on this page: MedicinalProductDefinition/mp1mg</li></ul><blockquote><p><b>interaction</b></p><h3>Interactants</h3><table class="grid"><tr><td style="display: none">-</td><td><b>Item[x]</b></td></tr><tr><td style="display: none">*</td><td>telaprevir <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (beta#655M5O3W0U)</span></td></tr></table></blockquote></div>
</text>
<identifier>
<use value="official"/>
<system value="https://gsrs.ncats.nih.gov/ginas/app/beta"/>
<value value="655M5O3W0U"/>
</identifier>
<type value="interaction"/>
<subject>
<reference value="MedicinalProductDefinition/mp01mg"/>
</subject>
<subject>
<reference value="MedicinalProductDefinition/mp025mg"/>
</subject>
<subject>
<reference value="MedicinalProductDefinition/mp1mg"/>
</subject>
<interaction>
<interactant>
<itemCodeableConcept>
<coding>
<system value="https://gsrs.ncats.nih.gov/ginas/app/beta"/>
<code value="655M5O3W0U"/>
<display value="telaprevir"/>
</coding>
</itemCodeableConcept>
</interactant>
</interaction>
</ClinicalUseDefinition>
</resource>
</entry>
<entry>
<fullUrl value="ClinicalUseDefinition/interactiontipranavir"/>
<resource>
<ClinicalUseDefinition>
<id value="f05bbecb-ba90-4d52-ae05-b13502954530"/>
<meta>
<profile
value="http://hl7.org/fhir/uv/emedicinal-product-info/StructureDefinition/ClinicalUseDefinition-interaction-uv-epi"/>
</meta>
<text>
<status value="generated"/>
<div xmlns="http://www.w3.org/1999/xhtml"><a name="ClinicalUseDefinition_f05bbecb-ba90-4d52-ae05-b13502954530"> </a><p><b>Generated Narrative: ClinicalUseDefinition</b><a name="f05bbecb-ba90-4d52-ae05-b13502954530"> </a><a name="hcf05bbecb-ba90-4d52-ae05-b13502954530"> </a></p><div style="display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%"><p style="margin-bottom: 0px">Resource ClinicalUseDefinition "f05bbecb-ba90-4d52-ae05-b13502954530" </p><p style="margin-bottom: 0px">Profile: <a href="https://build.fhir.org/ig/HL7/emedicinal-product-info/StructureDefinition-ClinicalUseDefinition-interaction-uv-epi.html">ClinicalUseDefinition Interaction (ePI)</a></p></div><p><b>identifier</b>: <code>https://gsrs.ncats.nih.gov/ginas/app/beta</code>/ZZT404XD09 (use: official)</p><p><b>type</b>: interaction</p><p><b>subject</b>: </p><ul><li>See on this page: MedicinalProductDefinition/mp01mg</li><li>See on this page: MedicinalProductDefinition/mp025mg</li><li>See on this page: MedicinalProductDefinition/mp1mg</li></ul><blockquote><p><b>interaction</b></p><h3>Interactants</h3><table class="grid"><tr><td style="display: none">-</td><td><b>Item[x]</b></td></tr><tr><td style="display: none">*</td><td>tipranavir <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (beta#ZZT404XD09)</span></td></tr></table></blockquote></div>
</text>
<identifier>
<use value="official"/>
<system value="https://gsrs.ncats.nih.gov/ginas/app/beta"/>
<value value="ZZT404XD09"/>
</identifier>
<type value="interaction"/>
<subject>
<reference value="MedicinalProductDefinition/mp01mg"/>
</subject>
<subject>
<reference value="MedicinalProductDefinition/mp025mg"/>
</subject>
<subject>
<reference value="MedicinalProductDefinition/mp1mg"/>
</subject>
<interaction>
<interactant>
<itemCodeableConcept>
<coding>
<system value="https://gsrs.ncats.nih.gov/ginas/app/beta"/>
<code value="ZZT404XD09"/>
<display value="tipranavir"/>
</coding>
</itemCodeableConcept>
</interactant>
</interaction>
</ClinicalUseDefinition>
</resource>
</entry>
<entry>
<fullUrl value="ClinicalUseDefinition/interactionCiclosporin"/>
<resource>
<ClinicalUseDefinition>
<id value="f35aa761-20e7-4e66-9ac6-2c4ab3d42507"/>
<meta>
<profile
value="http://hl7.org/fhir/uv/emedicinal-product-info/StructureDefinition/ClinicalUseDefinition-interaction-uv-epi"/>
</meta>
<text>
<status value="generated"/>
<div xmlns="http://www.w3.org/1999/xhtml"><a name="ClinicalUseDefinition_f35aa761-20e7-4e66-9ac6-2c4ab3d42507"> </a><p><b>Generated Narrative: ClinicalUseDefinition</b><a name="f35aa761-20e7-4e66-9ac6-2c4ab3d42507"> </a><a name="hcf35aa761-20e7-4e66-9ac6-2c4ab3d42507"> </a></p><div style="display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%"><p style="margin-bottom: 0px">Resource ClinicalUseDefinition "f35aa761-20e7-4e66-9ac6-2c4ab3d42507" </p><p style="margin-bottom: 0px">Profile: <a href="https://build.fhir.org/ig/HL7/emedicinal-product-info/StructureDefinition-ClinicalUseDefinition-interaction-uv-epi.html">ClinicalUseDefinition Interaction (ePI)</a></p></div><p><b>identifier</b>: <code>https://gsrs.ncats.nih.gov/ginas/app/beta</code>/83HN0GTJ6D (use: official)</p><p><b>type</b>: interaction</p><p><b>subject</b>: </p><ul><li>See on this page: MedicinalProductDefinition/mp01mg</li><li>See on this page: MedicinalProductDefinition/mp025mg</li><li>See on this page: MedicinalProductDefinition/mp1mg</li></ul><blockquote><p><b>interaction</b></p><h3>Interactants</h3><table class="grid"><tr><td style="display: none">-</td><td><b>Item[x]</b></td></tr><tr><td style="display: none">*</td><td>Ciclosporin <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (beta#83HN0GTJ6D)</span></td></tr></table></blockquote></div>
</text>
<identifier>
<use value="official"/>
<system value="https://gsrs.ncats.nih.gov/ginas/app/beta"/>
<value value="83HN0GTJ6D"/>
</identifier>
<type value="interaction"/>
<subject>
<reference value="MedicinalProductDefinition/mp01mg"/>
</subject>
<subject>
<reference value="MedicinalProductDefinition/mp025mg"/>
</subject>
<subject>
<reference value="MedicinalProductDefinition/mp1mg"/>
</subject>
<interaction>
<interactant>
<itemCodeableConcept>
<coding>
<system value="https://gsrs.ncats.nih.gov/ginas/app/beta"/>
<code value="83HN0GTJ6D"/>
<display value="Ciclosporin"/>
</coding>
</itemCodeableConcept>
</interactant>
</interaction>
</ClinicalUseDefinition>
</resource>
</entry>
<entry>
<fullUrl value="ClinicalUseDefinition/interactionLapatinib"/>
<resource>
<ClinicalUseDefinition>
<id value="5c6da0df-7747-490c-8ae4-93d8883b059b"/>
<meta>
<profile
value="http://hl7.org/fhir/uv/emedicinal-product-info/StructureDefinition/ClinicalUseDefinition-interaction-uv-epi"/>
</meta>
<text>
<status value="generated"/>
<div xmlns="http://www.w3.org/1999/xhtml"><a name="ClinicalUseDefinition_5c6da0df-7747-490c-8ae4-93d8883b059b"> </a><p><b>Generated Narrative: ClinicalUseDefinition</b><a name="5c6da0df-7747-490c-8ae4-93d8883b059b"> </a><a name="hc5c6da0df-7747-490c-8ae4-93d8883b059b"> </a></p><div style="display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%"><p style="margin-bottom: 0px">Resource ClinicalUseDefinition "5c6da0df-7747-490c-8ae4-93d8883b059b" </p><p style="margin-bottom: 0px">Profile: <a href="https://build.fhir.org/ig/HL7/emedicinal-product-info/StructureDefinition-ClinicalUseDefinition-interaction-uv-epi.html">ClinicalUseDefinition Interaction (ePI)</a></p></div><p><b>identifier</b>: <code>https://gsrs.ncats.nih.gov/ginas/app/beta</code>/0VUA21238F (use: official)</p><p><b>type</b>: interaction</p><p><b>subject</b>: </p><ul><li>See on this page: MedicinalProductDefinition/mp01mg</li><li>See on this page: MedicinalProductDefinition/mp025mg</li><li>See on this page: MedicinalProductDefinition/mp1mg</li></ul><blockquote><p><b>interaction</b></p><h3>Interactants</h3><table class="grid"><tr><td style="display: none">-</td><td><b>Item[x]</b></td></tr><tr><td style="display: none">*</td><td>Lapatinib <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (beta#0VUA21238F)</span></td></tr></table></blockquote></div>
</text>
<identifier>
<use value="official"/>
<system value="https://gsrs.ncats.nih.gov/ginas/app/beta"/>
<value value="0VUA21238F"/>
</identifier>
<type value="interaction"/>
<subject>
<reference value="MedicinalProductDefinition/mp01mg"/>
</subject>
<subject>
<reference value="MedicinalProductDefinition/mp025mg"/>
</subject>
<subject>
<reference value="MedicinalProductDefinition/mp1mg"/>
</subject>
<interaction>
<interactant>
<itemCodeableConcept>
<coding>
<system value="https://gsrs.ncats.nih.gov/ginas/app/beta"/>
<code value="0VUA21238F"/>
<display value="Lapatinib"/>
</coding>
</itemCodeableConcept>
</interactant>
</interaction>
</ClinicalUseDefinition>
</resource>
</entry>
<entry>
<fullUrl value="ClinicalUseDefinition/interactionCurcumin"/>
<resource>
<ClinicalUseDefinition>
<id value="36fe191e-1b9c-11ee-be56-0242ac120002"/>
<meta>
<profile
value="http://hl7.org/fhir/uv/emedicinal-product-info/StructureDefinition/ClinicalUseDefinition-interaction-uv-epi"/>
</meta>
<text>
<status value="generated"/>
<div xmlns="http://www.w3.org/1999/xhtml"><a name="ClinicalUseDefinition_36fe191e-1b9c-11ee-be56-0242ac120002"> </a><p><b>Generated Narrative: ClinicalUseDefinition</b><a name="36fe191e-1b9c-11ee-be56-0242ac120002"> </a><a name="hc36fe191e-1b9c-11ee-be56-0242ac120002"> </a></p><div style="display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%"><p style="margin-bottom: 0px">Resource ClinicalUseDefinition "36fe191e-1b9c-11ee-be56-0242ac120002" </p><p style="margin-bottom: 0px">Profile: <a href="https://build.fhir.org/ig/HL7/emedicinal-product-info/StructureDefinition-ClinicalUseDefinition-interaction-uv-epi.html">ClinicalUseDefinition Interaction (ePI)</a></p></div><p><b>identifier</b>: <code>https://gsrs.ncats.nih.gov/ginas/app/beta</code>/IT942ZTH98 (use: official)</p><p><b>type</b>: interaction</p><p><b>subject</b>: </p><ul><li>See on this page: MedicinalProductDefinition/mp01mg</li><li>See on this page: MedicinalProductDefinition/mp025mg</li><li>See on this page: MedicinalProductDefinition/mp1mg</li></ul><blockquote><p><b>interaction</b></p><h3>Interactants</h3><table class="grid"><tr><td style="display: none">-</td><td><b>Item[x]</b></td></tr><tr><td style="display: none">*</td><td>Curcumin <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (beta#IT942ZTH98)</span></td></tr></table></blockquote></div>
</text>
<identifier>
<use value="official"/>
<system value="https://gsrs.ncats.nih.gov/ginas/app/beta"/>
<value value="IT942ZTH98"/>
</identifier>
<type value="interaction"/>
<subject>
<reference value="MedicinalProductDefinition/mp01mg"/>
</subject>
<subject>
<reference value="MedicinalProductDefinition/mp025mg"/>
</subject>
<subject>
<reference value="MedicinalProductDefinition/mp1mg"/>
</subject>
<interaction>
<interactant>
<itemCodeableConcept>
<coding>
<system value="https://gsrs.ncats.nih.gov/ginas/app/beta"/>
<code value="IT942ZTH98"/>
<display value="Curcumin"/>
</coding>
</itemCodeableConcept>
</interactant>
</interaction>
</ClinicalUseDefinition>
</resource>
</entry>
<entry>
<fullUrl value="ClinicalUseDefinition/interactionCarbamazepine"/>
<resource>
<ClinicalUseDefinition>
<id value="c579a16e-deaf-47b7-a9ba-19b0f2396e0f"/>
<meta>
<profile
value="http://hl7.org/fhir/uv/emedicinal-product-info/StructureDefinition/ClinicalUseDefinition-interaction-uv-epi"/>
</meta>
<text>
<status value="generated"/>
<div xmlns="http://www.w3.org/1999/xhtml"><a name="ClinicalUseDefinition_c579a16e-deaf-47b7-a9ba-19b0f2396e0f"> </a><p><b>Generated Narrative: ClinicalUseDefinition</b><a name="c579a16e-deaf-47b7-a9ba-19b0f2396e0f"> </a><a name="hcc579a16e-deaf-47b7-a9ba-19b0f2396e0f"> </a></p><div style="display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%"><p style="margin-bottom: 0px">Resource ClinicalUseDefinition "c579a16e-deaf-47b7-a9ba-19b0f2396e0f" </p><p style="margin-bottom: 0px">Profile: <a href="https://build.fhir.org/ig/HL7/emedicinal-product-info/StructureDefinition-ClinicalUseDefinition-interaction-uv-epi.html">ClinicalUseDefinition Interaction (ePI)</a></p></div><p><b>identifier</b>: <code>https://gsrs.ncats.nih.gov/ginas/app/beta</code>/33CM23913M (use: official)</p><p><b>type</b>: interaction</p><p><b>subject</b>: </p><ul><li>See on this page: MedicinalProductDefinition/mp01mg</li><li>See on this page: MedicinalProductDefinition/mp025mg</li><li>See on this page: MedicinalProductDefinition/mp1mg</li></ul><blockquote><p><b>interaction</b></p><h3>Interactants</h3><table class="grid"><tr><td style="display: none">-</td><td><b>Item[x]</b></td></tr><tr><td style="display: none">*</td><td>Carbamazepine <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (beta#33CM23913M)</span></td></tr></table></blockquote></div>
</text>
<identifier>
<use value="official"/>
<system value="https://gsrs.ncats.nih.gov/ginas/app/beta"/>
<value value="33CM23913M"/>
</identifier>
<type value="interaction"/>
<subject>
<reference value="MedicinalProductDefinition/mp01mg"/>
</subject>
<subject>
<reference value="MedicinalProductDefinition/mp025mg"/>
</subject>
<subject>
<reference value="MedicinalProductDefinition/mp1mg"/>
</subject>
<interaction>
<interactant>
<itemCodeableConcept>
<coding>
<system value="https://gsrs.ncats.nih.gov/ginas/app/beta"/>
<code value="33CM23913M"/>
<display value="Carbamazepine"/>
</coding>
</itemCodeableConcept>
</interactant>
</interaction>
</ClinicalUseDefinition>
</resource>
</entry>
<entry>
<fullUrl value="ClinicalUseDefinition/interactionphenytoin"/>
<resource>
<ClinicalUseDefinition>
<id value="323b0573-7a65-4747-a2d4-0077092b1845"/>
<meta>
<profile
value="http://hl7.org/fhir/uv/emedicinal-product-info/StructureDefinition/ClinicalUseDefinition-interaction-uv-epi"/>
</meta>
<text>
<status value="generated"/>
<div xmlns="http://www.w3.org/1999/xhtml"><a name="ClinicalUseDefinition_323b0573-7a65-4747-a2d4-0077092b1845"> </a><p><b>Generated Narrative: ClinicalUseDefinition</b><a name="323b0573-7a65-4747-a2d4-0077092b1845"> </a><a name="hc323b0573-7a65-4747-a2d4-0077092b1845"> </a></p><div style="display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%"><p style="margin-bottom: 0px">Resource ClinicalUseDefinition "323b0573-7a65-4747-a2d4-0077092b1845" </p><p style="margin-bottom: 0px">Profile: <a href="https://build.fhir.org/ig/HL7/emedicinal-product-info/StructureDefinition-ClinicalUseDefinition-interaction-uv-epi.html">ClinicalUseDefinition Interaction (ePI)</a></p></div><p><b>identifier</b>: <code>https://gsrs.ncats.nih.gov/ginas/app/beta</code>/6158TKW0C5 (use: official)</p><p><b>type</b>: interaction</p><p><b>subject</b>: </p><ul><li>See on this page: MedicinalProductDefinition/mp01mg</li><li>See on this page: MedicinalProductDefinition/mp025mg</li><li>See on this page: MedicinalProductDefinition/mp1mg</li></ul><blockquote><p><b>interaction</b></p><h3>Interactants</h3><table class="grid"><tr><td style="display: none">-</td><td><b>Item[x]</b></td></tr><tr><td style="display: none">*</td><td>phenytoin <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (beta#6158TKW0C5)</span></td></tr></table></blockquote></div>
</text>
<identifier>
<use value="official"/>
<system value="https://gsrs.ncats.nih.gov/ginas/app/beta"/>
<value value="6158TKW0C5"/>
</identifier>
<type value="interaction"/>
<subject>
<reference value="MedicinalProductDefinition/mp01mg"/>
</subject>
<subject>
<reference value="MedicinalProductDefinition/mp025mg"/>
</subject>
<subject>
<reference value="MedicinalProductDefinition/mp1mg"/>
</subject>
<interaction>
<interactant>
<itemCodeableConcept>
<coding>
<system value="https://gsrs.ncats.nih.gov/ginas/app/beta"/>
<code value="6158TKW0C5"/>
<display value="phenytoin"/>
</coding>
</itemCodeableConcept>
</interactant>
</interaction>
</ClinicalUseDefinition>
</resource>
</entry>
<entry>
<fullUrl value="ClinicalUseDefinition/interactionHypericumperforatum"/>
<resource>
<ClinicalUseDefinition>
<id value="e66ad89e-0f85-48f0-833f-dbf95ea270af"/>
<meta>
<profile
value="http://hl7.org/fhir/uv/emedicinal-product-info/StructureDefinition/ClinicalUseDefinition-interaction-uv-epi"/>
</meta>
<text>
<status value="generated"/>
<div xmlns="http://www.w3.org/1999/xhtml"><a name="ClinicalUseDefinition_e66ad89e-0f85-48f0-833f-dbf95ea270af"> </a><p><b>Generated Narrative: ClinicalUseDefinition</b><a name="e66ad89e-0f85-48f0-833f-dbf95ea270af"> </a><a name="hce66ad89e-0f85-48f0-833f-dbf95ea270af"> </a></p><div style="display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%"><p style="margin-bottom: 0px">Resource ClinicalUseDefinition "e66ad89e-0f85-48f0-833f-dbf95ea270af" </p><p style="margin-bottom: 0px">Profile: <a href="https://build.fhir.org/ig/HL7/emedicinal-product-info/StructureDefinition-ClinicalUseDefinition-interaction-uv-epi.html">ClinicalUseDefinition Interaction (ePI)</a></p></div><p><b>identifier</b>: <code>https://gsrs.ncats.nih.gov/ginas/app/beta</code>/UFH8805FKA (use: official)</p><p><b>type</b>: interaction</p><p><b>subject</b>: </p><ul><li>See on this page: MedicinalProductDefinition/mp01mg</li><li>See on this page: MedicinalProductDefinition/mp025mg</li><li>See on this page: MedicinalProductDefinition/mp1mg</li></ul><blockquote><p><b>interaction</b></p><h3>Interactants</h3><table class="grid"><tr><td style="display: none">-</td><td><b>Item[x]</b></td></tr><tr><td style="display: none">*</td><td>St. John’s wort (Hypericum perforatum) <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (beta#UFH8805FKA)</span></td></tr></table></blockquote></div>
</text>
<identifier>
<use value="official"/>
<system value="https://gsrs.ncats.nih.gov/ginas/app/beta"/>
<value value="UFH8805FKA"/>
</identifier>
<type value="interaction"/>
<subject>
<reference value="MedicinalProductDefinition/mp01mg"/>
</subject>
<subject>
<reference value="MedicinalProductDefinition/mp025mg"/>
</subject>
<subject>
<reference value="MedicinalProductDefinition/mp1mg"/>
</subject>
<interaction>
<interactant>
<itemCodeableConcept>
<coding>
<system value="https://gsrs.ncats.nih.gov/ginas/app/beta"/>
<code value="UFH8805FKA"/>
<display value="St. John’s wort (Hypericum perforatum)"/>
</coding>
</itemCodeableConcept>
</interactant>
</interaction>
</ClinicalUseDefinition>
</resource>
</entry>
<entry>
<fullUrl value="ClinicalUseDefinition/interactionturmericroot"/>
<resource>
<ClinicalUseDefinition>
<id value="976b30de-f1a2-4d9c-9351-c4087206cbf1"/>
<meta>
<profile
value="http://hl7.org/fhir/uv/emedicinal-product-info/StructureDefinition/ClinicalUseDefinition-interaction-uv-epi"/>
</meta>
<text>
<status value="generated"/>
<div xmlns="http://www.w3.org/1999/xhtml"><a name="ClinicalUseDefinition_976b30de-f1a2-4d9c-9351-c4087206cbf1"> </a><p><b>Generated Narrative: ClinicalUseDefinition</b><a name="976b30de-f1a2-4d9c-9351-c4087206cbf1"> </a><a name="hc976b30de-f1a2-4d9c-9351-c4087206cbf1"> </a></p><div style="display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%"><p style="margin-bottom: 0px">Resource ClinicalUseDefinition "976b30de-f1a2-4d9c-9351-c4087206cbf1" </p><p style="margin-bottom: 0px">Profile: <a href="https://build.fhir.org/ig/HL7/emedicinal-product-info/StructureDefinition-ClinicalUseDefinition-interaction-uv-epi.html">ClinicalUseDefinition Interaction (ePI)</a></p></div><p><b>identifier</b>: <code>https://gsrs.ncats.nih.gov/ginas/app/beta</code>/856YO1Z64F (use: official)</p><p><b>type</b>: interaction</p><p><b>subject</b>: </p><ul><li>See on this page: MedicinalProductDefinition/mp01mg</li><li>See on this page: MedicinalProductDefinition/mp025mg</li><li>See on this page: MedicinalProductDefinition/mp1mg</li></ul><blockquote><p><b>interaction</b></p><h3>Interactants</h3><table class="grid"><tr><td style="display: none">-</td><td><b>Item[x]</b></td></tr><tr><td style="display: none">*</td><td>turmeric root <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (beta#856YO1Z64F)</span></td></tr></table></blockquote></div>
</text>
<identifier>
<use value="official"/>
<system value="https://gsrs.ncats.nih.gov/ginas/app/beta"/>
<value value="856YO1Z64F"/>
</identifier>
<type value="interaction"/>
<subject>
<reference value="MedicinalProductDefinition/mp01mg"/>
</subject>
<subject>
<reference value="MedicinalProductDefinition/mp025mg"/>
</subject>
<subject>
<reference value="MedicinalProductDefinition/mp1mg"/>
</subject>
<interaction>
<interactant>
<itemCodeableConcept>
<coding>
<system value="https://gsrs.ncats.nih.gov/ginas/app/beta"/>
<code value="856YO1Z64F"/>
<display value="turmeric root"/>
</coding>
</itemCodeableConcept>
</interactant>
</interaction>
</ClinicalUseDefinition>
</resource>
</entry>
</Bundle>
IG © 2022+ . Package hl7.fhir.uv.epi-test#0.1.0 based on FHIR 5.0.0. Generated 2024-04-04
Links: Table of Contents |
QA Report
The Gravitate Health project has received funding from the IMI 2 Joint Undertaking under grant agreement No 945334.
This joint undertaking receives support from the EU H2020 research and innovation programme and EFPIA.
